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Fear is an adaptive emotional response to threatening situations that is crucial for the survival 
of the individual. In human anxiety disorders, such as social anxiety disorder (SAD) and post-
traumatic stress disorder (PTSD), fear is unreasonable and excessive and becomes, therefore, 
maladaptive. SAD and PTSD are both characterized by debilitating fear and avoidance of 
fearful situations. These patients show similar dysfunctions in the activity of the brain regions 
implicated in the fear circuitry and are treated with similar psycho- and pharmacotherapy. 
However, the medication for SAD and PTSD is rather unspecific and, despite considerable 
efforts, their efficacy is unsatisfactory. The neuropeptide oxytocin (OT) has been suggested as 
a possible therapeutic agent for SAD and PTSD, as it facilitates a wide variety of social 
behaviors and decreases stress and anxiety in both humans and rodents.  
As the fear responses, the fear circuitry, and the behavioral and physiological effects of OT 
are highly conserved among mammalian species, findings from animal models of SAD and 
PTSD might provide important information for clinical trials using OT. The cued fear 
conditioning paradigm has proven to be a powerful model to study the normal and 
pathological processes involved in fear learning and extinction (the gradual decrease in the 
fear response as result of repeated exposure to the feared situation), and models some 
symptoms of PTSD. This paradigm implies exposing animals to a well-defined cue, usually a 
tone or light, which co-terminates with a foot shock, and results in specific fear of this certain 
cue. Although several paradigms have been shown to induce social avoidance and fear in 
addition to other behavioral deficits, there are no appropriate and specific animal models 
available to study SAD.    
Therefore, the three main aims of this thesis were (1) to develop and validate an animal model 
that mimics the main behavioral symptom of SAD, namely social fear and avoidance, and (2) 
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to use this paradigm, which I termed “social fear conditioning”, to assess the therapeutic 
efficacy of OT in reversing social fear. Finally, in order to compare OT effects on social and 
non-social fear, I aimed (3) to assess the effects of OT in cued fear in an animal model of 
PTSD, i.e. the cued fear conditioning paradigm.  
I could show that specific social fear can be induced in naïve mice by administering electric 
foot shocks when they approach and actively investigate a con-specific, i.e. a social stimulus. 
Social fear was expressed as reduced investigation of unfamiliar social stimuli and aversive 
responses towards them, such as freezing, stretched approaches, and defensive burying. 
Furthermore, the social fear was expressed for at least two weeks and sensitized over time; it 
was only triggered by social stimuli and did not lead to other behavioral deficits, such as fear 
of novelty, general anxiety, depression, or impaired locomotion. Moreover, I could 
demonstrate the predictive validity of the social fear conditioning model by showing that 
social fear is reversed by acute diazepam and chronic paroxetine treatment, pharmacotherapy 
currently used in SAD patients.  
Having achieved the first aim, I could then show that central infusion of synthetic OT before 
the extinction procedure, which would be the comparable time-point for psychotherapy in 
SAD and PTSD patients, reversed social fear, but impaired extinction of cued fear, indicating 
that OT might represent a promising therapeutic approach for SAD, but not PTSD patients 
when administered at this time-point. Both the reversing effect on social fear and the 
impairing effect on cued fear extinction were mediated by the OT receptors (OTR), as central 
administration of an OT receptor antagonist (OTR-A) prior to OT blocked the observed 
effects. Furthermore, blockade of OT neurotransmission with OTR-A before the extinction 
procedure impaired social investigation in unconditioned animals, indicating that the 
endogenous OT system is needed for naturally-occurring social investigation. In contrast, 
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blockade of OT neurotransmission at this same time-point did not affect cued fear extinction, 
indicating that the endogenous OT system is not involved in this process. 
Administration of OT before cued fear conditioning, however, facilitated, whereas OTR-A 
impaired cued fear extinction 24 h later, indicating that an activated endogenous OT system 
during traumatic events is likely to attenuate formation of fear memories. As both the 
conditioning and extinction procedure involve learning, these results suggest that exogenous 
OT impairs learning processes that occur during non-social fearful situations.  
In an attempt to identify the neurocircuitry of social fear, I could show that social fear was 
accompanied by alterations in the brain OT system at the level of the limbic system, namely 
by an increased OTR binding in the bilateral dorso-lateral septum (DLS), right central 
amygdala, and right hippocampus (dentate gyrus, cornu ammunis 1). Importantly, these 
alterations normalized after extinction of social fear, suggesting that OTR expression within 
these brain regions might be involved in the development and/or neural support of social fear. 
Based on these OTR alterations, I could localize the effects of OT on social fear within the 
DLS by bilateral administration. 
Taken together, I could show that OT has a differential effect on social versus cued fear in 
rodents, at least when administered before the extinction procedure. This result raises 
attention to the importance of the feared situation when recommending OT for the treatment 
of SAD and PTSD. Thus, OT represents a promising therapeutic approach for disorders 
associated with social deficits, such as SAD and possibly PTSD due to social trauma, but 
caution is needed before recommending OT for the treatment of PTSD due to non-social 
trauma. Furthermore, I could identify the DLS as a part of the brain network involved in 
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Fear and anxiety are crucial emotional behaviors that are expressed to some degree in all 
chordates. Although many definitions exist, most of these agree that fear is a normal 
emotional response to a real external threat or danger, whereas anxiety is an emotional 
response to a potential threat or danger (McNaughton and Zangrossi, 2008). From an 
ethological perspective, both fear and anxiety are highly adaptive responses, whereas in 
modern psychiatry fear is generally regarded as adaptive, while anxiety is generally regarded 
as maladaptive. For the purposes of this thesis, the term “fear” will refer to a response to 
threat in both humans and animals. The term “anxiety” will refer to a pathological condition 
in humans, and to an unconditioned fear response (see Table 1) in animals.   
The behavioral patterns, functions, and mechanisms of fear and anxiety received intense 
scientific attention, mainly fueled by the desire to understand and ameliorate human anxiety 
disorders. In this chapter, I will shortly address the behavioral and physiological fear 
responses, as well as their function and underlying neural circuitry. I will describe the 
symptoms, current treatment, and some animal models used to study two highly prevalent 
anxiety disorders, namely social anxiety disorder (SAD) and post-traumatic stress disorder 
(PTSD). This description will highlight the need for more specific models to assess the 
etiology and treatment of these disorders in preclinical research and the rationale for using 
oxytocin (OT) in the treatment of SAD- and PTSD-like symptoms. 
1.1.     Fear and the fear response 
The current belief is that fears can be both innate and learned throughout life. From an 
evolutionary perspective, innate fears have been selected for across generations as they help 
an organism to adapt better to the environment and, therefore, survive. Startle responses to 
loud noises and eye blinking when objects rapidly approach the eye are examples of innate 
fears. Fear can also be learned by direct experience, by observing the experiences of others, or 
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by verbal instruction. In humans and monkeys, for example, although fear of snakes is not 
innate, it can develop by getting attacked, observing a con-specific being attacked, or, at least 
in humans, by being told that snakes are dangerous.   
Activation of the fear system leads to a series of behavioral and physiological responses 
which are highly conserved among mammals, highlighting their evolutionary importance. 
These responses function to remove the organism from the threat, so called escape behaviors, 
or to prevent the organism from entering or re-entering a dangerous situation, so called 
avoidant behaviors. The behavioral responses have been characterized in a variety of species 
and include flight, avoidance, freezing, defensive threat, defensive attack, and risk assessment 
(Edmunds, 1974; Blanchard et al., 2003). Burying novel, aversive or potentially dangerous 
objects (Treit et al., 1981), alarm cries (Litvin et al., 2007), and cessation of ongoing behavior 
(Estes and Skinner, 1941; Brady and Hunt, 1951) have also been described. The physiological 
responses to threat include activation of the autonomic nervous system (Schneidermann et al., 
1974; Cohen and Randall, 1984), release of stress hormones (Mason et al., 1961; Korte et al., 
1992), pain suppression (Watkins and Mayer, 1982), and potentiation of somatic reflexes such 
as startle (Davis, 1986) and eyeblink (Weisz and McInerney, 1990). All these responses are 
innate and have evolved to increase the chance of survival and to reduce harm to the 
threatened individual. The freezing response, for example, reduces the likelihood of attack for 
two reasons. First, if the predator has not yet spotted the prey, it is more difficult to detect 
when motionless, and second, even if the prey is detected, it is less likely to be attacked if 
motionless (Fanselow and Lester, 1988). Defensive threat and attack reduce predation by 
signaling the intention to attack or by actually hurting the predator (Cowlishaw, 1994). Risk 
assessment enables the individual to assess the characteristics of a threatening stimulus or to 
determine whether a threat is present or not (Pinel et al., 1989), whereas defensive burying 
may reduce the risk of accidental contact with potentially harmful stimuli (Pinel et al., 1989). 
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Fear responses are therefore adaptive, as they protect the individual from life-threatening 
situations and improve the evolutionary fitness of a species.  
In the context of human pathology, however, fear responses become maladaptive as they are 
inappropriately activated by innocuous stimuli, or are activated in an excessive, recurring, or 
prolonged way. Excessive and debilitating fear is a prominent symptom in many anxiety 
disorders, such as generalized anxiety disorder, SAD, specific phobia, obsessive-compulsive 
disorder, panic disorder, and PTSD. As SAD and PTSD are the most relevant anxiety 
disorders for my thesis, I will describe them in more detail.  
1.2.     Social anxiety disorder 
SAD has been defined as a "marked and persistent fear of one or more social or performance 
situations in which the person is exposed to unfamiliar people or possible scrutiny by others” 
in the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV; 
American Psychiatric Association, 1994). SAD patients often avoid the feared social 
situations or else endure them with intense anxiety and distress. Epidemiologically, SAD is 
the second most common anxiety disorder after specific phobia, with a 12-month and lifetime 
prevalence of 6.8% and 12.1%, respectively (Kessler et al., 2005a,b), and is more prevalent in 
women than in men (Schneier et al., 1992; Talepasand and Nokani, 2010). Two subtypes of 
SAD can currently be diagnosed according to DSM-IV criteria, namely specific and 
generalized SAD. Specific SAD involves fear and avoidance of a particular social situation 
and includes performance anxiety (e.g. fear of public speaking, eating or drinking in public), 
interaction anxiety (fear of social interaction and observation situations), and fear of showing 
anxiety symptoms (Bögels et al., 2010). Patients with generalized SAD are more impaired as 
they fear and avoid a wide range of social situations (den Boer, 1997; Kessler et al., 1998; 
Ruipérez et al., 2002). The avoidant behavior is often the greatest impairment in SAD and 
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ranges from subtle safety behavior, such as avoidance of eye contact, to avoidance of all 
interpersonal contact outside the family. Moreover, the avoidant behavior plays a critical role 
in the maintenance of SAD and prevents the reversal of fear in social situations (American 
Psychiatric Association, 1994; Stangier et al., 2006). The majority of SAD patients report at 
least one other psychiatric disorder, such as agoraphobia (Magee et al., 1996), depression 
(Schneier et al., 1992; Regier et al., 1998), or substance abuse (Schneier et al., 2010; Regier et 
al., 1998). However, SAD generally precedes all these disorders, indicating that SAD is a 
major risk factor for developing additional psychiatric disorders and that the comorbid 
disorders are secondary to the main SAD symptoms.  
1.3.     Post-traumatic stress disorder 
PTSD is a severe anxiety disorder that can develop after exposure to an event that results in 
psychological trauma and is characterized by persistent re-experiencing of the trauma through 
flashbacks or nightmares, avoidance of stimuli associated with the trauma, and hyper-arousal. 
Although the consequences of severe trauma have been described since ancient times and 
several war-related syndromes were reported after the World Wars (Jones, 1995), PTSD has 
only been officially categorized as an anxiety disorder in DSM-III (American Psychiatric 
Association, 1980). Epidemiologically, PTSD is the third most common anxiety disorder, 
with a 12-month and lifetime prevalence of 3.5% and 6.8%, respectively (Kessler et al., 
2005a,b), and, like SAD, is more prevalent in women than in men (Kessler et al., 1995; 
Breslau et al., 1998). The type of trauma is an important predictor of PTSD, as individuals 
who experienced assaultive violence, especially rape and physical assault, are more likely to 
develop PTSD than individuals who experienced other types of trauma, such as natural 
disasters (Kilpatrick et al., 1989; Rothbaum et al., 1992; Breslau et al., 1998). PTSD patients 
who experienced assaultive violence often show impaired social interaction and emotional 
reward in addition to the main symptoms (Olff et al., 2010). Like SAD, PTSD is a highly 
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comorbid anxiety disorder, with depression, substance abuse, and specific phobia being the 
most common comorbid diagnoses (Kessler et al., 1995). However, unlike SAD, it is not clear 
which diagnosis occurred first. Estimates provided by Kessler et al., 1995 suggest that while 
PTSD often precedes other comorbid diagnoses, it usually succeeds at least one diagnosis.  
1.4.     Neurocircuitry of SAD and PTSD 
Given that excessive fear and avoidance of fearful situations are key components of both SAD 
and PTSD, it is not surprising that the neurocircuitry of these disorders show considerable 
overlap. A series of neuroimaging studies identified the amygdala, medial prefrontal cortex 
(mPFC), and hippocampus as the most important brain regions mediating learned fear 
responses in healthy humans (see Figure 1). These same brain regions are often dysfunctional 
in SAD and PTSD, as demonstrated by symptom provocation and cognitive-emotional 
studies. Symptom provocation studies are designed to elicit fear responses by public speaking 
anticipation and/or performance (SAD) or by specifically recalling a traumatic event (PTSD), 
whereas cognitive-emotional studies involve exposure to emotional stimuli, such as fearful or 
angry faces, to study generalization of fear responses. These studies indicate that the 
amygdala, an almond-shaped group of nuclei involved in the perception, learning, and 
expression of fear (Fanselow and LeDoux, 1999), is hyperactive in both SAD (Tillfors et al., 
2001; Lorberbaum et al., 2004; Phan et al., 2006; Guyer et al., 2008) and PTSD (Shin et al., 
1997; Liberzon et al., 1999; Rauch et al., 2000; Pissiota et al., 2002) patients, which might 
account for exaggerated fear responses and persistence of traumatic memories.  
The mPFC, a brain region involved in decision making, goal-directed behavior, and working 
memory (Vertes, 2004), regulates amygdala output and, thereby, the fear response. More 
specifically, a region in the ventral part of the mPFC (vmPFC), the infralimbic cortex (IL), 
inhibits amygdala output and fear expression, whereas a region in the dorsal part of the mPFC 
General introduction                       10  
 
 
(dmPFC), the prelimibic cortex (PL), increases amygdala output and promotes fear expression 
(Sotres-Bayon and Quirk, 2010). Accordingly, symptom provocation and cognitive-emotional 
studies indicate that the vmPFC is hypoactive in PTSD patients (Bremner et al., 1999; 
Lindauer et al., 2004; Shin et al., 2004a; Yang et al., 2004; Hou et al., 2007) and fails to 
inhibit the amygdala, whereas the dmPFC shows either normal activity or hyperactivity 
(Bryant et al., 2005; Felmingham et al., 2009). It is not clear which of these dysfunctions is 
responsible for the overall outcome in PTSD patients, but a hyperactive amygdala coupled 
with a hypoactive vmPFC may lead to deficits in fear extinction and emotion regulation in 
these patients (Liberzon and Sripada, 2008). The involvement of vmPFC in SAD is less clear, 
with studies showing either hyperactivity (Guyer et al., 2008; Blair et al., 2010), or 
hypoactivity (Van Ameringen et al., 2004; Evans et al., 2009) of the vmPFC. Additionally, 
both SAD and PTSD patients show reduced functional connectivity between the amygdala 
and mPFC during resting-states (Hahn et al., 2011; Sripada et al., 2012), which may 
contribute to the pathological fear responses observed in these patients.  
The hippocampus, a brain region involved in declarative memory (Squire, 1992), processes 
information about the context, i.e. environment of a fearful situation (Kim et al., 1993). Its 
involvement in SAD and PTSD is less clear, with studies showing either hypoactivity of this 
region in SAD (Kilts et al., 2006) and PTSD (Bremner et al., 2003; Shin et al., 2004b) 
patients, or hyperactivity in SAD (Schneider et al., 1999) and PTSD (Thomaes et al., 2009; 
Werner et al., 2009) patients. The differences in brain activity between studies may relate to 
the type of task employed and the selection of patients, as both SAD and PTSD are highly 
heterogeneous anxiety disorders.   
Preclinical research using SAD- and PTSD-relevant animal models (see section 1.7. for more 
details) has identified that the same neurocircuity mediates learned fear responses in animals 
(especially rodents and primates; Figure 1), highlighting again the evolutionary importance of 
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the fear responses. Although human studies tend to focus on the amygdala, mPFC, and 
hippocampus, animal studies revealed additional brain regions, such as the striatum, lateral 
septum (LS), bed nucleus of the stria terminalis (BNST), dorsal raphe nucleus, and 
periaqueductal gray (Maren, 2001; Calandreau et al., 2007), which are critical either for 
recognition of a dangerous situation, fear learning, or for appropriate fear expression. 
Considering the highly conserved fear circuitry among mammals, these regions are likely to 
play an important role in humans as well.   
 
Figure 1. Simplified 
diagram depicting the 
major components of 
the fear circuitry. The 
amygdala is the central 
component of the fear 
circuitry. The lateral 
amygdala (LA) receives 
sensory information 
from the thalamus and 
sensory cortex. The tha- 
lamo-amygdala pathway sends rapid and crude information about the fear-eliciting stimulus without filtering by 
conscious control. The cortico-amygdala pathway provides slower, but more detailed sensory information. The 
LA also receives information about the context of the fear-eliciting stimulus from the hippocampus either 
directly or indirectly through the perirhinal, entorhinal, and parahippocampal cortices. The LA projects to the 
central amygdala (CeA) either directly or indirectly through the basal amygdala (BA). The LA and BA also 
project to the intercalated (ITC) cell masses, a GABAergic neuronal network that inhibits the CeA when 
activated. The CeA mediates fear responses through projections to the hypothalamus and brainstem. The 
expression of fear is regulated by the medial prefrontal cortex (mPFC) via projections to the LA, BA, and ITC. A 
region in the dorsal part of the mPFC, the prelimbic cortex (PL), projects to the BA, which excites the CeA, 
thereby promoting fear expression, whereas a region in the ventral part of the mPFC, the infralimbic cortex (IL), 
projects to ITC, which inhibits the CeA, and, thereby, fear expression. Red lines indicate pathways that promote 
CeA output, green lines indicate pathways that dampen CeA output, and black lines provide input to or output 
from the amygdala. 
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1.5.     Treatment of SAD and PTSD 
The best treatment outcomes in both SAD and PTSD patients are obtained with cognitive-
behavioral therapy (Gould et al., 1997; Fedoroff and Taylor, 2001), a psychotherapeutic 
approach where the maladaptive thoughts that produce and maintain anxiety are identified and 
replaced with more realistic and positive thoughts, thereby reducing emotional distress. One 
of the techniques used in cognitive-behavioral therapy is exposure therapy, which leads to a 
gradual fear extinction, i.e. a decline in the fear response as a result of repeated exposure to 
the feared situation. This psychotherapy is often combined with a rather unspecific 
pharmacotherapy, originally designed for generalized anxiety or depression, such as 
benzodiazepines and antidepressants, with selective serotonin reuptake inhibitors (SSRIs) 
providing the best response rates in both SAD (Liebowitz et al., 1992; Baldwin et al., 1999; 
Van Ameringen et al., 2001) and PTSD (Marshall and Pierce, 2000; Stein et al., 2006, 2009) 
patients. Probably due to the insufficient understanding of these disorders and the unspecific 
medication, many SAD and PTSD patients fail to respond to the available treatment options, 
achieve only partial remission of symptoms, or show a high relapse rate after treatment 
discontinuation (Blanco et al., 2002; Davidson et al., 2004; Bisson et al., 2007; Brunello et al., 
2001; Ipser et al., 2006). Novel therapeutic strategies make use of cognitive enhancers, which 
are administered either before the psychotherapy session to increase learning, or immediately 
after the psychotherapy session to facilitate the consolidation of the “safety” memory trained 
during the session. For example, augmentation of exposure therapy with D-cycloserine, a 
glutamatergic N-methyl-d-aspartate receptor agonist, was shown to improve some anxiety 
symptoms in both SAD (Hofmann et al., 2006; Guastella et al., 2008) and PTSD (Heresco-
Levy et al., 2002; de Kleine et al., 2012) patients. Brain neuropeptide systems, such as OT, 
arginine vasopressin (AVP), neuropeptide Y, neuropeptide S (NPS), and substance P (Fendt 
et al., 2010; Viero et al., 2010; Meyer-Lindenberg et al., 2011; Bowers et al., 2012; Dunlop et 
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al., 2012), characterized by discrete neuropeptide synthesis and release sites, distinct receptor 
distribution, and multiple behavioral functions, represent other interesting research candidates 
with respect to both pathophysiology and treatment of SAD and PTSD. In this thesis, I 
investigated the effects of OT in two animal models of SAD and PTSD.  
1.6.     Oxytocin 
OT is a nine amino acid neuropeptide that has been recently proposed as a potential 
therapeutic agent for SAD (Heinrichs et al., 2003; Kirsch et al., 2005; Labuschagne et al., 
2010) and PTSD (Olff et al., 2010) due to its pro-social, anxiolytic, and stress-attenuating 
effects. OT is mainly synthesized in magnocellular neurons of the paraventricular (PVN) and 
supraoptic (SON) nuclei of the hypothalamus, which project to the posterior pituitary and 
release OT into the bloodstream (Swaab et al., 1975; Vandesande et al., 1975; Brownstein et 
al., 1980). OT is also synthesized in parvocellular neurons of the PVN, which project to the 
brainstem, spinal cord, and the limbic system (Swanson and McKellar, 1979; de Vries and 
Buijs, 1983; Wagner and Clemens, 1991). Centrally, OT is released within the PVN and SON 
(Moos et al., 1989; Russell et al., 1992; Neumann et al., 1993; Bosch et al., 2005) from 
dendrites or perikarya of magnocellular neurons (Ludwig and Leng, 2006), and within limbic 
regions, such as the septum, hippocampus, and central amygdala (CeA; Landgraf et al., 1988; 
Neumann and Landgraf, 1989; Ebner et al., 2000, 2005; Bosch et al., 2005) from axonal or 
collateral projections of parvocellular and magnocellular neurons. 
The effects of OT are mediated via one single type of OT receptor (OTR), which is a 
polypeptide with 7 transmembrane domains belonging to the G protein-coupled receptor 
family. OTR are widespread throughout the central nervous system, in regions such as the 
cortex, the olfactory system, the basal ganglia, limbic areas such as the BNST, septum, 
hippocampus, CeA, and ventral subiculum, the thalamus, hypothalamus, the brain stem, and 
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the spinal cord (Brinton et al., 1984; de Kloet et al., 1985; Elands et al., 1988; Tribollet et al., 
1988). Therefore, OT can exert its effects in all brain regions implicated in the fear circuitry 
so far (see section 1.4. and Figure 1), providing an important reason for studying its 
involvement in SAD and PTSD, especially in fear learning and extinction (see section 1.7.2. 
and Table 1). 
The reason for the interest in OT in relation with SAD and PTSD includes the fact that OT 
has been shown to exert pro-social, anxiolytic, and stress-attenuating effects both in rodents 
and humans. In more detail, OT facilitates a broad variety of social behaviors in rodents, 
including the onset and maintenance of maternal behavior in lactation (Pedersen and Prange, 
1979; Bosch et al., 2005), regulation of male and female sexual behavior (Arletti and 
Bertolini, 1985; Arletti et al., 1985; Waldherr and Neumann, 2007; Nyuyki et al., 2011), pair 
bonding in female voles (Williams et al., 1994), social preference (Lukas et al., 2011), and 
social recognition in male and female rodents (Popik and van Ree, 1991; Ferguson et al., 
2000; Choleris et al., 2003; Engelmann et al., 1998; Lukas, Toth et al., in press). In addition to 
these pro-social effects, both synthetic and endogenous OT exert anxiolytic properties in 
rodents (McCarthy et al., 1996; Waldherr and Neumann, 2007; Blume et al., 2008; Jurek et 
al., 2012), and inhibit the activity of the hypothalamic-pituitary-adrenal (HPA) axis (Windle 
et al., 1997; Neumann et al., 2000).  
Comparable effects have also been described in humans, where synthetic OT was shown to 
exert pro-social effects, such as increased trust and social risk-taking (Kosfeld et al., 2005; 
Baumgartner et al., 2008; Theodoridou et al., 2009; Mikolajczak et al., 2010a,b), increased 
attachment (Buchheim et al., 2009), cooperative behavior (Declerck et al., 2010), emotional 
and cognitive empathy (Bartz et al., 2010; Hurlemann et al., 2010), improved emotion 
recognition (Domes et al., 2007a; Savaskan et al., 2008) and memory for positive social 
information (i.e. happy faces, Di Simplicio et al., 2009; Rimmele et al., 2009; Marsh et al., 
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2010). Additionally, OT was shown to reduce the autonomic response to stress (Heinrichs et 
al., 2003; Kirsch et al., 2005; Kubzansky et al., 2009; Quirin et al., 2011), to decrease 
aversion to angry faces (Evans et al., 2010), and to increase positive communication during 
couple conflict (Ditzen et al., 2009). Imaging studies revealed that OT reduces the activity of 
the amygdala to painful stimulation (Singer et al., 2008), threatening faces and scenes (Kirsch 
et al., 2005; Domes et al., 2007b; Gamer et al., 2010), and conditioned faces (Petrovic et al., 
2008a). Although OT did not reduce anxiety symptoms in SAD patients (Kirsch et al., 2005; 
Domes et al., 2007b), it improved speech performance (Guastella et al., 2009) and dampened 
the hyperactivity of the amygdala to fearful faces (Labuschagne et al., 2010). In autistic 
patients, which are characterized by marked social deficits, OT was shown to increase social 
interaction (Andari et al., 2010), emotion recognition (Guastella et al., 2010), comprehension 
of affective speech (Hollander et al., 2007), and gaze to the eye region (Andari et al., 2010). 
More indirect evidence for the anxiolytic and antistress effects of OT in humans comes from 
nursing mothers who are calmer and less anxious during stressful situations, possibly due to 
high brain OT activity (Heinrichs et al., 2001; Carter et al., 2001; Slattery and Neumann, 
2008).  
As fear responses are highly conserved across species, studies on the neural basis of fear in 
experimental animals made important contribution to understanding the normal processes 
underlying fear responses. Importantly, the highly conserved fear circuitry combined with the 
highly conserved effects of OT among mammalian species suggests that findings from 
experimental animals might be translatable to humans. However, in order to understand the 
etiology and the underlying neurobiological mechanisms of pathological social and cued fear, 
which might in turn provide important information for the development of more specific 
medication for SAD and PTSD, animal models that mimic the main behavioral symptoms of 
these anxiety disorders are needed.  
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1.7.     Animal models used to study SAD and PTSD 
As both SAD and PTSD are complex anxiety disorders with strong psychological 
components, animal models cannot mimic these disorders in their entire complexity. 
However, although human performance anxiety and fear of showing anxiety symptoms (see 
section 1.2.) cannot be reliably modeled in laboratory animals, several paradigms have been 
shown to induce severe behavioral deficits in rodents, including social avoidance and fear, 
and can be used to model human interaction anxiety. These paradigms include social defeat 
(Huhman, 2006; Yan et al., 2010), conditioned defeat (Hammack et al., 2012), foot-shock 
exposure (Haller and Bakos, 2002; Louvart et al., 2005), maternal separation (Franklin et al., 
2011), and restraint stress (Gehlert et al., 2005; Doremus-Fitzwater et al., 2010). Among the 
animal models used to study PTSD, cued and context fear conditioning (Sanders et al., 2003), 
active and passive avoidance (Kovács et al., 1979; Ibragimov, 1990), predator and predator 
scent exposure (Adamec and Shallow, 1993, Takahashi et al., 2008), and fear potentiated 
startle (Davis, 1986) have proven to be powerful models to study the neural circuitries and 
mechanisms involved in fear learning and, perhaps more importantly, in fear extinction. As 
social defeat and cued fear conditioning are the most relevant models for my thesis, I will 
describe these two paradigms in more detail. For more details about the other models, please 
see the following reviews: Davis, 1986; Korte, 2001; Sanders et al., 2003; Henn and 
Vollmayr, 2005; Takahashi et al., 2008; Kikusui and Mori, 2009; Hammack et al., 2012. 
1.7.1.      Social defeat  
The social defeat paradigm was established by Klaus Miczek (1979) and consists of placing a 
smaller animal in the home cage of a larger aggressive male, which defends its territory and 
defeats the experimental animal, forming thereby a typical dominant-subordinate relationship. 
This procedure can be performed once, i.e. acute social defeat, or repeatedly using several 
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dominant males, i.e. chronic social defeat (Huhman, 2006; Yan et al., 2010). Both acute and 
chronic social defeat result in persistent fear and avoidance of con-specifics, however, the 
severity of the induced behavioral alterations depends on the type and length of the defeat. 
Acute social defeat induces avoidance only of the dominant con-specific that performed the 
defeat (Lai et al., 2005; Lukas et al., 2011) and is, therefore, less relevant as an animal model 
of SAD. Chronic social defeat, on the other hand, induces a general avoidance of con-
specifics (Avgustinovich et al., 2005; Berton et al., 2006), which makes this model a powerful 
tool to study the neural circuitries underlying social fear. However, chronic social defeat also 
induces a large variety of behavioral and physiological alterations, such as increased general 
anxiety (Keeney and Hogg, 1999; Avgustinovich et al., 2005; Denmark et al., 2010), 
decreased locomotor activity (Koolhaas et al., 1997; Rygula et al., 2005), depressive-like 
behavior (Avgustinovich et al., 2005; Rygula et al., 2005; Hollis et al., 2010), anhedonia (Von 
Frijtag et al., 2000; Rygula et al., 2005), changes in circadian rhythms (Tornatzky and 
Miczek, 1993; Meerlo et al., 1997), sleep patterns (Kinn et al., 2008), feeding and body 
weight (Foster et al., 2006), increased heart rate and blood pressure (Fokkema et al., 1986; 
Sgoifo et al., 1999; Costoli et al., 2004), increased body temperature (Keeney et al., 2001; 
Hayashida et al., 2010), and suppression of immune responses (Stefanski, 1998; Avitsur et al., 
2009; Chester et al., 2010). Given that social fear might either represent the major symptom 
of the anxiety disorder, as seen in SAD, or a comorbid condition to other psychiatric 
disorders, such as depression and schizophrenia, animal models that induce specific social 
fear without any confounding behavioral alterations are required to study the etiology of 
social fear, which might lead to more specific and efficient medications for these patients.  
1.7.2.      Cued fear conditioning 
The cued fear conditioning paradigm was originally developed in humans (Watson and 
Rayner, 1920) and later translated to animals (Estes and Skinner, 1941). With their famous 
General introduction                       18  
 
 
experiment on “little Albert”, an eleven-month-old child, Watson and Rayner could 
demonstrate for the first time that fear responses can be conditioned in humans. They exposed 
the child to a rat, to which he initially showed no fear response, and made a loud noise by 
hitting a metal pipe with a hammer, causing Albert to startle and fall forward. After 
repeatedly pairing the rat with the loud noise, Albert started crying at the sight of the rat and 
crawled away from it (Watson and Rayner, 1920).  
Although fear conditioning studies employing association of innocuous stimuli, such as 
pictures of faces or landscapes, tones, and words with mild aversive stimuli, such as electric 
shocks, painful pressure, heat pain, air puffs, and aversive pictures, tones, tastes or odors 
(Mechias et al., 2010) are largely being used in humans nowadays, most of the indepth 
knowledge we have about the pathways and neural mechanisms involved in conditioned fear 
(see section 1.4.) comes from studies in rodents. A typical cued fear conditioning experiment 
in rodents consists of three experimental phases, namely fear conditioning, fear extinction, 
and extinction recall (see Table 1 for terminology used in fear conditioning experiments and 
throughout this thesis). During fear conditioning, rodents are presented with an innocuous 
stimulus, usually a tone or light (conditioned stimulus, CS), which co-terminates with an 
aversive stimulus, such as an electrical foot shock (unconditioned stimulus, US). Through 
repeated CS-US associations (typically 2 - 5), animals learn that the CS predicts the US, and 
the CS will elicit a fear response even when presented in the absence of the US. The 
conditioned fear responses elicited by the CS are highly conserved among mammals and are 
similar to those elicited by natural threats, such as predators (see section 1.1.). During fear 
extinction, rodents are repeatedly presented with the CS without the US, which leads to a 
gradual decrease in the fear responses, and is similar to the repeated exposure to the feared 
situation during cognitive-behavioral therapy in humans (see section 1.5.). There is a growing 
body of evidence suggesting that fear extinction is different from forgetting and does not 
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eliminate the original fear memory, but generates new “safety” memory that inhibits the 
expression of fear in response to the CS (Bouton, 2004; Quirk et al., 2010). During extinction 
recall, rodents are presented with the CS without the US to determine whether the “safety” 
memory trained during fear extinction was consolidated. Although the cued fear conditioning 
paradigm does not fully model PTSD due to the complexity of the disorder, it allows the 
study of the neural circuitries and mechanisms involved in fear learning and fear extinction. 
Fear conditioning A process by which fear of an innocuous stimulus is 
learned through repeated associations of this stimulus 
with a noxious stimulus 
Unconditioned stimulus (US) A noxious stimulus (i.e. electric foot shock) that triggers 
an automatic, unlearned fear response  
Unconditioned response (UR) An automatic, unlearned fear response (i.e. freezing, 
startle) to an US  
Conditioned stimulus (CS) An innocuous stimulus (i.e. tone, light, context) that, 
after fear conditioning, triggers a learned fear response  
Conditioned response (CR) A learned fear response (i.e. freezing) to a CS 
Fear acquisition A process by which the association between the CS and 
US is encoded; it represents the initial stage of fear 
conditioning 
Fear consolidation A process by which the association between the CS and 
US is stabilized and maintained after fear acquisition 
Fear expression A process by which CR are triggered by the CS 
Fear extinction A process by which CR gradually decrease as a result of 
repeated presentations of the CS without the US 
Extinction recall  
 
A process by which is determined whether CR are 
triggered by the CS after consolidation of fear extinction 
Table 1. Terminology used in fear conditioning experiments 
1.8. Aim of the present thesis 
Given the lack of animal models that induce general social fear without confounding deficits, 
the high prevalence and unsatisfactory treatment options for both SAD and PTSD, and the  
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potential therapeutic role of OT in SAD and PTSD, I aimed to: 
1. Develop and validate an animal model that mimics the main behavioral symptom of 
SAD, namely social fear and avoidance.                                                                                                                                                                                                                                                                                             
2. Use this novel animal model, i.e. the social fear conditioning paradigm, to verify the 
therapeutic efficacy of OT in reversing social fear. 
3. Verify the therapeutic efficacy of OT in reversing cued fear in an animal model of 
PTSD, the cued fear conditioning paradigm. 
1.9.     Outline of the present thesis 
Chapter 2 describes a novel and specific animal model to study SAD, the social fear 
conditioning paradigm, and its effects on social investigation, general anxiety, depressive-like 
behavior, and locomotion. It also describes the effects of typical SAD medication, i.e. the 
benzodiazepine diazepam and the antidepressant paroxetine, on the induced social fear. 
Chapter 3 describes step by step how to perform the social fear conditioning paradigm. It 
also describes theoretical and practical considerations for rats and mice, and for the analysis 
and interpretation of the obtained data. 
Chapter 4 describes the central and local effects of synthetic OT on social fear induced by 
social fear conditioning. It also describes the alterations that occur at the level of the brain OT 
system after social fear conditioning and social fear extinction.  
Chapter 5 describes the central effects of synthetic OT on cued fear induced by cued fear 
conditioning, and emphasizes the importance of the time-point of OT administration during 
the conditioning procedure. 
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SAD is a major health concern with high lifetime prevalence. The current medication is rather 
unspecific and, despite considerable efforts, its efficacy is still unsatisfactory. However, there 
are no appropriate and specific animal models available to study the underlying etiology of 
the disorder. Therefore, we aimed to establish a model of specific social fear in mice and use 
this social fear conditioning paradigm to assess the therapeutic efficacy of the benzodiazepine 
diazepam and of the antidepressant paroxetine, treatments currently used for SAD patients. 
We show that by administering electric foot shocks (2 - 5, 1 s, 0.7 mA, pulsed current) during 
the investigation of a con-specific, the investigation of unfamiliar con-specifics was reduced 
for both the short- and long-term, indicating lasting social fear. The induced fear was specific 
to social stimuli and did not lead to other behavioral alterations, such as fear of novelty, 
general anxiety, depression, and impaired locomotion. We show that social fear was dose-
dependently reversed by acute diazepam, at doses that were not anxiolytic in a non-social 
context, such as the elevated plus-maze (EPM). Finally, we show that chronic paroxetine 
treatment reversed social fear. All in all, we demonstrated robust social fear after exposure to 
social fear conditioning in mice, which was reversed with both acute benzodiazepine and 
chronic antidepressant treatment. We propose the social fear conditioning model as an 








SAD, often referred to as social phobia, is characterized by persistent fear and avoidance of 
social situations. Epidemiologically, SAD is the third most common psychiatric disorder, with 
a 12-month and lifetime prevalence of 6.8% and 12.1%, respectively (Kessler et al., 2005a,b). 
For diagnostic purposes, SAD has been divided in two subtypes: specific and generalized 
SAD. The specific form refers to the fear and avoidance of a particular social situation and 
includes performance anxiety (e.g. fear of giving a public speech), interaction anxiety (fear of 
social interaction and observation situations), and fear of showing anxiety symptoms 
(Bögels et al., 2010). Patients with generalized SAD are more impaired as they fear and avoid 
a wide range of social situations (den Boer., 1997; Kessler et al., 1998; Ruipérez et al., 2002). 
This avoidant behavior has an important role in the maintenance of SAD and prevents the 
reversal of fear in social situations (American Psychiatric Association, 1994; Stangier et al., 
2006). 
At present, SAD treatment consists of cognitive-behavioral therapy (Gould et al., 
1997; Fedoroff and Taylor, 2001), which leads to gradual fear extinction, i.e. a decline in the 
fear response as a result of repeated exposure to the feared situation, and is often combined 
with medication originally designed for depression or generalized anxiety, such as 
antidepressants, β-blockers, and benzodiazepines. However, a high percentage of SAD 
patients fail to respond to the available treatment options, or achieve only partial remission of 
symptoms, with SSRIs providing the best response rates (Liebowitz et al., 1992; Baldwin et 
al., 1999; Van Ameringen et al., 2001). Given the high prevalence and unsatisfactory 
treatment options for SAD, a better understanding of the etiology and underlying 
neurobiological mechanisms of social fear, particularly extinction of social fear, is urgently 
needed. This, in turn, might provide important information for the development of more 
specific medication and an improved treatment outcome for SAD patients. 
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However, there are currently no appropriate animal models available to study the disorder. 
Social fear and avoidance is presently induced using a number of paradigms, including the 
social defeat paradigm, which can be used both acutely and chronically (Huhman, 2006; 
Yan et al., 2010), and foot-shock exposure (Haller and Bakos, 2002; Louvart et al., 2005; 
Mikics et al., 2008a). However, these paradigms are rather unspecific with respect to the 
behavioral alterations they induce, as increased general anxiety, depression, and impaired 
locomotion were found to accompany the social avoidance (Denmark et al., 2010; Hollis et 
al., 2010). 
Therefore, we aimed to establish a novel and specific animal model of SAD using the social 
fear conditioning paradigm, and use this model to assess the therapeutic efficacy of diazepam 
and paroxetine, currently used for SAD patients. The SAD-like phenotype was induced in 
naïve mice by punishing them when investigating an unfamiliar con-specific. Mice were 
conditioned to associate a shock-induced pain with the investigation of a social stimulus and, 
therefore, avoid social stimuli. The conditioned social fear is specific to several social stimuli, 
long-lasting and not accompanied by changes in general anxiety, depressive-like behavior, 
and locomotion. The social fearful phenotype was dose-dependently reversed by acute 
diazepam, at a dose that was not anxiolytic in a non-social context, i.e. the EPM. Furthermore, 
chronic antidepressant treatment also reversed social fear, thus validating the social fear 
conditioning model. 
 
MATERIALS AND METHODS 
Animals 
Male CD1 mice (Charles River, Sulzfeld, Germany) weighing 30 - 35 g were individually 
housed in polycarbonate cages (16 × 22 × 14 cm) for 1 week before experiments started, and 
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remained isolated throughout. Isolation was shown to increase social motivation (Niesink and 
Van Ree, 1982) and prevent the attenuation of behavioral effects of stressors observed in 
group-housed mice (Ruis et al., 1999; Cherng et al., 2010). Mice were transferred to 
observation cages (30 × 23 × 36 cm) 3 days before experiments started. Age- and weight-
matched male CD1 mice were used as social stimuli. 
Mice were maintained under standard laboratory conditions (12:12 light/dark cycle, lights on 
at 06:00, 22°C, 60% humidity, food and water ad libitum). Experiments were performed 
during the light phase, between 08:00 and 12:00, in accordance with the Guide for the Care 
and Use of Laboratory Animals of the Government of Oberpfalz and the guidelines of the 
National Institutes of Health. 
Social fear conditioning paradigm 
On day 1, mice were conditioned for social fear, whereas on days 2 and 3 or 15 and 16, social 
investigation was assessed as readout of short- and long-term social fear and fear extinction. 
Social fear conditioning was performed with a computerized fear conditioning system (TSE 
System GmbH, Bad Homburg, Germany). The conditioning chamber consisted of a 
transparent Perspex box (45 × 22 × 40 cm) enclosed in a wooden chamber to reduce external 
noise and visual stimulation. The floor consisted of a removable stainless steel grid connected 
to a shock delivery unit used for manual application of foot shocks. A video camera at the top 
of the chamber enabled video recording. 
Social fear conditioning (day 1). Mice were placed in the conditioning chamber and, after a 
30-s adaptation period, an empty wire mesh cage (7 × 7 × 6 cm) was placed as a non-social 
stimulus near one of the short walls. Mice were allowed to investigate the non-social stimulus 
for 3 min, before it was replaced by an identical cage containing an unfamiliar male mouse. 
Unconditioned (UC) mice were allowed to investigate the social stimulus for 3 min. 
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Conditioned (C) mice were given a 1-s electric foot shock (0.7 mA, pulsed current) each time 
they investigated the social stimulus, defined by direct contact with the mouse. Mice received 
between 2 and 5 foot shocks, with a variable inter-shock interval, depending on when direct 
social contact was made. The first social contact and, therefore, foot shock occurred within 15 
- 30 s. Mice were returned to their home cage when no further social contact was made for 2 
min, meaning that conditioned mice spent between 3 and 6 min in the conditioning chamber 
while the social stimulus was present. The time mice spent investigating the non-social 
stimulus, as a pre-conditioning measure of non-social anxiety, was analyzed using the 
JWatcher program (V 1.0, Macquarie University and UCLA). 
Social fear extinction (day 2 or 15). To investigate whether conditioned mice displayed 
social fear and whether this fear could be extinguished, social investigation was assessed in 
the home cage 1 or 15 days after social fear conditioning for short-term and long-term social 
fear, respectively. In detail, social fear extinction consisted of exposing the mice to 3 empty 
cages identical to the cage used during day 1 (non-social stimuli) to assess non-social 
investigation. Mice were then exposed to 6 unfamiliar male mice enclosed in wire mesh cages 
(social stimuli) to assess social investigation. Each stimulus was placed near a short wall of 
the home cage and presented for 3 min, with a 3-min inter-exposure interval. Reduced social 
investigation and aversive responses toward the social stimuli, such as freezing, stretched 
approaches, and defensive burying indicated social fear and successful social fear 
conditioning. As the non-social stimulus elicited a fear response in conditioned mice, an 
empty cage was placed over night in the home cage to extinguish the fear of the cage. 
Extinction recall (day 3 or 16). To investigate whether repeated exposure to social stimuli 
during social fear extinction leads to a complete reversal of social fear, social investigation 
was assessed in the home cage 1 day after social fear extinction. Extinction recall consisted of 
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exposing the mice to 6 unfamiliar social stimuli for 3 min, with a 3-min inter-exposure 
interval. 
Elevated plus-maze 
The EPM (Pellow et al., 1985; Lister, 1987) was performed 1 day after social fear 
conditioning to assess general anxiety-related behavior as previously described (Reber et al., 
2007). Briefly, the maze consisted of two open (6 × 30 x 0.2 cm, 110 lx) and two closed (6 × 
30 × 16 cm, 25 lx) arms radiating from a central platform (6 × 6 cm) elevated 35 cm above 
the ground. Mice were placed on the central platform facing a closed arm and allowed to 
explore the maze for 5 min. The percentage of time spent on the open arms was considered as 
anxiety-related parameter. The number of entries into the closed arms was considered as 
indicator of locomotor activity. The experiment was analyzed using the Plus-maze program 
(version 2.0; E. Fricke). 
Forced swim test  
The forced swim test (FST; Porsolt et al., 1977) was performed 1 day after social fear 
conditioning to assess depressive-like behavior. Mice were individually placed into a 
plexiglass cylinder (13 cm diameter, 25 cm height) filled with 25°C water to a depth of 14 cm 
for 6 min. Immobility was scored during the last 4 min using the JWatcher program, and was 
defined as the animal floating in water without swimming and making only movements 
necessary to maintain its head above the water (Slattery et al., 2005).  
Locomotor activity  
Home cage locomotion was assessed 1 day after social fear conditioning. Mice were taken out 
of the cage for 1 min to achieve similar arousal levels in all mice and returned to the home 
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cage thereafter. Locomotion was measured for 1 h using the Noldus Ethovision XT 5.1 
program (Noldus Information Technology, Wageningen, The Netherlands).  
Novel object investigation 
Novel object and social investigation were assessed in the home cage 1 day after social fear 
conditioning to differentiate between fear of novelty and social fear. Mice were exposed to 
three non-social stimuli, three cages containing a white ball (novel object stimuli, size and 
color matched to the social stimuli), and three unfamiliar social stimuli. Each stimulus was 
presented for 3 min, with a 3-min inter-exposure interval. 
Electric foot-shock exposure 
To assess the effects of foot-shock exposure in the absence of a social stimulus on social fear, 
mice were placed in the empty conditioning chamber and, after a 30-s adaptation period, 
received five electric foot shocks (1 s, 0.7 mA, pulsed current, i.e. the maximum number 
received during social fear conditioning), with a 2-min inter-shock interval. Mice were 
returned to their home cage 2 min after the last foot shock. An empty cage was placed in their 
home cage over night to allow for comparable behavioral effects with the social fear 
conditioning experiments. One day later, social investigation was assessed during social fear 
extinction.  
Drugs 
 Diazepam (Ratiopharm GmbH, Germany) was freshly dissolved in saline and administered 
intraperitoneally (i.p.) at a volume of 5 ml/kg and doses between 0.5 and 1.25 mg/kg. The 
highest doses were chosen based on previous studies (Corbett et al., 1993; Dalvi and Rodgers, 
1996; Stachowicz et al., 2008). Paroxetine (Bayer Schering, Germany) was administered over 
14 days via the drinking water at a dose of 10 mg/kg/ day. The paroxetine dose was chosen 
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based on previous studies (Da-Rocha et al., 1997; Hascoët et al., 2000a,b; Massé et al., 2005; 
Elizalde et al., 2008; Thoeringer et al., 2010). 
Experimental design 
Effects of social fear conditioning on short- and long-term social fear  
Initial experiments were designed to characterize the effects of social fear conditioning on 
short- and long-term social fear. Therefore, separate groups of mice were subjected to social 
fear conditioning and social investigation was assessed 1 or 15 days later during social fear 
extinction (n = 13 per group for short- and n = 9 per group for long-term effects). Extinction 
recall was measured 1 day later. 
Specificity of the induced social fear  
To verify the specificity of the induced social fear, separate groups of mice were subjected to 
general anxiety (EPM; n = 8 per group), depressive-like behavior (FST; n = 8 per group), 
home cage locomotion (n = 7 per group), or novel object investigation (n = 8 per group) 
testing 1 day after social fear conditioning. Another group of mice was exposed to electric 
foot shocks in the absence of the social stimulus, and social investigation was assessed 1 day 
later during social fear extinction (n = 8 per group). 
Reversal of short- and long-term social fear by acute diazepam and chronic paroxetine 
treatment, respectively  
To determine whether the effects of social fear conditioning on short- and long-term social 
fear could be reversed by medication used for SAD patients, we assessed the effects of 
diazepam and paroxetine, respectively. Mice (n = 10 per group) were subjected to social fear 
conditioning. The following day, 30 min before social fear extinction, mice were injected i.p. 
either with vehicle (5 ml/kg saline) or diazepam (0.5, 0.75, 1.0, and 1.25 mg/kg). Extinction 
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recall was measured 1 day later. To determine whether diazepam has anxiolytic effects in a 
non-social context at doses used to reverse social fear, naïve mice were injected i.p. either 
with vehicle (5 ml/kg saline) or with diazepam (0.5, 0.75, 1.0, and 1.25 mg/kg) 30 min before 
EPM testing. In a separate group of mice (n = 8 per group), social investigation was assessed 
15 days after social fear conditioning. Paroxetine (10 mg/kg/day) was administered 
chronically via the drinking water over 14 days, starting 1 day after social fear conditioning to 
prevent possible confounding effects on fear memory consolidation. Extinction recall was 
measured 1 day later. 
Statistical analysis  
For statistical analysis PASW/SPSS (Version 17) was used. Data were analyzed by 
Student's t-tests, one-way or two-way analysis of variance (ANOVA) for repeated measures, 
followed by a Bonferroni post-hoc analysis whenever appropriate. Statistical significance was 
set at p<0.05. Overall statistics are shown in Table 2. 
 
RESULTS  
Effects of social fear conditioning on short- and long-term social fear 
Short-term social fear  
Mice showed similar non-social anxiety during social fear conditioning on day 1 (Figure 
2A, Table 2). During social fear extinction on day 2, conditioned mice showed similar non-
social investigation, but reduced social investigation (p<0.05; Figure 2B) compared with 
unconditioned mice, reflecting social fear. No difference between the mice was found during 
extinction recall on day 3 (Figure 2C). 
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Experiment  Group effect Group × stimulus effect 
Short-term social fear (Figure 2) 
 Social fear conditioning (day 1)      T(24)=0.89, p=0.38   
 Social fear extinction (day 2)      F(1,24)=13.70, p<0.01
*
     F(8,192)=8.96, p<0.01
*
 
 Extinction recall (day 3)     F(1,24)=0.92, p=0.35     F(5,120)=1.64, p=0.16 
 
Long-term social fear (Figure 3) 
 Social fear conditioning (day 1)     T(16)=0.08, p=0.94   
 Social fear extinction (day 15)     F(1,16)=10.73, p<0.01
*
     F(8,128)=4.41, p<0.01
*
 
 Extinction recall (day 16)     F(1,16)=4.60, p=0.05
*
     F(5,80)=1.37, p=0.25 
 
Specificity of the induced social fear (Figure 4) 
 General anxiety     T(14)=0.84, p=0.42   
 Depressive-like behavior     T(14)=−0.70, p=0.50   
 EPM locomotion     T(14)=−0.19, p=0.86   
 Home cage locomotion     F(1,12)<0.01, p=0.99   
 
Fear of novelty (Figure 5) 
 Social fear conditioning (day 1)     T(14)=0.43, p=0.67   
 Social fear extinction (day 2)     F(1,14)=6.54, p=0.02
*




Foot-shock exposure (Figure 6) 
 
    F(1,14)=1.11, p=0.31 
 
    F(8,112)=0.33, p=0.95 
 
Short-term social fear by diazepam (Figure 7) 
 Social fear conditioning (day 1)     F(3,36)=0.01, p=0.99   
 Social fear extinction (day 2)     F(3,36)=7.68, p<0.01
*
     F(24,288)=4.14, p<0.01
*
 
 Extinction recall (day 3)     F(3,36)=1.07, p=0.37     F(15,180)=1.01, p=0.45 
 
Long-term social fear by paroxetine (Figure 8) 
 Social fear conditioning (day 1)     F(3,28)=0.32, p=0.81   
 Social fear extinction (day 15)     F(3,28)=32.02, p<0.01
*
     F(24,224)=8.13, p<0.01
*
 
 Extinction recall (day 16)     F(3,28)=4.96, p<0.01
*




Table 2. Overall effects for the social fear conditioning data. Stimulus effect refers to both non-social and 
social stimuli during social fear extinction, while during extinction recall it refers to social stimuli only. EPM, 
elevated plus-maze. Student’s t-tests, one-way or two-way ANOVA for repeated measures followed by 
Bonferroni post-hoc test; * p<0.05. 




Figure 2. Social fear conditioning induces short-term social fear in mice. (A) Investigation of the non-social 
stimulus (empty cage) by unconditioned (UC) and conditioned (C) mice during social fear conditioning on day 1 
(n = 13 per group). (B) Investigation of non-social (ns1-ns3) and social (cages with mice; s1-s6) stimuli during 
social fear extinction on day 2 (3 min exposure to stimulus, 3 min inter-exposure interval). (C) Investigation of 
social stimuli (s1-s6) during extinction recall on day 3. Data represent mean percentage of investigation time ± 
SEM. * p<0.05 vs. UC mice. 
 
 
Figure 3. Social fear conditioning induces long-term social fear in mice. (A) Investigation of the non-social 
stimulus (empty cage) by unconditioned (UC) and conditioned (C) mice during social fear conditioning on day 1 
(n = 9 per group). (B) Investigation of non-social (ns1-ns3) and social (cages with mice; s1-s6) stimuli during 
social fear extinction on day 15 (3 min exposure to stimulus, 3 min inter-exposure interval). (C) Investigation of 
social stimuli (s1-s6) during extinction recall on day 16. Data represent mean percentage of investigation time ± 
SEM. * p<0.05 vs. UC mice. 
 
Long-term social fear  
Mice showed similar non-social anxiety during social fear conditioning on day 1 (Figure 
3A, Table 2). During social fear extinction on day 15, conditioned mice showed similar non-
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social investigation, but reduced social investigation (p<0.05; Figure 3B) compared with 
unconditioned mice, reflecting social fear. In contrast to short-term social fear, conditioned 
mice still showed reduced social investigation during extinction recall on day 16 
(p<0.05; Figure 3C). 
 
Specificity of the induced social fear 
No effect of social fear conditioning on general anxiety, depressive-like behavior, and 
home cage locomotion 
Conditioned mice showed no changes in general anxiety (percentage of time on open 
arms; Figure 4A, Table 2) or locomotion on the EPM (number of closed arm entries; Figure 
4C), in depressive-like behavior in the FST (percentage immobility; Figure 4B), or in home 
cage locomotion (distance moved; Figure 4D) compared with unconditioned mice 1 day after 
social fear conditioning. 
 
Figure 4. No effect of social fear conditioning on general anxiety on the elevated plus-maze (EPM) (A), 
depressive-like behavior in the forced swim test (B), and locomotor activity on the EPM (C) and in the home 
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No effect of social fear conditioning on fear of novelty 
Mice showed similar non-social anxiety during social fear conditioning on day 1 (Figure 
5A, Table 2). One day after social fear conditioning, conditioned mice showed similar non-
social and novel object investigation, but reduced social investigation (p<0.01; Figure 5B) 
compared with unconditioned mice. 
 
Figure 5. Social fear 
conditioning does not 
induce fear of novelty. 
(A) Investigation of the 
non-social stimulus 
(empty cage) by 
unconditioned (UC) and 
conditioned (C) mice 
during social fear 
conditioning on day 1 
(n = 8 per group). (B) Investigation of non-social stimuli (ns1-ns3), novel object stimuli (cages with objects; 
no1-no3), and social stimuli (cages with mice; s1-s6) during novel object investigation on day 2 (3 min exposure 
to stimulus, 3 min inter-exposure interval). Data represent mean percentage of investigation time ± SEM. 
* p<0.05 vs. UC mice. 
 
 
Figure 6. Exposure to five electric foot shocks in 
the absence of a social stimulus does not induce 
social fear. Investigation of non-social (empty cages; 
ns1-ns3) and social (cages with mice; s1-s6) stimuli 
by non-shocked and shocked mice (n = 8 per group) 
during social fear extinction 1 day after foot-shock 
exposure (3 min exposure to stimulus, 3 min inter-
exposure interval). Data represent mean percentage 
of investigation time ± SEM. 
 
No effect of foot-shock exposure on social fear  
Exposure to foot shocks in the absence of the social stimulus did not alter social investigation 
1 day later (Figure 6, Table 2). 
Chapter 2                       35  
 
 
Reversal of short- and long-term social fear by acute diazepam and chronic paroxetine 
treatment, respectively 
Dose-dependent reversal of short-term social fear by diazepam 
Acute diazepam dose-dependently reversed social fear in conditioned mice 
(F(4,44)=5.16, p=0.02; Table 3), with doses higher than 0.5 mg/kg being unsuccessful in 
reversing social fear because of their sedative properties (Table 3). However, these higher 
doses were not sedative on the EPM and caused a dose-dependent anxiolysis (Table 3).  






  UC mice Vehicle 23.6±1.7 69.6±2.5 0±0 100±5.6 100±11.0 
  0.5 Dia 20.3±3.0 68.8±2.4 n.a. 88.5±10.9 97.8±6.0 
  0.75 Dia 7.6±1.8* 40.1±3.2*   28.4±4.8* 99.5±7.7 120.2±9.0 
  1.0 Dia 12.2±5.3* 31.8±12.2*   34.3±13.9* 75.1±11.5 151.1±66.0 
  1.25 Dia 4.7±3.7* 7.9±2.3*   51.8±8.0* 115.6±13.8 238.7±34.3* 














  0.5 Dia 22.1±6.3 64.6±7.7* n.a. — — 
  0.75 Dia 18.3±4.6 27.0±12.2 n.a. — — 
  1.0 Dia 8.4±2.3 19.8±8.8 n.a. — — 
  1.25 Dia 13.9±7.1 10.1±5.8 n.a. — — 
 
Table 3. Dose-dependent effects of diazepam in the social fear conditioning and the elevated plus-maze 
(EPM). Unconditioned (UC) and conditioned (C) mice were injected intraperitoneally with either vehicle (5 
ml/kg saline) or diazepam (Dia; 0.5, 0.75, 1.0, or 1.25 mg/kg) 30 min before social fear extinction in the social 
fear conditioning paradigm or EPM testing. Data represent mean values ± SEM. NSI, non-social investigation; 
SI, social investigation; CA, closed arms of the EPM; OA, open arms of the EPM; n.a., not analysed; —, not 
performed. The sedative index is defined as the percentage of time lacking muscle tone and movement. * 
p<0.05. 
 
Mice showed similar non-social anxiety before treatment during social fear conditioning on 
day 1 (Figure 7A, Table 2). Conditioned mice received a similar number of foot shocks 
during social fear conditioning (vehicle 2.3±0.15 vs. 0.5 mg/kg diazepam 2.2±0.19; 
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T(18)=0.42, n.s.). During social fear extinction on day 2, the four groups showed similar non-
social investigation. Although conditioned vehicle-treated mice showed reduced social 
investigation compared with all other groups (p<0.05; Figure 7B), in conditioned diazepam-
treated mice social investigation returned to levels found in unconditioned mice. No 
difference between the mice was found during extinction recall on day 3 (Figure 7C). 
 
Figure 7. Acute diazepam (Dia) treatment reverses short-term social fear. (A) Investigation of the non-
social stimulus (empty cage) during social fear conditioning on day 1 (n = 10 per group). (B) Investigation of 
non-social (ns1 ns3) and social (cages with mice; s1-s6) stimuli during social fear extinction on day 2 (3 min 
exposure to stimulus, 3 min inter-exposure interval). Unconditioned (UC) and conditioned (C) mice were 
injected intraperitoneally either with vehicle (Veh; 5 ml/kg saline) or with Dia (0.5 mg/kg) 30 min before social 
fear extinction. (C) Investigation of social stimuli (s1-s6) during extinction recall on day 3. Data represent mean 
percentage of investigation time ± SEM. * p<0.05 vs. the other three groups.  
 
Reversal of long-term social fear by paroxetine 
Mice showed similar non-social anxiety before treatment during social fear conditioning on 
day 1 (Figure 8A, Table 2). Conditioned mice received a similar number of foot shocks 
during social fear conditioning (vehicle 2.38±0.18 vs. paroxetine 2.31±0.16; T(14)=0.26, n.s.). 
During social fear extinction on day 15, the four groups showed similar non-social 
investigation. Although conditioned vehicle-treated mice showed reduced social investigation 
compared with all other groups (p<0.05; Figure 8B), in conditioned paroxetine-treated mice 
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social investigation returned to levels found in unconditioned mice. During extinction recall 
on day 16, conditioned vehicle-treated mice still showed reduced social investigation 
compared with all other groups (p<0.05; Figure 8C). 
 
Figure 8. Chronic paroxetine (Par) treatment reverses long-term social fear. (A) Investigation of the non-
social stimulus (empty cage) during social fear conditioning on day 1 (n = 8 per group). Par (10 mg/kg/day) was 
administered over 14 days in the drinking water (Veh) of unconditioned (UC) and conditioned (C) mice starting 
1 day after social fear conditioning. (B) Investigation of non-social (ns1-ns3) and social (cages with mice; s1-s6) 
stimuli during social fear extinction on day 15 (3 min exposure to stimulus, 3 min inter-exposure interval). (C) 
Investigation of social stimuli (s1-s6) during extinction recall on day 16. Data represent mean percentage of 
investigation time ± SEM. * p<0.05 vs. the other three groups.  
 
DISCUSSION 
To the best of our knowledge, this study describes the first animal model of SAD that 
specifically induces social fear without potentially confounding alterations in other behavioral 
measures. We show that the novel social fear conditioning model induces both short- and 
long-term specific fear of social stimuli, and that this fear sensitizes over time. Furthermore, 
social fear conditioning does not induce other behavioral changes that might account for the 
observed social fear, such as fear of novelty, increased general anxiety, depressive-like 
behavior, and impaired locomotion. We further show that social fear is dose-dependently 
reversed by acute diazepam, at a dose that is not anxiolytic in a non-social context. Finally, 
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we show that chronic paroxetine treatment reverses social fear, similar to the best outcomes in 
SAD patients, validating the social fear conditioning model. Therefore, the social fear 
conditioning model represents a unique and novel model to gain a better understanding of the 
underlying etiology of SAD and to test compounds with novel mechanisms of action that 
could provide better treatment outcome for patients. 
Despite its prevalence and symptom severity, the etiology of SAD remains poorly understood, 
due in part to a lack of appropriate animal models. Currently, lasting social fear and 
avoidance in both rats and mice can be induced by two main traumatic stress procedures, 
namely social defeat and foot-shock exposure. Social defeat is used both acutely, i.e. one 
defeat by a dominant male and chronically, i.e. repeated defeat by several dominant males 
(Huhman, 2006; Yan et al., 2010). Foot-shock exposure is used as exposure to a single (Short 
and Maier, 1993; Siegmund and Wotjak, 2007) or to repeated foot shocks (Haller and Bakos, 
2002; Louvart et al., 2005; Mikics et al., 2008a). Although social defeat and foot-shock 
exposure decrease social investigation, they also lead to behavioral alterations including 
increased general anxiety, depression, and impaired locomotion that might account for the 
observed social deficit (Denmark et al., 2010; Hollis et al., 2010). Furthermore, in the case of 
acute social defeat, the induced social avoidance is generally directed toward the con-specific 
that performed the defeat (Lai et al., 2005; Lukas et al., 2011). Although such models are 
useful and have improved our understanding of SAD, there is a need for animal models that 
lead to specific social fear, without any confounding behavioral alterations, to further 
elucidate the mechanisms underlying SAD. 
Our social fear conditioning model is based on operant conditioning, where animals learn to 
associate a voluntary behavior with its consequences. When the consequence is favorable the 
behavior will occur more frequently, whereas when the consequence is unfavorable the 
behavior will occur less frequently (Thorndike, 1933; White, 1989). Social fear conditioning 
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implies punishing naïve mice when investigating a con-specific and results in fear and 
avoidance of social stimuli. The social fearful phenotype is expressed in reduced investigation 
of social stimuli and intense aversive responses toward them, such as freezing (absence of 
movement except that required for respiration; Fanselow, 1980), stretched approaches, and 
defensive burying (Table 4). Although all these behaviors have been linked with increased 
anxiety and fear, the reduced social investigation was the most robust indicator of social fear 
in our paradigm and, therefore, the one we focused on. Furthermore, as none of the 
unconditioned mice showed freezing, stretched approaches, or defensive burying, by using 
social investigation as the main readout of social fear direct comparison with unconditioned 
mice is possible. 





Short-term social fear (Figure 2) 92.3% (12/13) 61.5% (8/13) 61.5% (8/13) 38.5% (5/13) 
 


































Short-term social fear by diaze-
pam (Figure 7) 
90% (9/10) 90% (9/10) 80% (8/10) 30% (3/10) 
Long-term social fear by paroxe-
tine (Figure 8) 
100% (8/8) 75% (6/8) 75% (6/8) 75% (6/8) 
 
Table 4. Behavioral parameters indicating social fear during social fear extinction. Decreased social 
investigation (SI) represents the percentage of conditioned mice in each experiment that showed a decrease of at 
least 50 % in investigation of the first social stimulus compared with the mean of their respective unconditioned 
mice. Freezing, stretched approaches, and defensive burying represent the percentage of conditioned mice that 
showed those behaviors when the social stimuli were in their home cage during social fear extinction. None of 
the unconditioned mice showed these behaviors. Data from Figure 7 and 8 includes only conditioned vehicle-
treated mice. 
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To evaluate the effects of social fear conditioning on social fear, we used a modified version 
of the social approach/avoidance paradigm (Berton et al., 2006), where we first exposed mice 
to non-social stimuli, i.e. empty cages to exclude possible confounding effects due to fear of 
the cage itself. As the stimulus mouse used during social fear conditioning was enclosed in a 
cage that was identical to the cages used as non-social stimuli during social fear extinction, 
the cage additionally served as a cue and, therefore, elicited a fear response in conditioned 
mice (Table 5). However, this fear was extinguished by placing the empty cage in the home 
cage of the mice over night. As non-social investigation was not decreased in conditioned 
mice after extinguishing the fear of the cage, it is unlikely that fear renewal to the cage 
occurred and thereby decreased social investigation (Table 5). Furthermore, exposure to non-
social stimuli during social fear extinction did not affect the level of social investigation in 
either conditioned or unconditioned mice (Table 5). Therefore, to allow for a within-
individual assessment of non-social and social fear, mice were exposed to both non-social and 
social stimuli throughout the experiments. For assessing social investigation, mice were 
repeatedly exposed to different unfamiliar con-specifics. Different individuals were used for 
two reasons. First, we aimed to obtain a reversal of social fear in general and not a reversal of 
fear toward a specific individual. Second, we aimed to maintain high interest in the social 
stimuli as repeated exposure to the same con-specific has been shown to decrease social 
interest in both mice (Ferguson et al., 2002; Choleris et al., 2009) and rats (Thor et al., 
1982; Popik and van Ree, 1998). This exposure-like paradigm is similar to exposure therapy 
during cognitive-behavioral therapy in humans, where patients are repeatedly exposed to the 
feared situation. 
Social fear conditioning induced both short- and long-term specific fear of social stimuli. 
Social investigation increased with each exposure to the social stimuli, indicating gradual 
extinction of social fear, which is similar to the outcome during cognitive-behavioral therapy 
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in SAD patients (Clark et al., 2003), and extinction after cued and context fear conditioning in 
mice and rats (Myers and Davis, 2002). When the social fear extinction procedure was 
performed 1 day after social fear conditioning, social fear was completely reversed by the 
next day, during extinction recall. However, when the social fear extinction was performed 15 
days after social fear conditioning, conditioned mice still showed social fear during extinction 
recall, indicating that the social fear sensitized over time. Previous studies also showed 
sensitization of fear responses over time after single or repeated foot-shock exposure 
(Siegmund and Wotjak, 2007; Mikics et al., 2008a), suggesting that the circuitry underlying 
the conditioned social fear not only remains stable, but may even strengthen over time. 
Moreover, the maintenance of social fear over both short- and long-term not only offers the 
possibility to test medication with fast onset of action, such as benzodiazepines, but also with 
a delayed onset of action, such as antidepressants (Katz et al., 2006; Mitchell, 2006; Priest, 
2006). 
Unlike acute social defeat, social fear conditioning induced a general fear of social stimuli, 
which was not limited to the stimulus to which the mouse has been conditioned, but extended 
to unfamiliar social stimuli as well. This general social fear is similar to the general social 
avoidance induced by chronic social defeat (Avgustinovich et al., 2005; Berton et al., 2006), 
where several dominant males are consecutively used to defeat a subordinate animal (Miczek, 
1979; Rodgers and Randall, 1986; Kabbaj et al., 2001). However, chronic social defeat also 
increased general anxiety (Keeney and Hogg, 1999; Avgustinovich et al., 2005; Berton et al., 
2006; Denmarket al., 2010), decreased locomotor activity (Koolhaas et al., 1997; Rygula et 
al., 2005), and induced a depressive-like phenotype (Avgustinovich et al., 2005; Rygula et al., 
2005; Berton et al., 2006; Hollis et al., 2010). Correspondingly, these behavioral changes 
might account for the decreased social investigation observed. Unlike chronic social defeat, 
social fear conditioning induced a specific fear of social stimuli without inducing changes in 
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general anxiety on the EPM, depressive-like behavior in the FST, or in home cage and novel 
environment (EPM) locomotion. We could also show that the induced social fear was specific 
to a social stimulus, as novel objects that were similar in size and color to the social stimuli 
did not induce fear responses in conditioned mice. Thus, in future studies it would be 
interesting to compare treatments that are effective in the social fear conditioning paradigm in 
such social defeat models to determine their specificity. 
The social fear conditioning model involves the use of aversive stimuli, in this case electric 
foot shocks. Previous studies have shown that foot-shock exposure alone decreased social 
investigation for both short- and long-term, however, only when assessed in a novel 
environment (Short and Maier, 1993; Haller and Bakos, 2002; Haller et al., 2003; Louvart et 
al., 2005; Leveleki et al., 2006; Siegmund and Wotjak, 2007; Mikics et al., 2008a,b). When 
social investigation was assessed in the home cage, no differences were found, suggesting that 
the former result is due to novelty-induced anxiety (Mikics et al., 2008a). Shock exposure 
also increased general anxiety and decreased locomotion and exploratory behavior in the open 
field and EPM (Van Dijken et al., 1992; Bruijnzeel et al., 2001; Pijlman and van Ree, 
2002; Kavushansky et al., 2009), indicating that the decreased social investigation observed 
after foot-shock exposure may rather be due to an increase in general anxiety. Our paradigm 
assessed the experimental mice in their home cage, which reduces the possibility of novelty-
induced anxiety. Moreover, we did not observe changes in home cage social investigation 
when mice were exposed to foot shocks in the absence of the stimulus mouse, indicating that 
the fear induced during social fear conditioning is a result of the association between the 
experienced pain and investigation of a con-specific rather than a direct result of foot-shock 
exposure. 
  
NS and S investigation ns1 ns2 ns3 s1 s2 s3 s4 s5 s6 
1. Without over night extinction of fear of the empty cage 
  1.1. Without previous non-social exposure 
            UC mice (n=9)       42.3±8.3 75.0±5.8 77.0±3.2 69.8±4.7 69.4±4.7 66.2±3.7 
            C mice (n=9)       0.3±0.2* 1.7±1.2* 1.8±1.0* 1.2±0.5* 3.7±1.3* 5.6±2.4* 
  1.2. With previous non-social exposure 
            UC mice (n=6) 27.0±10.2 40.1±16.2 44.4±16.3 66.3±11.1 78.4±3.8 71.0±11.5 72.7±9.7 72.5±9.5 79.7±5.1 
            C  mice (n=6) 0.8±0.4* 0.6±0.4* 1.3±0.7* 1.2±0.5* 2.7±1.3* 1.7±1.1* 2.6±1.6* 2.4±1.6* 3.2±1.3* 
2. With over night extinction of fear of the empty cage 
    2.1. Without previous non-social exposure 
            UC mice (n=8)       72.4±7.7 80.7±3.0 85.8±3.0 81.1±3.0 82.0±4.0 79.7±5.1 
            C mice (n=9)       5.3±3.2* 18.7±9.5* 32.0±11.9* 37.7±12.5* 40.7±13.2* 3.2±1.3* 
    2.2. With previous non-social exposure 
        2.2.1. Short-term social fear (Figure 2) 
         UC mice (n=13) 38.7±3.8 13.5±2.5 12.5±3.6 71.2±4.7 83.3±1.7 73.1±5.0 71.8±6.3 71.0±5.7 68.8±7.9 
         C mice (n=13) 32.4±5.6 21.2±7.1 7.5±2.0 13.1±6.3* 35.9±9.9* 42.8±9.5* 48.0±8.7* 56.2±8.9 42.0±8.0* 
        2.2.2. Short-term social fear by diazepam (Figure 7) 
         UC mice (n=10) 44.4±3.4 16.2±4.5 10.2±4.2 52.6±7.7 69.7±8.4 67.5±8.3 68.0±5.4 62.8±6.1 72.9±3.8 
         C mice (n=10) 33.3±6.7 17.6±5.6 11.1±3.7 8.8±4.4* 25.4±8.8* 27.0±9.6* 23.3±9.4* 31.2±8.6 30.4±9.3* 
        2.2.3. Long-term social fear (Figure 3) 
         UC mice (n=9) 46.8±10.2 48.3±10.6 37.7±8.7 73.5±8.0 75.9±7.0 79.3±3.6 77.6±5.1 76.8±4.7 75.7±3.7 
         C mice (n=9) 48.2±8.3 39.3±8.0 28.0±6.8 15.3±9.9* 28.5±11.5* 35.9±12.4* 41.4±13.2* 39.0±12.5* 38.8±12.4* 
       2.2.4. Long-term social fear by paroxetine (Figure 8) 
         UC mice (n=8) 31.2±4.1 25.8±6.7 8.5±1.9 83.0±2.1 90.5±2.7 88.6±2.9 88.5±2.1 85.8±3.7 83.8±2.6 
         C mice (n=8) 18.8±3.9 10.7±4.6 6.9±2.0 5.2±5.1* 10.8±6.7* 22.2±9.0* 34.7±8.8* 43.6±8.5* 51.7±7.9* 
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Table 5. Investigation of the non-social (NS; ns1-ns3) and social stimuli (S; s1-s6) during social fear 
extinction in relation with overnight exposure to the empty cage and to non-social stimuli during social 
fear extinction. Mice were exposed to social fear conditioning and the empty cage was either placed or not in 
their home cage over night. Social fear extinction was assessed 1 day or 15 days after social fear conditioning. 
Data represent mean percentage of investigation time ± SEM. * p<0.05 versus unconditioned (UC) mice. 
Statistical significance shown in points 2.2.2. and 2.2.4. represents those from all treatment groups, as shown in 
the results section. C; conditioned mice. 
 
Having shown the specificity of the fear induced during social fear conditioning, we assessed 
the therapeutic efficacy of benzodiazepines (diazepam) and antidepressants (paroxetine) in 
reversing social fear in our model. Although β-blockers can be beneficial in humans, their 
efficacy is limited to performance anxiety (Faigel, 1991; Liebowitz et al., 1992), therefore we 
did not assess them in the social fear conditioning paradigm. 
Acute diazepam treatment dose-dependently reversed short-term social fear, without further 
increasing social investigation in unconditioned mice. Doses higher than 0.5 mg/kg (0.75, 1.0, 
and 1.25 mg/kg) had sedative effects in the home cage and even reduced investigation in 
unconditioned mice, counter indicating, therefore, their use in the social fear conditioning 
paradigm (Table 3). Diazepam reversed social fear at a dose (0.5 mg/kg) that did not alter 
general anxiety on the EPM (Table 3). We could only demonstrate anxiolytic effects of 
diazepam on the EPM at a dose of 1.25 mg/kg, confirming recent findings (Hascoët et al., 
2000a). The sedative effect of doses higher than 0.5 mg/kg diazepam might not have been 
observed in previous studies, as the increased arousal level in novel environments, such as the 
EPM, open field, and light-dark box, may have masked the sedative effect of diazepam. 
Chronic paroxetine treatment, started 1 day after social fear conditioning to prevent possible 
confounding effects on fear memory consolidation, was also successful in reversing long-term 
social fear, without further increasing social investigation in unconditioned mice. However, 
acute SSRI treatment increased social fear in conditioned mice (data not shown). This is in 
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line with data showing that SSRI treatment reduces cued fear after chronic treatment, but 
increases cued fear after acute treatment (Burghardt et al., 2004, 2007). All in all, the reversal 
of social fear by medication used for SAD patients provides predictive validity to the social 
fear conditioning model. 
Finally, it is of interest to note that the use of the social fear conditioning model is not 
restricted to male CD1 mice, as shown in this study. Preliminary data have shown that the 
paradigm can also be used successfully in inbred lines such as C57/Bl6, and in a different 
species, namely Wistar rats (data not shown). This further demonstrates the utility of the 
novel paradigm for gaining a better understanding of the etiology of SAD. Moreover, social 
fear conditioning has not been used to induce social fear in female mice or rats yet, which, 
however, would be promising given the higher prevalence of SAD in women (Schneier et al., 
1992; Talepasand and Nokani, 2010). 
In summary, we have established a novel social fear conditioning paradigm that induces 
specific and long-lasting fear of social stimuli in naïve mice, and shows both face and 
predictive validity to SAD. The induced social fear is specific to several social stimuli and not 
the result of fear of novelty, increased general anxiety, depressive-like behavior, or impaired 
locomotion. Our model might, therefore, be used to gain a better understanding of the 
underlying causes and mechanisms of SAD in humans and also to test compounds with novel 
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Social fear and avoidance of social situations represent the main behavioral symptoms of 
SAD, a disorder that is poorly elucidated and has rather unsatisfactory therapeutic options. 
Therefore, animal models are needed to study the underlying etiology of the disorder and 
possible novel treatment approaches. However, the current paradigms modeling SAD-like 
symptoms in rodents are not specific, as they induce numerous other behavioral deficits in 
addition to social fear and avoidance. Here, we describe the protocol for the social fear 
conditioning paradigm, an animal model of SAD that specifically induces social fear of 
unfamiliar con-specifics, without potentially confounding alterations in other behavioral 
measures. Theoretical and practical considerations for performing the social fear conditioning 
paradigm in both rats and mice, as well as for the analysis and interpretation of the obtained 








SAD is defined as a "marked and persistent fear of one or more social or performance 
situations in which the person is exposed to unfamiliar people or possible scrutiny by others” 
(American Psychiatric Association, 1994). SAD patients often avoid the feared social 
situations or else endure them with intense anxiety and distress. SAD is a common anxiety 
disorder with a lifetime prevalence of 12.1% (Kessler et al., 2005a), and is more prevalent in 
women than in men (Talepasand and Nokani, 2010). Two subtypes of SAD have been 
described, namely specific and generalized SAD. Specific SAD involves fear and avoidance 
of a particular social situation and includes performance anxiety (e.g. fear of public speaking, 
eating or drinking in public), interaction anxiety (fear of social interaction and observation 
situations), and fear of showing anxiety symptoms (Bögels et al., 2010). Patients with 
generalized SAD are more impaired as they fear and avoid a wide range of social situations 
(Ruipérez et al., 2002). The avoidant behavior is often the greatest impairment in these 
patients, plays a critical role in the maintenance of SAD, and prevents the reversal of fear in 
social situations (American Psychiatric Association, 1994).  
Currently, the best treatment responses in SAD patients are obtained with a combination of 
psychotherapy and pharmacotherapy. One of the techniques used in psychotherapy is 
exposure therapy (Gould et al., 1997; Fedoroff and Taylor, 2001), which leads to a gradual 
fear extinction, i.e. a decline in the fear response as a result of repeated exposure to the feared 
situation. This psychotherapeutic technique is often combined with a rather unspecific 
pharmacotherapy, originally designed for depression or generalized anxiety, such as 
benzodiazepines and antidepressants (Gould et al., 1997; Fedoroff and Taylor, 2001). Many 
SAD patients fail to respond to the available treatment options, achieve only partial remission 
of symptoms, or show a high relapse rate after treatment discontinuation (Blanco et al., 2002), 
due at least in part to the insufficient understanding of the disorder and the unspecific 
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medication. Therefore, a better understanding of the etiology and underlying neurobiological 
mechanisms of social fear, particularly extinction of social fear, is needed. However, for these 
purposes, animal models of are needed.  
Although human performance anxiety and fear of showing anxiety symptoms (see above) 
cannot be reliably modeled in laboratory animals, several paradigms have been shown to 
induce social avoidance and fear in rodents and can be used as animal models of human 
interaction anxiety. Such paradigms include social defeat (Huhman, 2006), foot-shock 
exposure (Haller and Bakos, 2002), maternal separation (Franklin et al., 2011), and restraint 
stress (Gehlert et al., 2005). While these paradigms have contributed a great deal of 
knowledge regarding the mechanisms underlying social avoidance and fear, they are rather 
unspecific with respect to the behavioral alteration they induce. Thus, increased general 
anxiety, depressive-like behavior, anhedonia, and numerous other changes have often been 
shown to accompany the induced social fear (Avgustinovich et al., 2005; Rygula et al., 2005). 
When using these paradigms, it is therefore not clear whether social fear is the major deficit 
induced, or whether it is a consequence of one of the aforementioned behavioral alterations. 
Given that social fear might either represent the major symptom of the disorder, as seen in 
SAD, or a co-morbid condition to other psychiatric disorders, such as depression and 
schizophrenia, animal models that induce specific social fear without any confounding 
behavioral alterations are required to study the etiology and underlying mechanisms of pure 
social fear, which might lead to a better understanding of the disorder and more specific and 
efficient medications for disorders associated with social deficits.  
In this Unit we describe the social fear conditioning paradigm, which induces specific social 
fear in naïve animals and shows both face and predictive validity to SAD (Toth et al., 2012b). 
The social fear conditioning paradigm is based on operant conditioning, where animals learn 
to associate a voluntary behavior with its consequences. When the consequence is favorable 
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the behavior will occur more frequently, whereas when the consequence is unfavorable the 
behavior will occur less frequently. Social fear conditioning implies punishing naïve animals 
by administrating mild electric foot shock when they investigate a con-specific and results in 
fear and avoidance of social stimuli. The socially-fearful phenotype is expressed as reduced 
investigation of social stimuli and intense aversive responses toward them, such as freezing, 
stretched approaches, and defensive burying. Importantly, the social fear conditioning induces 
a long-lasting (at least two weeks) social fear, which offers not only the possibility to test 
medication with fast, but also with delayed onset of action. Additionally, the induced social 
fear is not accompanied by alterations in general anxiety, novelty anxiety, and depressive-like 
behavior, as occurs in most of the animal models mentioned above.  
 
MATERIALS 
 Experimental animals: male or female rats or mice, 8 to 12 weeks of age unless otherwise 
wished 
 Stimulus animals: same species, strain, sex, age, and weight as experimental animals 
Calculate the number of stimulus animals needed as follows: 1 stimulus per 6 experimental 
animals during social fear conditioning + minimum 6 (6 different stimuli needed during 
social fear extinction). For example, if you plan an experiment with 6 animals, you need 7 
stimulus animals; for an experiment with 12 animals or more you need at least 8 stimulus 
animals 
 Experimental room with controlled temperature (22 - 24°C) and humidity (60 - 70 %) and 
12-hr light/dark cycle 
Unless otherwise wished, experiments are performed during the early light phase. 
However, when other time-points of experimenting are wished, preliminary validation of 
Chapter 3                       51  
 
 
 the paradigm is recommended 
 Conditioning room close to the experimental room, where the computerized fear 
conditioning system is located 
The experimental and conditioning room should be close by so that animals can be 
transported from one room to the other as quickly as possible 
 Computerized fear conditioning system that allows manual administration of foot shocks, 
such as that from TSE Systems. The conditioning box needs to be equipped with a video 
camera that allows the visualization and recording of the experiment 
The size of the conditioning box should be similar to the size of the observation cages (see 
below), i.e. large enough to allow the experimental animal to avoid the stimulus animal. 
Care is needed that the conditioning box is not too large, especially when conditioning 
mice, as they might be distracted by the novelty of the conditioning box (see Figure 9) 
 Standard cages with sawdust bedding for single- or group-housing of animals 
 Transparent “observation” cages with sawdust bedding: for mice ca. 30 x 25 x 35 cm; for 
rats ca. 55 x 35 x 35 cm 
These cages are needed to allow behavioral monitoring and videotaping. The observation 
cages need to be large enough to allow the experimental animal to avoid the stimulus 
animal. Calculate the approximate size of the observation cage as follows: length =  width 
of the stimulus cage x 4 - 5; width = length of the stimulus cage x 1.5 - 3; height =  height 
of the stimulus cage x 3 - 4.5 to allow unrestrained climbing on the stimulus cage by the 
experimental animal (see Figure 10) 
 Stimulus cages: wire mesh cages or plastic cages with large perforations for encaging 
stimulus animals: for mice ca. 7 x 7 x 6 cm; for rats ca. 20 x 10 x 9 cm 
These cages will be used either as non-social stimuli, i.e. they will remain empty, or as 
social stimuli, i.e. a stimulus animal will be enclosed in the cage. The size of the stimulus 
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cage needs to correspond to the size of the stimulus animals, so that stimulus animals are 
comfortably encaged but cannot move too freely and influence, thereby, the behavior of the 
experimental animal (see Figure 11). Calculate the number of stimulus cages needed as 
the number of animals tested per day + 2  
 
Figure 9. Photograph depicting the conditioning box 
and an experimental mouse investigating the non-
social (left) and social (right) stimuli during social 
fear conditioning. The conditioning box needs to be 
large enough to allow the experimental mouse to 
avoid the social stimulus.  
 
Figure 10. Photograph depicting the observation 
cage and an experimental mouse investigating a 
social stimulus during social fear extinction (see 
section 16.2.). The observation cage needs to be 
large enough to allow the experimental mouse to 
avoid the social stimulus. 
 
Figure 11. Photograph depicting the stimulus cages, 
which are used either as non-social stimuli (up), i.e. 
they remain empty, or as social stimuli (bottom); i.e. 
they are used for enclosing mice (left) and rats 
(right). The size of the stimulus cages needs to 
correspond to the size of the stimulus animals, so 
that stimulus animals are comfortably encaged but 
cannot move too freely.  
 
 Video cameras with tripod. In case you intend to perform the experiments in the dark 
phase, video cameras with night-shot or an infra-red camera and source are needed 
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 Two differently-smelling detergents or cleaning solutions 
 Behavioral analysis program that allows scoring several behaviors at a time, such as 
JWatcher or EventLog  
These programs can be downloaded for free at www.jwatcher.ucla.edu and 
www.manageengine.com/products/eventlog/download 
 Balance to weigh animals 
 Stopwatches (1 for each animal tested in parallel per day) 
NOTE: All protocols using live animals and fear conditioning procedures must first be 
reviewed and approved by an Institutional Animal Care and Use Committee and must follow 
the officially approved procedures for the care and use of laboratory animals.  
Prepare the animals for the experiment  
1. Order animals at least 7 days before they will be used. House experimental mice singly in 
standard cages for 7 days before social fear conditioning. House stimulus animals in 
groups of 4 to 6. If more experimental rooms are available, house experimental animals in 
a separate room from stimulus animals. If only one experimental room is available, avoid 
housing experimental and stimulus animals close to each other 
2. Weigh experimental animals and house them singly in transparent observation cages 3 
days before social fear conditioning. Split the animals into the required number of groups 
based on body weight, such that the mean weight of the groups does not differ 
If experimental animals are housed longer than 3 days in the observation cages, they are 
generally aggressive towards the stimulus animals. You can avoid this by changing the 
sawdust bedding 2-3 days before social fear conditioning 
3. Acclimatize stimulus animals to being enclosed in stimulus cages. Repeat the procedure 10 
min each day for 3 days before social fear conditioning  
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Set up the conditioning environment and perform the social fear conditioning 
(experimental day 1) 
4. Use detergent number 1 to clean 2 stimulus cages and the conditioning box before 
conditioning the first animal 
Use one of the stimulus cages as a non-social stimulus, i.e. this cage will remain empty. 
Use the other stimulus cage as a social stimulus, i.e. enclose a stimulus animal in this 
cage. Change this stimulus animal with a novel one after a maximum of 6 experimental 
animals have been conditioned. This is needed to maintain low stress levels in the stimulus 
animals. Mark the stimulus animals with a waterproof pen and if required use them again, 
however, only for social fear conditioning 
IMPORTANT! Do not use detergent number 1 again! Smell serves as a cue and will 
become associated with the conditioning procedure, and will induce non-social and, 
therefore, unspecific fear 
5. Use detergent number 2 to clean the rest of the stimulus cages 
These cages will be placed over night in the home cage of the experimental animals, i.e. if 
you test 12 animals you need 12 stimulus cages  
6. Set up the computerized fear conditioned system for manual application of 0.7 mA foot 
shocks using a pulsed current. Set up the video camera to record the experiment. Prepare a 
stopwatch 
 
7. Protocol for conditioned animals  
7.1.Take the experimental animal out of its home cage, place it in a standard cage with 
clean sawdust and transport it to the conditioning room. Turn the video camera on to 
record the experiment. Place the animal in the conditioning box and start the stopwatch  
7.2.After a 30-s habituation time, place the non-social stimulus, i.e. empty stimulus cage, in 
a corner of the conditioning box for 3 min  
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7.3.After 3 min, take the non-social stimulus out of the conditioning box and place the 
social stimulus, i.e. the stimulus cage with the enclosed stimulus animal,  in the same 
place where the non-social stimulus has previously been 
7.4.Allow the experimental animal to sniff for 2 - 3 s at the social stimulus, then administer 
a short (ca. 1 s) foot shock. For reliable social fear conditioning, animals should receive 
at least 2 foot shocks (if more than 5 foot shocks are required, exclude the animal from 
the study; see section 7.4.1.1). Two possible scenarios apply here: the experimental 
animal will either approach the social stimulus again or not.  
7.4.1. When the experimental animal approaches the social stimulus again and makes 
nasal contact with the social stimulus, administer immediately a short (ca. 1 s) foot 
shock 
7.4.1.1.If, after the second approach, the experimental animal approaches the social 
stimulus for a third time within 2 min, administer immediately a short foot 
shock. Do not repeat this procedure for more than five times! 
7.4.1.2.If, after the second approach, the experimental animal does not approach the 
social stimulus for 2 min, follow the steps described in point 7.5. and 7.6. 
7.4.2. In rare cases, experimental animals do not approach the social stimulus for a 
second time. If the experimental animal does not approach the social stimulus for 5 
min, follow the steps described in point 7.5. and 7.6. 
7.5.Turn the video camera off. Remove the social stimulus. Take the experimental animal 
out of the conditioning box, place it in the standard cage and transport it back to its 
home cage. Place an empty stimulus cage (cleaned with detergent number 2!) in the 
home cage of the experimental animal over night  
IMPORTANT! It is essential to place the empty stimulus cage over night in the home 
cage of the experimental animals, as the stimulus cage, just like the smell of detergent 
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number 1, serves as a cue and will become associated with the conditioning procedure. 
By placing the stimulus cage over night in the home cage of the experimental animals, 
the fear of this cage will extinguish or not consolidate so that the fear responses 
observed later on are triggered only by the encaged stimulus animals   
7.6.Use detergent number 1 to clean the conditioning box before conditioning the next 
animal 
 
8. Protocol for unconditioned (control) animals 
8.1.Follow the same steps as described in points 7.1. and 7.2.  
8.2.After 3 min, take the non-social stimulus out of the conditioning box and place the 
social stimulus in the same place where the non-social stimulus has previously been, 
again for 3 min 
8.3.After 3 min, follow the steps described in points 7.5. and 7.6.  
IMPORTANT! In case you intend to assess short-term social fear, perform the social fear 
extinction one day after social fear conditioning. In this case, remove the empty stimulus 
cages from the home cage of the experimental animals 1 h before social fear extinction. In 
case you intend to assess long-term social fear, perform the social fear extinction 15 days after 
social fear conditioning. In this case, remove the empty stimulus cages 24 h after social fear 
conditioning 
Set up the testing environment and perform the social fear extinction (day 2 or 15) 
9. Use detergent number 2 to clean the stimulus cages 
These cages can be used as both non-social and social stimuli. If you intend to test 6 
experimental animals at a time you need 6 stimulus cages, 6 stimulus animals – different 
from those used during social fear conditioning, 6 video cameras each with a tripod, and 6 
stopwatches. If you intend to test less than 6 experimental animals, you need the 
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corresponding number of video cameras and stopwatches. However, you will still need 6 
stimulus animals, as each of the 6 social stimuli used during social fear extinction needs to 
be unfamiliar to the experimental animals  
10. Prepare for recording the experiment. Place a video camera on a tripod in front of an 
observation cage, so that you obtain a ca. 45° angle to the long wall of the cage. Place a 
stopwatch next to the observation cage 
 
11. Protocol for short-term social fear assessment (day 2) 
11.1. One hour after removing the stimulus cages, start the social fear extinction procedure. 
Turn the video camera on and place the non-social stimulus in the home cage of the 
experimental animal near a short wall of the cage. Start the stopwatch 
11.2. After 3 min, remove the non-social stimulus and wait for 3 min 
11.3. After 3 min, repeat the procedure 2 more times, so that you expose the experimental 
animal to 3 non-social stimuli for 3 min, with a 3-min inter-exposure interval 
IMPORTANT! In case you do not have enough time to clean the non-social stimuli 
between exposures with detergent number 2, place each non-social stimulus always to 
the same experimental animal. This is essential to prevent unspecific fear responses to 
the smell of a different animal 
11.4. After 3 min pause, place a social stimulus in the home cage for 3 min. Repeat the 
procedure 5 more times, so that you expose the experimental animal to 6 social stimuli 
for 3 min, with a 3-min inter-exposure interval 
IMPORTANT! For each of the 6 social exposures use a different social stimulus! This 
is essential, as fear of general social stimuli is assessed. In case you use the same social 
stimulus for each of the 6 exposures, you can only draw conclusions about social fear 
towards this individual social stimulus (see section Animal considerations: Stimulus 
animals) 
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12. Protocol for long-term social fear assessment (day 15)  
The social fear extinction procedure is performed exactly the same as described for short-
term social fear in point 11. The only point that needs to be considered is that experimental 
animals have been housed in the observation cages for more than two weeks. In this case, 
clean the observation cage and change the sawdust bedding 2 - 3 days before social fear 
extinction. Alternatively, if the animals have been housed in standard cages, house them in 
observation cages 3 days before social fear extinction  
Set up the testing environment and perform the extinction recall (day 3 or 16) 
13. Set up the testing environment as described in points 9. and 10. 
14. Turn the video camera on and place a social stimulus in the home cage of the experimental 
animal near a short wall of the cage. Start the stopwatch 
15. After 3 min, remove the social stimulus and wait for 3 min. Repeat the procedure 5 more 
times, so that you expose the experimental animal to 6 different social stimuli for 3 min, 
with a 3-min inter-exposure interval 
IMPORTANT! For each of the 6 social exposures use a different social stimulus, like 
during social fear extinction! (see section Animal considerations: Stimulus animals for 
more details) 
 
Analysis and interpretation of the obtained data 
16. Social fear conditioning data 
The video of each experimental animal contains the 30 s habituation time, the 3 min with 
the non-social stimulus, and the 3 min with the social stimulus  
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16.1. Analyze and calculate the percentage of non-social investigation and exploration that 
both conditioned and unconditioned animals show during the 3 min with the non-social 
stimulus 
Non-social investigation is defined as sniffing, touching, gnawing, and climbing on the 
non-social stimulus, i.e. the empty stimulus cage 
Exploration is defined as all other behaviors showed, such as sniffing the air or walls of 
the conditioning box, rearing, cleaning, moving, resting, etc 
16.2. Analyze and calculate the percentage of social investigation and exploration that 
unconditioned animals show during the 3 min with the social stimulus 
As conditioned mice receive electric foot shocks when they investigate the social 
stimulus, analysis of social investigation is not needed 
Social investigation is defined as sniffing, touching, biting the stimulus animal, and 
sniffing, touching, gnawing, and climbing on the stimulus cage containing the stimulus 
animal 
Exploration is defined as in point 16.1. 
16.3. Compare the non-social investigation between conditioned and unconditioned animals 
This will be your parameter of pre-conditioning non-social anxiety and should not be 
different between conditioned and unconditioned animals  
16.4. Compare the non-social and social investigation of the unconditioned animals 
This will be your indicator that the animals you are using show social preference, i.e. 
an increased percentage of social compared with non-social investigation 
 
17. Social fear extinction data 
The social fear extinction data of one experimental animal contains nine 3-min videos, 3 
with the non-social stimuli and 6 with the social stimuli 
 
IMPORTANT! If a video contains less than 3 min, it has to be disregarded 




17.1. Analyze and calculate the percentage of non-social and social investigation, defensive 
burying, freezing, and exploration that experimental animals show during each of the 
nine 3-min videos. Count the number of attempt approaches 
Non-social investigation, social investigation, and exploration are defined as in points 
16.1. and 16.2. Reduced non-social and social investigation are indicators of non-social 
and social fear, respectively  
Defensive burying is defined as pushing the sawdust with the forelimbs in the direction 
of the non-social or social stimulus, and is an indicator of fear  
Freezing is defined as absence of movement except that required for respiration, and is 
an indicator of fear 
Attempt approaches are defined as approaches towards the non-social or social 
stimulus with elongation of the body and forward movement of the forepaws, while the 
hind paws are not moved. After an attempt approach, animals often run away. Attempt 
approaches are an indicator of fear 
17.2. Compare the non-social investigation between conditioned and unconditioned animals 
This will be your parameter of non-social fear and should not be different between 
conditioned and unconditioned animals. The animals that do not show non-social 
investigation or show aversive responses towards the non-social stimuli, i.e. defensive 
burying, freezing, or attempt approaches, should be removed from the study, as they are 
probably still afraid of the stimulus cage and the fear they show is not specific to the 
social stimulus 
17.3. Compare the social investigation between conditioned and unconditioned animals 
This will be your parameter of social fear and should be different between conditioned 
and unconditioned animals, with conditioned animals showing reduced levels of social 
investigation 




18. Extinction recall data 
The extinction recall data of one experimental animal contains six 3-min videos with the 




Although a number of paradigms have been shown to induce social fear and avoidance in 
animals (Haller and Bakos, 2002; Gehlert et al., 2005; Huhman, 2006; Franklin et al., 2011), 
most of these paradigms also induce a number of other behavioral alterations, which might 
contribute to the observed social avoidance. These alterations include increased general 
anxiety, depressive-like behavior, and motivation-related alterations such as anhedonia. It 
should be kept in mind, however, that for studying the etiology and the underlying 
mechanisms of pure social fear, animal models that induce specific social fear without any 
confounding behavioral alterations are required. These animal models might lead to a better 
understanding of social fear and, in turn, more specific and efficient medications for patients 
suffering from disorders associated with social deficits, such as SAD, autism spectrum 
disorders, and possibly post-traumatic stress disorder due to social trauma. Additionally, by 
understanding the basic neural circuitries important for the expression of adaptive social fear 
and the way how these circuitries are altered in patients displaying pathological social fear, 
patients that present social fear and anxiety as a co-morbid symptom to other psychiatric 
disorder, such as schizophrenia and depression might also benefit.     
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Critical parameters and Troubleshooting 
Animal considerations: Sex of experimental animals 
Most of the studies on social fear and anxiety have been performed on male rodents for two 
main reasons. First, males lack the potential confounding hormonal fluctuations associated 
with the estrous cycle, which might interact with other experimental parameters. Second, the 
social defeat paradigms, which are the most reliable models to induce social fear and 
avoidance in rodents, and are based on territoriality and establishment of dominant-
subordinate relationships between con-specifics, cannot be reliably used in females of most 
rodent species, except the California mice and Syrian hamsters. This is because females are 
usually not territorial and do not form typical dominant-subordinate relationships with other 
females (Palanza, 2001). The social fear conditioning paradigm can be reliably used to induce 
social fear in females that are not territorial, and the behavioral phenotype induced is very 
specific and comparable to the behavioral phenotype induced in males (Toth et al., 2012b). It 
should be noted, however, that preliminary studies should assess the effects of the estrous 
cycle-associated hormonal fluctuations on female social fear conditioning and extinction. 
Nevertheless, the etiology of social fear and the efficacy of medication needs to be studied 
both in male and female rodents, given the higher prevalence of anxiety disorders, including 
SAD, in women (Talepasand and Nokani, 2010), and the different responses to medication 
between men and women (Franconi et al., 2007). The social fear conditioning paradigm might 
be, therefore, used to assess possible sex differences in both the etiology and treatment of 
social fear.  
Animal considerations: Species-specific factors 
When using the social fear conditioning model, a second point that needs to be considered is 
the species used. Although the paradigm has been originally reported to induce social fear in 
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the CD1 outbred mouse line (Toth et al., 2012b), which might represent a more relevant 
animal model of SAD due to the higher genetic variability, preliminary data have shown that 
the social fear conditioning paradigm can also be reliably used in inbred lines, such as 
C57/Bl6 mice and Wistar rats (Toth et al., unpublished). Although the CD1 and C57/Bl6 are 
both highly social species, we found differences in social behavior, with C57/Bl6 mice 
showing lower levels of social investigation, less social motivation following repeated social 
exposure, and less aggressive behavior towards social stimuli. Therefore, preliminary studies 
should assess the basal level of social investigation and intra-species aggression when using 
different breeding lines for the social fear conditioning experiments. Given the possible inter-
species differences in social behavior, the use of different breeding lines as experimental and 
stimulus animals may lead to inconsistent results (see next section).  
Animal considerations: Stimulus animals 
A highly important aspect that needs to be considered is the selection of stimulus animals, 
namely the age, weight, sex, and strain.  
The use of age- and weight-matched social stimuli is recommended to minimize unspecific 
social avoidance, especially when using male individuals, as previous studies identified 
increased levels of terpenic constituents in the urine of single-housed, dominant or aggressive 
males that work as ‘aversion signals’ for other males and discourage investigation of areas 
marked with this urine (Jones and Nowell, 1973; Novotny et al., 1990). Although females of 
most rodent species do not form typical dominant-subordinate relationships, preliminary 
studies should assess the effects of using larger females as social stimuli on social 
investigation.  
The sex of the stimulus animals may affect not only the level of social investigation, but also 
the neural circuitries recruited by the task. Due to sexually-motivated behaviors, it is expected 
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that male experimental animals spend more time investigating receptive stimulus females and, 
therefore, the social fear will be extinguished faster. If the purpose of the study is not related 
to sexual behavior, the use of ovariectomized females as social stimuli should be considered. 
However, it should be taken into account that investigation of male versus ovariectomized 
female social stimuli by male experimental animals recruits separate neural circuitries (Lukas, 
Toth et al., in press).  
The strain of the stimulus animals should also be taken into account, as different strains of 
rats and mice show different levels of social motivation, social preference, and aggressive 
behavior (Miczek et al., 2001; Lim and Young, 2006). When using genetically-modified 
animals as both experimental and stimulus animals, preliminary screening should assess the 
level of social investigation showed by and directed towards these animals. If not specifically 
otherwise intended, using con-specifics of the same age, weight, sex, and strain as social 
stimuli is, therefore, the best option for the social fear conditioning paradigm to prevent any 
unspecific alterations in social avoidance or investigation.  
Depending on the type of social fear studied, different unknown con-specifics or a single con-
specific can be used as social stimuli during social fear extinction. In this Unit, we described 
the social fear conditioning protocol employed to induce and assess general social fear, such 
as observed in SAD patients. For this purpose, different unknown con-specifics are used for 
social fear conditioning and each of the 6 social exposures during social fear extinction and 
extinction recall. On the other hand, individual social fear, i.e. fear of a specific individual can 
be induced and assessed by using a single con-specific for both social fear conditioning, 
social fear extinction, and extinction recall. In this case, however, it has to be considered that, 
although social investigation might gradually increase in conditioned animals during social 
fear extinction as a result of decreased social fear, a decrease in social investigation does not 
necessary reflect social fear. Repeated exposure to the same con-specific has been shown to 
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decrease social interest in rodents (Thor et al., 1982; Ferguson et al., 2002), and is rather an 
indicator of social memory.  
The protocol described in this Unit implies that single-housed experimental animals show a 
short-lasting social memory, i.e. less than 24 h, which allows the use of the same 6 stimulus 
animals for both social fear extinction and extinction recall. Single-housed rats and mice 
typically show a short-term social memory, i.e. up to 1 h, whereas group-housed mice show a 
long-term social memory, i.e. for 24 h up to 7 days (Kogan et al., 2000; Noack et al., 2010). 
Although the social fear conditioning paradigm implies single-housing the experimental 
animals for 7 days before social fear conditioning, preliminary studies should assess long-
term social memory to exclude any bias on social investigation. If these preliminary studies 
reveal long-term social memory in experimental animals, different unknown con-specifics 
should be used during social fear extinction and extinction recall. 
Impact of housing conditions 
The importance of the size of the observation cage has been briefly discussed in the Materials 
section and plays a relevant role during social fear extinction. Given that exposure to social 
stimuli triggers intense fear responses and avoidance of social stimuli in conditioned animals, 
the home cage where the social fear extinction procedure is performed needs to be large 
enough to allow the free manifestation of these behaviors. The size of the home cage directly 
influences the speed of social fear extinction, i.e. in small cages social fear will be 
extinguished faster, as conditioned animals cannot appropriately avoid the social stimuli, 
whereas in large cages social fear will be extinguished slower, as conditioned animals avoid 
social stimuli when possible (unpublished observations).  
The housing conditions prior to and after social fear conditioning are very important. To 
stimulate social motivation, experimental animals should be single-housed for several days 
Chapter 3                       66  
 
 
prior to social fear conditioning (Niesink and Van Ree, 1982). Single-housing of experimental 
animals after social fear conditioning is essential, as group-housing extinguishes social fear 
and is also known to attenuate the behavioral effects of other stressors, such as social defeat, 
foot-shock exposure, and restraint in water (Ruis et al., 1999; Cherng et al., 2010). 
Given that housing in novel environments triggers short-term increases in locomotor activity 
and arousal, experimental animals should be housed in observation cages at least 24 h prior to 
social fear conditioning to prevent possible novelty-induced anxiety and unspecific anxiety 
responses during social fear extinction. For the best behavioral results, the sawdust bedding 
should be changed 2 - 3 days prior to social fear conditioning. Housing the animals on the 
same bedding and performing the social fear conditioning experiment without changing the 
sawdust bedding should be avoided due to potential increases in territorial-motivated 
aggressive behavior. 
Specificity of the behavioral effects 
The specificity of the behavioral effects induced by social fear conditioning has been verified 
and published for male CD1 mice (Toth et al., 2012b). When using other breeding lines, 
however, preliminary studies should assess the effects of social fear conditioning on basal 
behavioral parameters, such as general anxiety, depressive-like behavior, novelty-induced 
anxiety, and locomotor behavior to rule out other possible confounding behavioral alterations. 
When using the stimulus cages during both social fear conditioning and extinction, a highly 
relevant aspect is that during social fear conditioning the stimulus cage becomes associated 
with the conditioning procedure and triggers fear responses, which lead to unspecific social 
fear during social fear extinction. A reliable way to ensure that social fear is only triggered by 
social stimuli has been described in the method presented and consists of extinguishing the 
fear of the stimulus cage by exposing the experimental animals to this cage over night. 
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Another possibility is to use two different types of cages during social fear conditioning and 
social fear extinction/extinction recall. For this approach, however, unspecific anxiety 
responses to the novel stimulus cage used during social fear extinction need to be ruled out in 
preliminary studies.  
Anticipated results 
The effects of social fear conditioning on both short- and long-term social investigation in 
male CD1 mice have been recently published (Toth et al., 2012b). The social fear 
conditioning induces both short- and long-term social fear, which is expressed as decreased 
social investigation (see Figure 12 for a set of expected results). During social fear extinction, 
the social fear is gradually extinguished as a result of repeated social exposure. While short-
term social fear can be completely extinguished during the social fear extinction procedure, 
long-term social fear is still expressed during extinction recall, indicating that social fear 
sensitizes over time (see Figure 12 for a set of expected results).   
 
Figure 12. Social fear conditioning induces short- and long-term social fear. (A) Pre-conditioning 
investigation of the non-social stimulus (empty cage) by unconditioned (UC) and conditioned (C) mice during 
social fear conditioning on day 1. (B) Investigation of non-social (ns1–ns3) and social (cages with mice; s1–s6) 
stimuli during social fear extinction on day 2 (black line) or on day 15 (dotted line; 3-min exposure to stimulus, 
3-min inter-exposure interval). (C) Investigation of social stimuli (s1–s6) during extinction recall on day 3 (black 
line) or on day 16 (dotted line). Adapted from Toth et al., 2012b. 
 




This section assumes that one experimenter is performing all the procedures. Actual 
performance of the social fear experiment requires a minimum of 3 days, depending on the 
number of experimental animals and the type of social fear assessed, i.e. short- or long-term. 
Long-term social fear studies require ≥ 16 days, depending on the experimental design. In 
more detail, setting up the testing environment for social fear conditioning, social fear 
extinction, and extinction recall requires ca. 30 min each. Social fear conditioning requires a 
maximum of 10 to 15 min per animal. Social fear extinction and extinction recall require cca. 
1 h and 40 min per animal, however, several animals can be tested in parallel. Analysis of the 
obtained data requires ca. 1 h per animal.  
Unlike other animal models that induce social fear and avoidance, social fear conditioning 
experiments are fast, reliable, and do not require large animal numbers to reach statistical 
significance. However, at least 7 social stimuli and special resources are required, such as 
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Central OT has anxiolytic and pro-social properties both in humans and rodents, and has been 
recently proposed as a potential therapeutic agent for disorders associated with social deficits, 
such as SAD. Here, we aimed to verify and localize the effects of OT on social fear in a 
mouse model of SAD, the social fear conditioning, and to determine whether social fear is 
accompanied by alterations at the level of the brain OT system. Central infusion of synthetic 
OT, but not of the closely related neuropeptide AVP, reversed social fear via the OTR without 
decreasing general anxiety or increasing locomotion. Social fear was accompanied by 
alterations in the OT system, namely by increased OTR binding in the bilateral dorso-lateral 
septum (DLS), right CeA, right dentate gyrus (DG), and right cornu ammunis 1 (CA1). These 
alterations normalized after social fear was extinguished and suggest that the DLS, amygdala, 
and the hippocampus might be part of a brain network involved in the development and/or 
neural support of social fear. Infusion of OT into this network, namely into the DLS reversed 
social fear, confirming the involvement of the DLS in social fear. These results demonstrate 
that OT has the potential to reverse social fear in male mice by local effects within the DLS, 
and suggest OT as potential add-on drug in the treatment of disorders associated with social 
deficits, such as SAD.  
  




The appropriate display of social behaviors is essential for the well-being and survival of 
social species, and disorders associated with social deficits, such as SAD are highly 
debilitating (Blanco et al., 2002; Labuschagne et al., 2010). Therefore, substantial research 
has been performed to identify the neuronal circuitries involved in the control of complex 
social behaviors, and to determine how these circuitries are affected in subjects displaying 
social deficits. Given that social fear and avoidance of social situations are the main 
behavioral symptoms of SAD, the best treatment outcomes are obtained with cognitive-
behavioral therapy (Fedoroff and Taylor, 2001), which leads to a gradual fear extinction, i.e. a 
decline in the fear response as a result of repeated exposure to the feared situation. The 
pharmacotherapy for SAD is limited to medication originally designed for depression or 
generalized anxiety, such as antidepressants and benzodiazepines. Even with therapy, many 
SAD patients achieve only partial remission of symptoms, or show a high rate of relapse after 
treatment discontinuation (Blanco et al., 2002). Therefore, the development of approaches 
that combine psychotherapy with more specific pharmacotherapies is still needed.  
One target that has recently received attention is OT, a neuropeptide synthesized within the 
PVN and SON of the hypothalamus (Neumann, 2007). Despite these discrete synthesis sites, 
OTR are widespread throughout the brain (Gimpl and Fahrenholz, 2001). The reason for the 
interest in OT includes the fact that synthetic OT has been shown to facilitate social 
encounters and to decrease anxiety and stress in humans (Bartz and Hollander, 2006; 
Heinrichs et al., 2009). Similar effects were found in rodents, where both synthetic and 
endogenous OT were shown to exert pro-social (Popik and van Ree, 1991; Ferguson et al., 
2001), anxiolytic (Bale et al., 2001; Waldherr and Neumann, 2007; Blume et al., 2008), and 
stress-attenuating (Windle et al., 1997; Neumann et al., 2000) effects. More relevant for SAD, 
we have recently shown that brain OT is essential for social preference in rats and mice and 
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synthetic OT reverses the social avoidance induced by acute social defeat (Lukas et al., 2011). 
However, given that acute social defeat induced a rather individual social fear, the effects of 
OT need to be verified in an animal model that induces general social fear and mimics the 
behavioral symptoms of SAD more accurately.  
Therefore, in the present study we aimed to verify and localize the effects of OT on social fear 
in a mouse model of SAD, the social fear conditioning (Toth et al., 2012b), which was shown 
to induce a behavioral phenotype similar to SAD. Furthermore, we aimed to determine 
whether the social fear induced by social fear conditioning is accompanied by alterations in 
the brain OT system.  
 
MATERIALS AND METHODS 
Animals 
Male CD1 mice (Charles River, Sulzfeld, Germany, 30 - 35 g) were individually housed for 1 
week and transferred to observation cages (30 x 23 x 36 cm) 3 days before experiments 
started. Age- and weight-matched male CD1 mice were used as social stimuli. Mice were kept 
under standard laboratory conditions (12:12 light/dark cycle, lights on at 06:00, 22°C, 60% 
humidity, food and water ad libitum). Experiments were performed during the light phase, 
between 08:00 and 12:00, in accordance with the Guide for the Care and Use of Laboratory 
Animals of the Government of Oberpfalz and the guidelines of the National Institutes of 
Health. 
Social fear conditioning paradigm 
Social fear conditioning (day 1). Mice were placed in the conditioning chamber (45 x 22 x 40 
cm) and, after a 30-s adaptation period, an empty wire mesh cage (7 x 7 x 6 cm) was placed as 
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a non-social stimulus near one of the short walls. After 3 min, the non-social stimulus was 
replaced by an identical cage containing an unfamiliar male mouse. Unconditioned (UC) mice 
were allowed to investigate this social stimulus for 3 min. Conditioned (C) mice were given a 
1-s electric foot shock (0.7 mA, pulsed current) each time they investigated the social 
stimulus. Mice received between 2 and 5 foot shocks, with a variable inter-shock interval, 
depending on when social contact was made. Mice were returned to their home cage when no 
further social contact was made for 2 min. The time investigating the non-social stimulus was 
considered as a pre-conditioning measure of non-social anxiety.  
Social fear extinction (day 2). One day after social fear conditioning, mice were exposed in 
their home cage to 3 different non-social stimuli, i.e. empty cages, to assess non-social 
investigation as a parameter of non-social fear. Mice were then exposed to 6 different 
unfamiliar social stimuli, i.e. male mice, each in a different cage, to assess social investigation 
as a parameter of social fear. Each stimulus was placed near a short wall of the home cage and 
presented for 3 min, with a 3-min inter-exposure interval.  
Extinction recall (day 3). One day after social fear extinction, mice were exposed in their 
home cage to 6 different unfamiliar social stimuli for 3 min, with a 3-min inter-exposure 
interval.  
Elevated plus-maze 
General anxiety was tested on the EPM as previously described (Toth et al., 2012b). Increased 
percentage of time spent on the open arms (110 lx) indicated reduced anxiety. The number of 
entries into the closed arms (25 lx) during the 5-min testing period indicated locomotor 
activity.  
 
Chapter 4                       74  
 
 
Home cage locomotion 
Locomotion was measured for 1 h using the Noldus system (Noldus Information Technology, 
Wageningen, The Netherlands) after a 1-min removal of the mice from the home cage (Toth 
et al., 2012b,c). 
Stereotaxic cannula implantation 
Implantation of guide cannulas (21 G, 8 mm length; Injecta GmbH, Germany) for 
intracerebroventricular (icv) or local infusions was performed under isoflurane anesthesia 
(Forene®, Abbott GmbH & Co. KG, Wiesbaden, Germany) as previously described (Toth et 
al., 2012c), either 2 mm above the right lateral ventricle (from Bregma: + 0.2 mm, lateral: + 
1.0 mm, depth: + 1.4 mm) or bilateral 1 mm above the DLS (from Bregma: - 0.3 mm, lateral: 
± 0.5 mm, depth: + 1.6 mm; Paxinos and Franklin, 1997). To avoid post-surgical infections, 
mice received subcutaneous antibiotics (s.c.; 3 mg/30 μl Baytril®, Bayer Vital GmbH, 
Leverkusen, Germany). After surgery, mice were handled for 5 days before experiments 
started.  
Intracerebral infusions 
Mice received icv or DLS infusions of either vehicle (sterile Ringer solution; icv 2 µl, DLS 
0.2 µl/side), synthetic OT (Sigma-Aldrich, Germany; icv: 0.1 or 0.5 µg/2 µl; DLS: 5 ng/0.2 
µl/side), synthetic AVP (Sigma-Aldrich, Germany; icv: 0.1 or 0.5 µg/2 µl), or a selective 
OTR antagonist (OTR-A; desGly-NH2,d(CH2)5[Tyr(Me)2,Thr4]OVT; icv: 2 µg/2 µl) via an 
infusion cannula connected via polyethylene tubing to a Hamilton syringe.  
The correct infusion site was histologically verified after the experiment. One DLS-infused 
mouse was removed from the study. Drug doses and timing were selected based on previous 
studies (Lukas et al., 2011; Kessler et al., 2011; Toth et al., 2012c). 




To determine the influence of social fear and its extinction on OTR binding, the following 
groups were studied: 1) naïve mice; 2) UC-ext: unconditioned mice without social fear 
extinction; 3) UC+ext: unconditioned mice with prolonged social fear extinction, i.e. 
exposure to 12 social stimuli instead of 6; 4) C-ext: conditioned mice without social fear 
extinction; 5) C+ext: conditioned mice with prolonged social fear extinction to ensure 
complete extinction of social fear in all mice. We have previously shown that social fear is 
completely extinguished 24h after the social fear extinction procedure (Toth et al., 2012b). 
Forty-eight hours after social fear conditioning (Litvin et al., 2011) mice were killed using 
CO2, brains were removed, snap frozen, and stored at -20°C. Brains were cut in 16 µm 
coronal sections targeting the CeA, basolateral (BLA) and medial (MeA) amygdala, DG, 
CA1, CA3, IL, PL, cingulate cortex (CC), medial preoptic area (MPOA), ventro-lateral 
septum (VLS), DLS, nucleus accumbens (NAc), and BNST (see Figure 13). These brain 
regions were selected based on their role in conditioned fear and social behavior (LeDoux and 
Muller, 1997; Neumann, 2008). OTR autoradiography was performed as previously described 
(Caughey et al., 2011). OTR binding was expressed as grey density and calculated for each 
mouse by taking the mean of 4 to 6 sections per region of interest. Left and right regions were 
scored separately.  
Statistical analysis 
PASW/SPSS (Version 17) was used. Data were analysed by Student’s t-tests, one- or two-
way ANOVA for repeated measures, followed by a Bonferroni post-hoc analysis whenever 
appropriate. Statistical significance was set at p<0.05. Overall statistics are shown in Table 6 
and 7. 





Figure 13. Autoradiograms showing the regions of 
interest where OTR binding was quantified. 
Arrowheads indicate the prelimbic (PL) and 
infralimbic (IL) cortex, nucleus accumbens (NAc), 
cingulate cortex (CC), dorso- (DLS) and ventro- 
(VLS) lateral septum, central (CeA), baso-lateral 
(BLA), and medial (MeA) amygdala,  bed nucleus of 
the stria terminalis (BNST), medial preoptic area  
(MPOA), cornu ammunis 1 (CA1) and 3(CA3), dentate gyrus (DG). 
 
 
                 Experiment Group effect 
Group × stimulus or time 
effect 
Effects of icv OT on: 
    Social fear (Figure 14) 
 
  
         Social fear conditioning (day 1)    F(5,46)=0.15; p=0.98  
         Social fear extinction (day 2)    F(5,46)=15.36; p<0.01*    F(40,368)=5.31; p<0.01* 
            Extinction recall (day 3)    F(5,46)=3.44; p=0.01 *     F(25,230)=1.45; p=0.08 
       General anxiety (EPM; Figure 19)      F(2,19)=0.42; p=0.66  
    EPM locomotion (Figure 19)    F(2,19)=0.13; p=0.88   
    Home cage locomotion (Figure 19)    F(2,17)=6.88; p=0.01*    F(10,85)=1.38; p=0.20 
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                 Experiment Group effect 
Group × stimulus or time 
effect 
 Effects of OTR-A on:  
    Social fear (Figure 15)   
         Social fear conditioning (day 1)    F(4,30)=0.26; p=0.90   
         Social fear extinction (day 2)    F(4,30)=7.54; p<0.01*     F(32,240)=2.61; p<0.01* 
            Extinction recall (day 3)    F(4,30)=3.87; p=0.01*     F(20,150)=0.67; p=0.85 
       General anxiety (EPM; Figure 19)    T(10)=0.61; p=0.56   
    EPM locomotion (Figure 19)    T(10)=1.54; p=0.16   
       Home cage locomotion (Figure 19)      F(1,18)=0.07; p=0.79       F(5,90)=0.41; p=0.84 
 
Effects of icv AVP on: 
    Social fear (Figure 16)     
         Social fear conditioning (day 1)    F(3,19)=0.39; p=0.76  
         Social fear extinction (day 2)    F(3,19)=7.10; p<0.01*     F(24,152)=3.97; p<0.01* 
            Extinction recall (day 3)      F(3,19)=3.47; p=0.04*       F(15,95)=0.64; p=0.84 
       General anxiety (EPM; Figure 19)    F(2,19)=19.76; p<0.01*  
    EPM locomotion (Figure 19)    F(2,19)=4.39; p=0.03*  
    Home cage locomotion (Figure 19)    F(2,15)=3.34; p = 0.06    F(10,75)=3.17; p<0.01* 
 
Effects of DLS OT on: 
    Social fear (Figure 18) 
  
         Social fear conditioning (day 1)    F(2,20)=1.00; p=0.38  
         Social fear extinction (day 2)      F(2,20)=11.47; p<0.01*      F(16,160)=5.58; p<0.01* 
            Extinction recall (day 3)    F(2,20)=7.10; p=0.01*    F(10,100)=2.17; p=0.03* 
       General anxiety (EPM; Figure 19)    T(15)=-0.64; p=0.53  
    EPM locomotion (Figure 19)    T(15)=-0.90; p=0.38 
 
 
Table 6. Overall statistics for the behavioral data. Icv, intracerebroventricular; OT, oxytocin; EPM, elevated 
plus-maze; OTR-A, OT receptor antagonist; AVP, arginine vasopressin; DLS, dorso-lateral septum. Stimulus 
effect refers to both non-social and social stimuli during social fear extinction, while only to social stimuli during 
extinction recall. Time effect refers to the time-bins during home cage locomotion measurements. Student’s t-
tests, one-way or two-way ANOVA for repeated measures followed by Bonferroni post-hoc test; *p<0.05. 
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Table 7. Overall statistics for the oxytocin receptor autoradiography. DLS, dorso-lateral septum; CeA, 
central amygdala; DG, dentate gyrus; CA1, cornu ammunis 1; MPOA, medial preoptic area. Student’s t-test 
refers to statistical comparison between naïve and UC-ext groups. Two-way ANOVA for repeated measures 
(comparison between UC-ext, UC+ext, C-ext and C+ext groups) followed by Bonferroni post-hoc test; *p<0.05. 
 
RESULTS 
Icv OT reverses social fear 
To verify whether OT reverses social fear, conditioned and unconditioned mice (n = 6 to 10 
per group) were infused icv with either vehicle or OT (0.1 or 0.5 µg) 10 min before social fear 
extinction on day 2.  
Mice showed similar non-social anxiety during social fear conditioning (Figure 14A, Table 
6). Conditioned mice received a similar number of foot shocks during social fear conditioning 
(vehicle 2.0±0.3; 0.1 µg OT 2.1±0.2; 0.5 µg OT 2.5±0.2; F(2,23)=0.79, p=0.47). During social 
fear extinction, all groups showed similar non-social investigation. While conditioned 
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vehicle-treated mice showed reduced social investigation compared with all other groups 
(p≤0.01; Figure 14B) reflecting social fear, both doses of OT increased social investigation to 
levels found in unconditioned mice. During extinction recall on day 3, conditioned vehicle-
treated mice still showed reduced social investigation compared with unconditioned vehicle- 
and OT-treated (0.1 µg) mice (p<0.05; Figure 14C).   
 
Figure 14. Intracerebroventricular oxytocin (OT) reverses social fear. (A) Investigation of the non-social 
stimulus (empty cage) during social fear conditioning on day 1 (n = 6 to 10 per group). (B) Investigation of the 
non-social (ns1-ns3) and social (cages with mice; s1-s6) stimuli during social fear extinction on day 2 (3 min 
exposure to stimulus, 3 min inter-exposure interval). Unconditioned (UC) and conditioned (C) mice were infused 
icv with either vehicle (Veh; 2 µl) or OT (0.1 or 0.5 µg/2 µl) 10 min before social fear extinction. (C) 
Investigation of social stimuli (s1-s6) during extinction recall on day 3. Data represent means ± SEM. *p<0.05 
vs. all groups. 
 
OT reverses social fear via OTR and is required for social investigation 
To verify the involvement of brain OTR in the effects of OT on social fear, conditioned and 
unconditioned mice (n = 7 per group) were infused icv with either vehicle or OTR-A 40 min 
before social fear extinction on day 2. Thirty min later, vehicle-treated mice were infused with 
vehicle, while OTR-A-treated mice were infused with either vehicle or OT (0.1 µg).  
Mice showed similar non-social anxiety during social fear conditioning (Figure 15A, Table 
6). Conditioned mice received a similar number of foot shocks during social fear conditioning 
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(Veh/Veh 2.3±0.4; OTR-A/Veh 2.1±0.3; OTR-A/OT 2.3±0.2; F(2,18)=0.07, p=0.93). During 
social fear extinction, all groups showed similar non-social investigation. All groups, 
including the unconditioned OTR-A/Veh-treated mice, showed reduced social investigation 
compared with unconditioned Veh/Veh-treated mice (p<0.05; Figure 15B). During extinction 
recall on day 3, conditioned Veh/Veh-treated mice still showed reduced social investigation 
compared with unconditioned Veh/Veh-treated mice (p<0.05; Figure 15C).   
 
Figure 15. Oxytocin (OT) reverses social fear via OT receptor (OTR) and is required for social 
investigation. (A) Investigation of the non-social stimulus (empty cage) during social fear conditioning on day 1 
(n = 7 per group). (B) Investigation of the non-social (ns1-ns3) and social (cages with mice; s1-s6) stimuli during 
social fear extinction on day 2 (3 min exposure to stimulus, 3 min inter-exposure interval). Unconditioned (UC) 
and conditioned (C) mice were infused icv with either vehicle (Veh; 2 µl) or OTR antagonist (OTR-A; 2 µg/2 
µl) 40 min before social fear extinction. Thirty min later, Veh-treated mice were infused with Veh, while OTR-
A-treated mice were infused with either Veh or OT (0.1 µg/2 µl). (C) Investigation of social stimuli (s1-s6) 
during extinction recall on day 3. Data represent means ± SEM. p<0.05 *vs. all groups; # vs. all groups except 
UC OTR-A/Veh. 
 
Icv AVP does not reverse social fear 
To confirm peptide-specificity of OT effects, conditioned and unconditioned mice (n = 5 to 6 
per group) were infused icv with either vehicle or AVP 10 min before social fear extinction 
on day 2.  
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Mice showed similar non-social anxiety during social fear conditioning (Figure 16A, Table 
6). Conditioned mice received a similar number of foot shocks during social fear conditioning 
(vehicle 2.6±0.4 vs. AVP 2.5±0.2; T(9)=0.23, p=0.82). During social fear extinction, 
conditioned mice showed similar non-social investigation, but reduced social investigation 
compared with unconditioned mice, independent of treatment (p<0.05; Figure 16B). During 
extinction recall on day 3, there was a main group effect (Figure 16C), but post-hoc analysis 
revealed no significant differences between the groups. 
 
Figure 16. Intracerebroventricular arginine vasopressin (AVP) does not reverse social fear. (A) 
Investigation of the non-social stimulus (empty cage) during social fear conditioning on day 1 (n = 5 to 6 per 
group). (B) Investigation of the non-social (ns1-ns3) and social (cages with mice; s1-s6) stimuli during social 
fear extinction on day 2 (3 min exposure to stimulus, 3 min inter-exposure interval). Unconditioned (UC) and 
conditioned (C) mice were infused icv with either vehicle (Veh; 2 µl) or AVP (0.1 µg/2 µl) 10 min before social 
fear extinction. (C) Investigation of social stimuli (s1-s6) during extinction recall on day 3. Data represent means 
± SEM. *p<0.05 vs. UC Veh. 
 
Social fear and its extinction alter OTR binding 
Given the role of OT in both social investigation (Lukas et al., 2011) and social fear reversal 
(Figure 14), we determined whether social fear conditioning and social fear extinction alter 
OTR binding in brain regions associated with conditioned fear and social behavior. Student’s 
t-tests revealed no difference between naïve and UC-ext mice in any of the brain regions 
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investigated (Figure 17A-E, Table 7). Therefore, two-way ANOVA with factors conditioning 
and extinction was performed between UC-ext, C-ext, UC+ext and C+ext mice. 
 
 
Figure 17. Social fear and its extinction alter 
oxytocin receptor (OTR) binding. Mice (n = 6 per 
group) were exposed to social fear conditioning, with 
naïve mice as control. Unconditioned (UC) and 
conditioned (C) mice were exposed (+) or not (-) to a 
prolonged social fear extinction 24 h after social fear 
conditioning. Forty eight hours after social fear 
conditioning, brains were collected and processed for 
OTR autoradiography. DLS, dorso-lateral septum;  
CeA, central amygdala; DG, dentate gyrus; CA1, cornu ammunis 1; MPOA, medial preoptic area; Data 
represent means ± SEM. *,(*)p<0.05; * Bonferroni post-hoc; (*) Mann-Whitney-U-test. 
 
A significant conditioning x extinction interaction effect was found bilaterally in the DLS, 
right CeA, right DG, and right CA1, where conditioned mice without social fear extinction 
(C-ext) showed an increased OTR binding compared with their respective unconditioned 
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controls (UC-ext; Figure 17A-D). After social fear extinction, however, OTR binding no 
longer differed between conditioned and unconditioned mice (C+ext vs. UC+ext). Separate 
statistics (Mann-Whitney-U-test) revealed a decreased OTR binding bilaterally in the DLS of 
conditioned mice after social fear extinction (C-ext vs. C+ext).  
Moreover, a significant extinction effect was observed within the MPOA and right DG 
(Figure 17C,E). In more detail, prolonged social fear extinction increased OTR binding in 
both conditioned and unconditioned mice in the MPOA, whereas in the right DG it increased 
OTR binding in unconditioned mice (UC-ext vs. UC+ext), while it decreased OTR binding in 
conditioned mice (C-ext vs. C+ext). 
There were no group differences in OTR binding in the BLA, MeA, CA3, IL, PL, CC, VLS, 
NAc, and BNST (data not shown). 
 
OT reverses social fear within the DLS 
To determine whether alterations in OTR binding in the DLS are involved in social fear, mice 
(n = 7 to 8 per group) were infused bilaterally into the DLS with either vehicle or OT 10 min 
before social fear extinction on day 2.  
Mice showed similar non-social anxiety during social fear conditioning (Figure 18A, Table 
6). Conditioned mice received a similar number of foot shocks during social fear conditioning 
(vehicle 2.8±0.3 vs. OT 2.8±0.4; T(14)=0.0, p=1.0). During social fear extinction, all groups 
showed similar non-social investigation. While conditioned vehicle-treated mice showed 
reduced social investigation compared with both groups (p<0.01; Figure 18B) reflecting 
social fear, OT increased social investigation to levels found in unconditioned mice. During 
extinction recall on day 3, conditioned vehicle-treated mice still showed reduced social 
investigation compared with both groups (p<0.05; Figure 18C).   




Figure 18. Oxytocin (OT) reverses social fear within the dorso-lateral septum (DLS). (A) Investigation of 
the non-social stimulus (empty cage) during social fear conditioning on day 1 (n = 7 to 8 per group). (B) 
Investigation of the non-social (ns1-ns3) and social (cages with mice; s1-s6) stimuli during social fear extinction 
on day 2 (3 min exposure to stimulus, 3 min inter-exposure interval). Unconditioned (UC) and conditioned (C) 
mice were infused bilaterally into the DLS with either vehicle (Veh; 0.2 µl/side) or OT (5 ng/0.2 µl/side) 10 min 
before social fear extinction. (C) Investigation of social stimuli (s1-s6) during extinction recall on day 3. Data 
represent means ± SEM. *p<0.05 vs. both groups. 
 
Effects of OT, OTR-A, and AVP on general anxiety and locomotion 
To verify the specificity of these effects on social fear conditioning, separate groups of mice 
(n = 6 to 9 per group) were infused icv or within the DLS with either vehicle, OT, OTR-A, or 
AVP at the same doses as for the social fear conditioning experiments, and tested either on 
the EPM 10 min later, or in the home cage immediately thereafter. 
Neither icv nor DLS infused OT affected general anxiety or locomotion on the EPM (Figure 
19, Table 6). Home cage locomotion was increased by 0.5, but not by 0.1 µg icv OT, as 
previously reported (Toth et al., 2012c). OTR-A did not affect general anxiety, EPM and 
home cage locomotion. Both doses of AVP increased general anxiety, while 0.5, but not 0.1 
µg AVP decreased EPM locomotion, and tended to decrease home cage locomotion.  
 
  




Figure 19. Effects of oxytocin (OT; intracerebroventricular [icv] A-C; dorso-lateral septum [DLS]: J,K), OT 
receptor antagonist (OTR-A; D-F), arginine vasopressin (AVP; G-I) on general anxiety on the elevated plus-
maze (EPM, time open arms), locomotor activity on the EPM (closed arm entries) and in the home cage. Mice 
were infused icv or bilaterally into the DLS with either vehicle (Veh; icv 2 µl; DLS 0.2 µl/side), OT (icv 0.1 or 
0.5 µg/2 µl; DLS 5 ng/0.2 µl/side), OTR-A (icv 2 µg/2 µl), or AVP (icv 0.1 or 0.5 µg/2 µl) and tested either on 
the EPM 10 min later, or in the home cage immediately thereafter. Data represent means ± SEM. *p<0.05. 




The present study demonstrates that OT has the potential to reverse social fear of unknown 
con-specifics in male mice through OTR-mediated actions, without causing any confounding 
behavioral alterations in general anxiety or locomotor activity. Social fear was accompanied 
by an increased OTR binding in the bilateral DLS, right CeA, right DG, and right CA1. These 
alterations normalized after extinction of social fear and suggest that the DLS, amygdala, and 
the hippocampus might be part of a brain network involved in the development and/or neural 
support of social fear. Importantly, infusion of OT within the DLS reversed social fear, 
thereby localizing the effects of OT on social fear. Taken together, these results suggest that 
the DLS is an important region in the expression and extinction of social fear and that OT 
may be a potential add-on drug for the treatment of disorders associated with social deficits, 
such as SAD.  
We have previously shown that OT reverses avoidance of a dominant con-specific induced by 
social defeat in male rats (Lukas et al., 2011). Here, we extend these findings by showing that 
OT not only reverses social avoidance towards a specific previously encountered con-specific, 
but also general social fear of several unknown con-specifics, making the translation of these 
findings to humans more applicable. Importantly, OT only increased social investigation in 
conditioned, but not in unconditioned mice, as we have previously shown in male rats (Lukas 
et al., 2011). Similarly, in male goldfish, icv infused isotocin, the teleost correspondent of OT 
(Acher et al., 1995), increased social approach only in individuals with low sociability 
(Thompson and Walton, 2004). Although synthetic OT decreased general anxiety when 
infused into the PVN (Blume et al., 2008) or into the CeA (Bale et al., 2001), icv OT did not 
alter general anxiety on the EPM, as previously reported in rats (Slattery and Neumann, 
2010), indicating that the reversal of social fear by OT is unlikely due to its general anxiolytic 
properties. Furthermore, the increased social investigation in conditioned OT-treated mice 
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was not due to increased locomotion, as neither EPM nor home cage locomotion was altered 
after OT (0.1 µg) treatment. However, the higher OT dose (0.5 µg) increased home cage 
locomotion, while slightly decreasing social investigation in both conditioned and 
unconditioned mice, indicating that, if anything, increases in locomotion have a rather 
distracting effect on social investigation. Interestingly, OT infused icv 10 min prior to social 
fear extinction seems to specifically reverse social fear, but not fear in general, as OT infused 
icv at a comparable time-point delayed extinction in a cued fear conditioning paradigm, where 
the feared stimulus is a tone (Toth et al., 2012c). Therefore, the effect of OT on social fear 
might be related to the social aspect of the social fear conditioning paradigm and the pro-
social properties of OT. 
We also showed that OT reversed social fear via the OTR, as pre-administration of an OTR-A 
blocked its effects. Interestingly, OTR-A decreased social investigation in unconditioned mice 
without inducing non-specific alterations in locomotion, general anxiety, or typical signs of 
social fear as those seen in conditioned mice, i.e. freezing, attempt approaches, and defensive 
burying (Toth et al., 2012b). This suggests that endogenous OT is required for naturally-
occurring social investigation, and confirms our previous study in male rats and mice (Lukas 
et al., 2011).  
We could show that the reversal of social fear was specific to OT, as the closely related 
neuropeptide AVP did not reverse social fear; however, its anxiogenic effect on the EPM 
could be confirmed (Bhattacharya et al., 1998; Kessler et al., 2011). High doses of AVP (0.5 
µg) decreased locomotion, contraindicating their use in the social fear conditioning 
experiment. As AVP and OT often exert opposite effects on behavior (Roozendaal et al., 
1992; Thompson and Walton, 2004), the use of AVP receptor antagonists could be considered 
for future social fear conditioning experiments.   
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Considering these findings and previous studies showing social interaction- (Murakami et al., 
2011) and social defeat- (Litvin et al., 2011) induced alterations in OTR expression, we 
determined the effect of social fear conditioning on OTR binding in brain regions involved in 
social behavior and conditioned fear (LeDoux and Muller, 1997; Neumann, 2008). Whereas a 
single 3-min exposure to a social stimulus was not sufficient to alter OTR binding in any of 
the brain regions investigated, alterations in OTR binding were found as a result of either 
social fear conditioning or repeated social exposure during the prolonged social fear 
extinction procedure. In more detail, OTR binding was increased in the MPOA of both 
conditioned and unconditioned mice in response to repeated social exposure. This result is in 
accordance with previous studies showing increased c-Fos expression in the MPOA in 
response to same-sex social stimuli (Ferguson et al., 2001; Richter et al., 2005). The increased 
OTR binding in the MPOA might be, therefore, relevant for recognition of social stimuli, as 
OT infusion into the MPOA facilitated social recognition (Popik and van Ree, 1991).  
OTR binding was increased in the right CeA, right DG, right CA1, and bilaterally in the DLS 
of conditioned mice without social fear extinction. Importantly, this increase in OTR binding 
normalized after extinction of social fear, suggesting that alterations at the level of the brain 
OT system might be involved in the development and/or neural support of social fear. 
Interestingly, we found no alterations in OTR binding in the rest of the brain regions 
investigated, suggesting that these alterations are specific to brain regions involved in 
processing social fear-related information and in the display of social fear.  
The CeA coordinates the behavioral and physiological correlates of fear expression (LeDoux 
et al., 1988), and both local infusion (Roozendaal et al., 1992; Viviani et al., 2011) and 
evoked axonal release of OT (Knobloch et al., 2012) attenuated the fear response in rodents. 
Similar to our conditioned mice, Rhesus monkeys with exaggerated defensive and fear-related 
behavior towards human intruders show increased activity in the right amygdala (Kalin et al., 
Chapter 4                       89  
 
 
1998). Furthermore, SAD patients show hyperactivity of the amygdala in response to 
threatening faces (Labuschagne et al., 2010), which can be attenuated by nasal OT (Kirsch et 
al., 2005; Labuschagne et al., 2010). The increased OTR binding in the CeA might be, 
therefore, relevant for processing threatening stimuli and for the display of social fear.  
The DG and CA1 are important for memory processing both in humans (Nadel et al., 2007) 
and rodents (Corcoran and Maren, 2001) and support, together with the amygdala, contextual 
fear conditioning (Kim et al., 1993). The increased OTR binding in the hippocampus might 
be, therefore, relevant for processing context-dependent information related to social fear. 
The increased OTR binding in the DLS of conditioned mice without social fear extinction is 
in accordance with a previous study showing increased OTR mRNA in the LS of chronically-
defeated mice (Litvin et al., 2011), and suggests that the DLS might be relevant for 
recognition of stimuli associated with the conditioning procedure. In support, increased c-Fos 
expression was found in the LS after cued fear conditioning (Calandreau et al., 2007), while 
pre-conditioning inactivation of the LS disrupted fear conditioning (Calandreau et al., 2007), 
indicating a role of the LS in fear learning. The LS was also involved in social and associative 
memory (Igelstrom et al., 2010), where the OT system plays a crucial role, with OT 
facilitating (Popik et al., 1992) and OTR-A impairing social recognition (Lukas, Toth et al., in 
press).  
Considering the same pattern of OTR binding alterations found in the CeA, hippocampus and 
DLS of conditioned mice and the interconnectivity between these regions (Gallagher et al., 
1995; Sheehan et al., 2004), it can be suggested that these limbic areas might be part of a 
brain network involved in the development and/or neural support of social fear. Given that the 
LS receives input from both the hippocampus (Gallagher et al., 1995) and the amygdala 
(Sheehan et al., 2004), and that the DLS was the only region where the OTR binding 
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alterations occurred bilaterally, we infused OT into the DLS and demonstrated its potential to 
reverse social fear. Similar to its icv effects, DLS-infused OT did not increase social 
investigation through unspecific alterations in general anxiety and locomotion. Although we 
have shown here that OT reverses social fear when infused into the DLS, it is not excluded 
that similar effects would be found when infused into the CeA, DG, or CA1. 
The findings of increased OTR binding in the DLS of conditioned mice with social fear, 
which might indicate a more efficient OT neurotransmission, and OT reversing social fear 
when infused into the DLS is intriguing. Two possible explanations are that OTR are up-
regulated in these mice to compensate for a decreased local OT release and thus extracellular 
availability or for an impaired OTR signaling. These hypotheses are not mutually exclusive, 
but whether social fear decreases OT release or impairs OTR signaling remains to be verified.  
Although most human studies focus on the amygdala in relation to social fear (Kirsch et al., 
2005; Domes et al., 2007b; Labuschagne et al., 2010), our study suggests the involvement of a 
more complex brain network in the development and/or neural support of social fear. Given 
the possibility of intranasal OT delivery in humans, it might seem relevant for future studies 
to focus on the lateral septum as well.  
In summary, we have shown that the brain OT system is altered in conditioned mice without 
social fear extinction, and that these alterations normalized after extinction of social fear. We 
have also shown that OT has the potential to reverse social fear, an effect that we localized 
within the DLS. Our findings suggest OT as potential add-on drug in the treatment of 
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OT has been proposed as a potential therapeutic agent for PTSD. In this study, we aimed to 
verify whether pharmacological manipulation of the brain OT system affects cued fear 
conditioning and extinction. Male rats and mice were administered icv synthetic OT (rats: 0.1 
or 1.0 μg/5 μl; mice: 0.1 or 0.5 μg/2 μl) and/or OTR-A (rats: 0.75 μg/5 μl) either before cued 
fear conditioning or cued fear extinction. Preconditioning administration of OT did not affect 
fear conditioning in rats, but decreased fear expression and facilitated fear extinction. In 
contrast, preconditioning blockade of OT neurotransmission by OTR-A did not affect fear 
conditioning or fear expression, but impaired fear extinction. When administered before cued 
fear extinction, OT impaired fear extinction in both rats and mice, indicating that the effects 
of OT on fear extinction are conserved across species. This impairment was OTR-mediated, 
as the inhibitory effect of OT on fear extinction was abolished by prior treatment with OTR-
A. The impaired fear extinction was not a result of reduced locomotion in rats, whereas an 
apparent decrease in fear expression and facilitation of fear extinction with the higher OT 
dose in mice was the result of behavioral hyperactivity. These results suggest that increasing 
OT neurotransmission during traumatic events is likely to prevent the formation of aversive 
memories. In contrast, OT treatment before cued fear extinction, which would be the 
comparable time-point for psychotherapy in PTSD patients, rather delays fear extinction and, 
therefore, caution is needed before recommending OT for the treatment of PTSD. 
 
  




Pavlovian fear conditioning is a form of learning in which an association between a stimulus 
and its aversive consequences is made. Cued fear conditioning has been used in laboratory 
animals as a model of PTSD and involves the presentation of a neutral stimulus, such as a 
tone or light (CS) in association with an aversive stimulus, such as a mild foot shock (US). 
Through repeated CS-US associations, animals learn that the CS predicts the US, and a 
conditioned response, such as freezing (Fanselow, 1980), is elicited in the absence of the US. 
Fear extinction is regarded as a form of new learning (for reviews see Cammarota et al., 2007; 
Quirk et al., 2010) and is defined as the attenuation of the conditioned response by repeated 
exposure to the CS without the US. Inability to extinguish fear memories was shown to 
involve hyperactivity of the amygdala (Rauch et al., 2000; Stein et al., 2002; Dilger et 
al., 2003) and is a core symptom in several psychiatric disorders, such as specific phobia, 
generalized anxiety disorder, SAD, panic disorder, and PTSD. The current treatment for 
PTSD consists of psychotherapy, often combined with antidepressant, benzodiazepine, and 
antipsychotic treatment, with SSRIs providing the best response rates (Marshall and 
Pierce, 2000; Stein et al., 2006, 2009). However, treatment-resistant PTSD patients achieve 
only partial symptom remission or show a high rate of relapse after treatment discontinuation 
(Davidson et al., 2004; Bisson et al., 2007; Brunello et al., 2001; Ipser et al., 2006). Therefore, 
the development of approaches that combine psychotherapy with novel pharmacotherapy is 
still needed. 
Neuropeptides, which have discrete synthesis, release, and receptor sites in the brain 
(Landgraf and Neumann, 2004; Wotjak et al., 2008), have emerged as viable research 
candidates with respect to both pathophysiology and treatment of PTSD (Gülpinar and 
Yegen, 2004; Viero et al., 2010). One such neuropeptide, OT, which is synthesized in the 
PVN and SON of the hypothalamus and centrally released within these hypothalamic and 
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other limbic regions, including the septum, hippocampus, and CeA in response to various 
stressful stimuli (Ebner et al., 2005; Neumann, 2007), has been recently proposed as a 
potential therapeutic agent for PTSD (Olff et al., 2010). Both synthetic and endogenous OT 
exert anxiolytic properties in rodents (McCarthy et al., 1996; Waldherr and Neumann, 2007; 
Blume et al., 2008) and inhibit the activity of the HPA axis (Windle et al., 1997; Neumann et 
al., 2000). Comparable effects were also found in humans (Heinrichs et al., 2003), as OT was 
shown to reduce the activation of the amygdala to threatening faces, thereby reducing the 
autonomic and behavioral manifestation of fear in healthy volunteers and SAD patients 
(Kirsch et al., 2005; Labuschagne et al., 2010). More indirect evidence for the anxiolytic and 
antistress effects of OT in humans comes from nursing mothers who are calmer and less 
anxious during stressful situations, possibly due to high brain OT activity (Heinrichs et 
al., 2001; Carter et al., 2001; Slattery and Neumann, 2008). Given that PTSD is marked by 
deficits in anxiety/stress regulation and hyperactivity of the amygdala (Rauch et al., 2000; 
Shin et al., 2004a), OT might be a good candidate for the treatment of PTSD (Olff et 
al., 2010; Viviani et al., 2011). Therefore, we aimed to study in detail whether OT affects fear 
conditioning and fear extinction and whether such effects depend on the timing of 
administration. The classical fear conditioning paradigm involves acquisition, expression, and 
extinction of fear memories, and drugs can differentially affect these processes (Lattal and 
Abel, 2001; Makkar et al., 2010). Therefore, we manipulated the OT system by icv 
administration of synthetic OT and/or OTR-A either before cued fear conditioning (also 
referred to as acquisition) or cued fear extinction. In order to be able to draw more general 
conclusions, we performed the experiments in both rats and mice and hypothesized that OT 
would facilitate cued fear extinction in both species. 
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MATERIALS AND METHODS 
Animals 
Male Wistar rats (280 - 300 g) and male CD1 mice (35 - 40 g) were purchased from Charles 
River, Sulzfeld, Germany. Animals were group-housed in polycarbonate cages (rats: 55 × 22 
× 18 cm; mice: 42 × 26 × 15 cm) for 1 week before surgery and kept under standard 
laboratory conditions (12:12 light/dark cycle, lights on at 06:00, 22 °C, 60 % humidity, food 
and water ad libitum). After surgery, animals were single-housed in observation cages (rats: 
40 × 24 × 36 cm; mice: 30 × 23 × 36 cm). All behavioral procedures took place during the 
light phase and were conducted in accordance with the local government of the Oberpfalz 
(Bavaria, Germany) and the guidelines of the National Institutes of Health. 
Stereotaxic cannula implantation 
Guide cannula implantation was performed under isoflurane anesthesia (Forene®, Abbott 
GmbH & Co. KG, Wiesbaden, Germany). To avoid post-surgical infections, all animals 
received antibiotics (s.c.; 3 mg/30 μl Baytril®, Bayer Vital GmbH, Leverkusen, Germany). 
Animals were mounted on a stereotaxic frame, and a guide cannula (21 G; rats: 12 mm 
length; mice: 8 mm length; Injecta GmbH, Klingenthal, Germany) was implanted above the 
right lateral ventricle (rats: from Bregma + 1.0 mm, lateral + 1.6 mm, depth + 1.8 mm; mice: 
from Bregma: + 0.2 mm, lateral + 1.0 mm, depth + 1.4 mm). The guide cannula was fixed 
with two stainless steel screws using dental cement (Kallocryl, Speiko-Dr. Speier GmbH, 
Münster, Germany) and closed by a stainless steel dummy cannula. After surgery, animals 
were handled daily (stroking, holding, and cleaning of dummy cannulas) for 5 days before 
experiments started. 
 




Animals received icv infusions of either vehicle (sterile Ringer solution; rats: 5 μl; mice: 
2 μl), synthetic OT (Sigma-Aldrich, Munich, Germany; rats:, 0.1 or 1.0 μg/5 μl; mice: 0.1 or 
0.5 μg/2 μl - from this point onward referred to as lower and higher OT doses for rats and 
mice, respectively), or a selective OTR-A (desGly-NH2,d(CH2)5[Tyr(Me)2,Thr4]OVT; rats: 
0.75 μg/5 μl) (Manning et al., 2008) via an infusion cannula (25 G, extended 2 mm beyond 
the guide cannula) connected via polyethylene tubing to a Hamilton syringe. The infusion 
system was left in place for 30 s following the infusion to allow diffusion of the solution. 
To verify the infusion site, animals were killed using CO2 and ink was infused icv before 
removal of the brain. Brains were cut coronally and checked for staining of the ventricle. 
Drug doses and timing were selected based on previous studies in our laboratory (Waldherr 
and Neumann, 2007; Bosch and Neumann, 2008; Lukas et al., 2011). 
Cued fear conditioning apparatus 
The cued fear experiments were performed in two different contexts, A and B, which differed 
in visual, tactile, and olfactory cues as previously described (Toth et al., 2012a). Briefly, cued 
fear conditioning occurred in context A, which consisted of a transparent Perspex box (rats: 
45 × 45 × 40 cm; mice: 23 × 23 × 36 cm) with an electric grid floor. Context A was cleaned 
with water containing a small amount of a neutral-smelling detergent before each trial. Cued 
fear extinction and extinction recall occurred in context B, which consisted of a black Perspex 
box (rats: 45 × 45 × 40 cm; mice: 23 × 23 × 36 cm) with a smooth floor. Context B was 
cleaned with water containing a small amount of a lemon-scented detergent before each trial. 
The boxes were enclosed in a wooden chamber to reduce external noise and visual 
stimulation. A low level of background noise was produced by ventilation fans within the 
chamber. Illumination (300 lx for context A and 20 lx for context B) was provided by four 
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white light-emitting diodes. Auditory stimuli were delivered through a speaker attached 
30 cm above the floor of the box. Freezing, defined as the absence of all movement except 
that required for respiration (Fanselow, 1980), was measured with the TSE fear conditioning 
system (TSE System GmbH, Bad Homburg, Germany). The conditioning chamber contained 
two horizontal detection fields, each with 32 (rats) or 16 (mice) infrared light beams set 
1.3 cm apart. Inactivity was measured by the infrared beams and defined as no light beam 
interruption for at least 3 s (rats) or 1 s (mice). We have previously shown that such 
measurements are comparable with hand-scoring by an experienced observer (Toth et 
al., 2012a). 
Cued fear conditioning procedure 
The procedure was adapted from the literature (Muigg et al., 2008) and has been shown to 
induce a robust cued fear conditioning in our laboratory (Toth et al., 2012a). 
Cued fear conditioning (day 1). Animals were placed in the conditioning chamber (context 
A) and, after a 5-min adaptation period, exposed to five CS-US pairings with a 2-min inter-
stimulus interval. The CS was an 80-dB, 4.5-kHz (rats) or 8-kHz (mice), 30-s white noise, 
which co-terminated with a mild electric foot shock (US; 0.7 mA, pulsed current, 2 s). 
Animals were returned to their home cage 5 min after the last CS-US pairing. 
Cued fear extinction (day 2). One day after cued fear conditioning, animals were placed in 
context B and, after a 5-min adaptation period, exposed to 30 (rats) or 20 (mice) CS 
presentations (30 s white noise, 5 s inter-stimulus interval). Animals were returned to their 
home cage 5 min after the last CS presentation. Freezing during the cued fear extinction 
session increased until the sixth CS; therefore, this period was defined as fear expression. 
After the sixth CS, freezing decreased; therefore, this period was defined as fear extinction. 
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These CS presentations were collapsed into ten blocks with the mean freezing percentage 
during three or two CS presentations represented in each block for rats and mice, respectively. 
Extinction recall (day 3). One day after cued fear extinction, animals were again placed in 
context B, and after a 5-min adaptation period, were exposed to five CS presentations (30 s 
white noise, 5 s inter-stimulus interval). Animals were returned to their home cage after the 
last CS presentation. These CS presentations were then collapsed into one block. 
Home cage locomotion 
In separate groups of rats and mice, locomotion was assessed immediately after OT 
administration in the home cage for 1 h using the Noldus Ethovision XT 5.1 program (Noldus 
Information Technology, Wageningen, The Netherlands), as previously described (Slattery et 
al., 2012; Toth et al., 2012b). 
Statistical analysis 
PASW/SPSS (Version 17) was used to perform all statistical analyses. Cued fear conditioning 
and extinction data were analyzed using repeated measures ANOVA, followed by a 
Bonferroni post hoc analysis whenever appropriate. Extinction recall and home cage 
locomotion data were analyzed using a one-way ANOVA, followed by a Bonferroni post hoc 
analysis whenever appropriate. The criterion for significance was p≤0.05. Overall statistics 









Effects of preconditioning manipulation of the OT system on cued fear in rats 
To determine whether preconditioning manipulation of the OT system influences cued fear, 
rats were infused icv with either vehicle (n = 12), OT (1.0 μg/5 μl; n = 13), or OTR-A (n = 
13) 10 min before cued fear conditioning. 
Experiment  Group effect Group × CS effect 
Preconditioning manipulation of the OT system (Figure 20) 
   Cued fear conditioning (day 1)      F(2,35)=0.48, p=0.63      F(8,140)=0.83; p=0.58 
   Cued fear extinction (day 2)      F(2,35)=11.50, p<0.01*      F(18,315)=2.40, p<0.01* 
   Extinction recall (day 3)      F(2,35) = 6.95, p<0.01* 
 
 
Pre-extinction manipulation of the OT system in rats (Figure 21) 
   Cued fear conditioning (day 1)      F(2,24)=0.07, p=0.94       F(8,96)=0.23, p=0.99 
   Cued fear extinction (day 2)      F(2,24) = 3.40, p = 0.05*       F(18,216)=1.22, p=0.25 
   Extinction recall (day 3)      F(2,24) = 2.88, p = 0.08 
 
 
Pre-extinction manipulation of the OT system in mice (Figure 22) 
   Cued fear conditioning (day 1)      F(2,42)=0.08, p=0.92       F(8,168)=0.27, p=0.97 
   Cued fear extinction (day 2)      F(2,42) = 24.33, p < 0.01*       F(18,378)=1.67, p=0.04* 
   Extinction recall (day 3)      F(2,42) = 0.32, p = 0.73 
 
 
OTR-A prior to OT (Figure 23)  
   Cued fear conditioning (day 1)        F(2,21)=0.02, p=0.98         F(8,84)=0.02, p=1.0   
   Cued fear extinction (day 2)      F(2,21) 0.42, p=0.66       F(18,189)=1.01, p=0.45 
   Extinction recall (day 3)      F(2,21)=0.99; p=0.39 
 
 
Effects of OT on home cage locomotion 
   In rats (Figure 24A)      F(2,19 =0.22, p =0.80   
   In mice (Figure 24B)      F(2,17)=6.88, p=0.01 
 
 
Table 8. Overall statistics for the behavioral data. OT, oxytocin; OTR-A, OT receptor antagonist; One-way 
ANOVA or repeated measures ANOVA followed by Bonferroni post-hoc test; *p<0.05. 
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Cued fear conditioning was successful in all groups, as the level of freezing increased across 
trials (F(4,140)=42.77; p<0.01; Figure 20A). There was no difference in conditioning between 
treatment groups (Table 8). During cued fear extinction on day 2, there was a significant 
difference in fear extinction between treatment groups, with OT-treated rats showing lower 
CS-elicited freezing during blocks 2 and 3 compared with vehicle-treated rats, while OTR-A-
treated rats showed higher freezing during blocks 6-10 compared with vehicle-treated rats 
(p<0.05; Figure 20B). During extinction recall on day 3, there was a significant difference 
between treatment groups (Figure 20C), with OTR-A-treated rats showing higher CS-elicited 
freezing compared with both vehicle- and OT-treated rats (p<0.05). There was no difference 
between vehicle- and OT-treated rats. 
 
Figure 20. Oxytocin (OT) facilitates, whereas OT receptor antagonist (OTR-A) impairs cued fear 
extinction when infused before cued fear conditioning in rats. (A) Rats were infused icv with either vehicle 
(Veh; 5 µl; n = 12), OT (1.0 µg/5 µl; n = 13), or OTR-A (0.75 µg/5 µl; n = 13) 10 min before cued fear 
conditioning. (B) On day 2, cued fear extinction was assessed. (C) On day 3, extinction recall was assessed. Data 
represent the mean time of CS-elicited freezing ± SEM. *p<0.05 vs. Veh-treated rats. 
 
Effects of OT administered before cued fear extinction on cued fear in rats and mice 
To determine whether OT administered before cued fear extinction influences cued fear, rats 
and mice were infused icv with either vehicle (rats: n = 9; mice: n = 21), a lower OT dose 
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(rats: n = 6; mice: n = 8), or a higher OT dose (rats: n = 12; mice: n = 16) 10 min before cued 
fear extinction. 
Cued fear conditioning was successful in both rats and mice, as the level of freezing increased 
across trials (rats: F(4,96)=14.84; p<0.01; Figure 21A; mice: F(4,168)=22.15; p<0.01; 
Figure 22A). There was no difference in conditioning between groups the day before 
treatment (Table 8). During cued fear extinction on day 2, there was a significant difference 
between treatment groups in both rats (Figure 21B) and mice (Figure 22B). While both OT 
doses increased CS-elicited freezing compared with vehicle in rats (0.1 μg, blocks 7, 10; 
1.0 μg, blocks 7-10), OT exhibited a dose-dependent effect in mice. More specifically, the 
lower OT dose increased (block 9; p<0.05), while the higher dose decreased (blocks 1-7, 
9; p<0.05) CS-elicited freezing compared with the vehicle-treated group (Figure 22B). During 
extinction recall on day 3, there was a tendency towards an increased CS-elicited freezing in 
OT-treated rats compared with vehicle-treated rats (Figure 21C), while no difference was 
found between treatment groups in mice (Figure 22C). 
 
Figure 21. Oxytocin (OT) impairs cued fear extinction when infused before cued fear extinction in 
rats. (A) On day 1, rats were cued fear conditioned. (B) On day 2, 10 min before cued fear extinction, rats were 
infused icv with either vehicle (Veh; 5 µl; n = 9), a lower OT dose (0.1 µg/5 µl; n = 6), or a higher OT dose 
(1.0 µg/5 µl; n = 12). (C) On day 3, extinction recall was assessed. Data represent the mean time of CS-elicited 
freezing ± SEM. *p<0.05 vs. Veh-treated rats. 




Figure 22. Oxytocin (OT) impairs cued fear extinction when infused in a low dose before cued fear 
extinction in mice. (A) On day 1, mice were cued fear conditioned. (B) On day 2, 10 min before cued fear 
extinction, mice were infused icv with either vehicle (Veh; 2 µl; n = 21), a lower OT dose (0.1 µg/2 µl; n = 8), or 
a higher OT dose (0.5 µg/2 µl; n = 16). (C) On day 3, extinction recall was assessed. Data represent the mean 
time of CS-elicited freezing ± SEM. *p<0.05 vs. Veh-treated mice. 
 
Effects of OTR-A alone and on OT-induced delay in cued fear extinction in rats 
To determine whether OTR-A infusion itself facilitates cued fear extinction and whether 
synthetic OT impairs cued fear extinction by binding to the OTR, rats were infused icv with 
either vehicle (n = 8) or OTR-A (n = 16) 40 min before cued fear extinction. Thirty minutes 
later, vehicle-treated rats were infused icv with vehicle, while OTR-A-treated rats were 
infused with either vehicle (n = 8) or OT (1.0 μg/5 μl; n = 8). 
Cued fear conditioning was successful in all groups, as the level of freezing increased across 
trials (F(4,84)=14.75; p<0.01; Figure 23A). There was no difference in conditioning between 
groups the day before treatment (Table 8). On day 2, cued fear extinction was successful in all 
treatment groups, as the high levels of freezing during the first trials decreased substantially 
by the last trial (F(9,189) = 8.29; p < 0.01; Figure 23B). There was no difference in cued fear 
extinction between treatment groups. During extinction recall on day 3, there was no 
difference between treatment groups (Figure 23C). 




Figure 23. Oxytocin (OT) impairs fear extinction via OT receptor (OTR) in rats. (A) On day 1, rats were 
cued fear conditioned. (B) On day 2, 40 min before cued fear extinction, rats were infused icv with either vehicle 
(Veh; 5 µl; n = 8) or OTR antagonist (OTR-A; 0.75 µg/5 µl; n = 16). Thirty minutes later, Veh-treated rats were 
infused again with 5 µl Veh (Veh/Veh), while OTR-A-treated rats were infused with either Veh (OTR-A/Veh; 
5 µl; n = 8) or OT (OTR-A/OT; 1.0 µg/5 µl; n = 8). (C) On day 3, extinction recall was assessed. Data represent 
the mean time of CS-elicited freezing ± SEM. 
 
Effects of OT on home cage locomotion in rats and mice 
To determine whether the doses of OT used for the cued fear experiments affect locomotion, 
separate groups of rats and mice were infused icv with either vehicle (rats: n = 8; mice: n = 6), 
a lower OT dose (rats: n = 7; mice: n = 7), or a higher OT dose (rats: n = 7; mice: n = 7) and 
home cage locomotion was measured immediately for 1 h. 
There was no difference in home cage locomotion between groups in rats (Figure 24A). In 
mice, however, there was a significant difference between groups (Figure 24B), with the 
higher OT dose increasing locomotion compared with both vehicle (p=0.03) and the lower OT 
dose (p=0.01). The lower OT dose, however, did not affect home cage locomotion. 
 




Figure 24. Oxytocin (OT) effects 
on home cage locomotion in rats 
(A) and mice (B). Separate groups 
of rats and mice were infused icv 
with either vehicle (Veh; rats: 
5 µl; n = 8; mice: 2 µl; n = 6), a 
lower OT dose (rats: 0.1 µg/5 µl; n 
= 7; mice: 0.1 µg/2 µl; n = 7), or a 
higher OT dose (rats: 1.0 µg/5 µl; n 
= 7; mice: 0.5 µg/2 µl; n = 7) imme- 
diately before home cage locomotion was monitored. Data represent the distance moved within 1 h ± SEM. 
*p<0.05 vs. Veh-treated mice. 
 
DISCUSSION 
The present study demonstrates that modulation of the central OT system affects cued fear 
extinction in a timepoint-dependent manner. In more detail, we could show that, when 
administered before cued fear conditioning, OT did not affect fear conditioning, but decreased 
fear expression during cued fear extinction and facilitated fear extinction. In contrast, OTR-A 
administered at the same time-point did not affect cued fear conditioning or fear expression, 
but impaired fear extinction. In contrast, when administered before cued fear extinction, OT 
impaired fear extinction, while OTR-A had no effect, suggesting a lack of involvement of the 
endogenous OT system at this timepoint. These findings could be observed both in rats and 
mice, indicating that the effects of OT on cued fear extinction are conserved across species, 
making the translation of these findings to humans more applicable. OT impaired cued fear 
extinction by binding to the OTR, as the inhibitory effect of icv OT on fear extinction was 
abolished by prior treatment with icv OTR-A. However, the impaired cued fear extinction 
was not a result of reduced locomotion, as neither rats nor mice showed changes in 
locomotion after OT treatment. These findings suggest that, while elevated OT levels at the 
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time of a traumatic event prevent the formation of aversive memories, caution is needed 
before recommending OT for the treatment of PTSD. 
Preconditioning manipulation of the OT system 
According to our hypothesis, preconditioning administration of OT decreased expression of 
cued fear and facilitated fear extinction, without directly affecting fear conditioning. In 
contrast, OTR-A administration impaired both fear extinction and extinction recall, indicating 
that an elevated activity of the endogenous OT during cued fear conditioning is required for 
successful fear extinction. 
A possible explanation for these effects is the modulatory effect of OT on corticosterone 
(CORT) secretion. In female rats, chronic OT reduced stress-induced CORT release (Windle 
et al., 1997), while OTR-A increased CORT secretion into the blood in both male and female 
rats via an activation of the HPA axis (Neumann et al., 2000). Previous studies demonstrated 
that decreasing CORT concentration before conditioning by glucocorticoid synthesis 
inhibitors, such as metyrapone (Loscertales et al., 1997; Cordero et al., 2002) or 
dehydroepiandrosterone (Fleshner et al., 1997), or by blocking CORT activity through a 
glucocorticoid receptor antagonist (Cordero and Sandi, 1998) attenuated fear expression. 
Although CORT activation before exposure to tasks that involve acquisition of information 
has been shown to impair cognitive processing (Conrad et al., 1996; Kirschbaum et al., 1996; 
Lupien and McEwen, 1997), CORT release during the actual learning process facilitates 
cognitive processing (for reviews see Sandi, 1998; de Kloet et al., 1999). However, whether 
alterations in available CORT mediate the facilitatory effects of preconditioning OT on cued 
fear extinction remain to be verified. 
As OT and OTR-A treatment did not alter cued fear conditioning itself, the observed effects 
on cued fear extinction are unlikely to be due to the antinociceptive properties of OT. 
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However, several studies have shown that the OT system modulates pain perception (Yang et 
al., 2007, 2011; Condés-Lara et al., 2009), with OT increasing and OTR-A decreasing the 
pain threshold in a dose-dependent manner (Uvnäs-Moberg et al., 1992; Lundeberg et al., 
1994; Yang et al., 2011). 
Although the mechanisms underlying the facilitatory effect of preconditioning OT on cued 
fear extinction are yet unknown, these findings suggest that activation of the endogenous OT 
system is beneficial during traumatic experiences to protect against the development of 
traumatic memory pathologies, such as PTSD. 
Manipulation of the OT system before cued fear extinction 
Contrary to our hypothesis, icv administration of OT before cued fear extinction impaired fear 
extinction as reflected by increased CS-elicited freezing. This was observed both in rats and 
mice, indicating that the inhibitory effects of OT on cued fear extinction are conserved across 
species. However, while we could show that the impairing effects of OT were mediated via 
the OTR as preadministration of an OTR-A blocked its effects, OTR-A treatment alone did 
not facilitate fear extinction, indicating that the endogenous OT system is not involved in 
cued fear extinction at this timepoint. The enhanced OT-induced freezing to the CS was tone-
specific and not generalized as neither rats nor mice froze before tone onset nor did they show 
increased freezing responses to the tone prior to its association with the shock. Taken 
together, these results suggest that OT treatment before cued fear extinction delays the 
extinction of cued fear. Considering that cued fear extinction is regarded as a form of new 
learning (for reviews see Cammarota et al., 2007; Quirk et al., 2010), when animals learn that 
the CS no longer predicts the US, drugs that interfere with the acquisition of fear learning 
should also block the acquisition of extinction memories when administered before the 
extinction procedure (Myers and Davis, 2002). This might explain why OT decreased fear 
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expression and facilitated fear extinction when administered before cued fear conditioning 
and impaired fear extinction when administered before cued fear extinction. 
We propose that CORT is a possible mediator of the pre-extinction effects of OT on cued fear 
extinction, similar to its preconditioning effects. While decreasing CORT concentrations 
before conditioning attenuates fear expression (Fleshner et al., 1997; Loscertales et al., 1997; 
Cordero and Sandi, 1998; Cordero et al., 2002), decreasing CORT concentrations before 
extinction by icv and BLA administration of metyrapone (Barrett and Gonzalez-Lima, 2004; 
Yang et al., 2006) blocks fear extinction. In contrast, glucocorticoid receptor agonists were 
shown to facilitate fear extinction when administered before the extinction procedure (Yang et 
al., 2006, 2007). 
Several studies have shown that OT facilitated, rather than impaired, fear extinction when 
administered before the extinction procedure directly into the CeA (Roozendaal et al., 1992; 
Viviani et al., 2011), a brain region that coordinates the behavioral and physiological 
correlates of fear expression (LeDoux et al., 1988). In our study, however, OT was 
administered icv, which is likely to explain the discrepant results. While OT administered into 
the cerebral ventricles may reach the CeA, it may not do so in a concentration sufficient to 
facilitate fear extinction. Moreover, it is likely to reach brain areas which increase fear 
responses, such as the BLA. The BLA, a storage site for fear memories, is thought to mediate 
the initial acquisition of extinction (Herry et al., 2006, 2008; Sotres-Bayon et al., 2007) and 
the expression of extinction memory via inhibition of CeA output neurons (Quirk et al., 2003; 
Likhtik et al., 2008). However, whether OT impairs fear extinction when administered into 
the BLA remains to be verified. 
In support of this region-dependent hypothesis, several studies have shown that OT facilitated 
the extinction of passive avoidance behavior, when applied either icv into the hippocampal 
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dentate gyrus or into the dorsal raphe nucleus immediately after the learning trial (Bohus et 
al., 1978; Kovács et al., 1979; de Wied et al., 1991). However, when applied into the dorsal 
septal nucleus, OT impaired the extinction of passive avoidance (Kovács et al., 1979), 
suggesting that OT affects extinction memory in a region-dependent manner. Although both 
passive avoidance and cued fear conditioning use foot shocks as the aversive sensory stimuli, 
several studies utilizing knockout mice have shown deficits in cued fear conditioning, while 
passive avoidance behavior was normal (Weeber et al., 2000; Takao et al., 2010; 
Kaidanovich-Beilin et al., 2009). The subtle differences between the two paradigms and the 
different timepoints of OT administration might also account for the different effects of 
central OT on extinction of cued fear versus passive avoidance behavior. 
Despite previous studies showing that OT causes sedation at high doses in rats (Uvnäs-
Moberg et al., 1994), neither dose of OT used in the present study altered home cage 
locomotion in rats. This indicates that the impairment of fear extinction by OT in rats is not 
due to nonspecific alterations in locomotion. In contrast, the higher OT dose employed in 
mice resulted in behavioral hyperactivity, defined as increased home cage locomotion and 
excessive scratching and grooming, confirming previous findings (Delanoy et al., 1979; 
Meisenberg and Simmons, 1982). This behavioral hyperactivity likely reflects the apparent 
decrease in fear expression and facilitation of fear extinction caused by the higher OT dose in 
mice as such behaviors would mask any underlying fear-related behaviors. However, the 
lower OT dose, which did not alter home cage locomotion, actually impaired fear extinction 
in mice. This is in agreement with the rat studies and strongly implies that OT administered 
before cued fear extinction has a detrimental outcome on fear extinction. 
In summary, we have shown that icv OT decreases fear expression and facilitates fear 
extinction when administered before cued fear conditioning, which might have a beneficial 
effect during traumatic events. In contrast, when applied before cued fear extinction, which 
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would be the comparable time-point for psychotherapy in PTSD patients, OT delays fear 
extinction. Considering that a more specific and local administration of OT is not possible in 









General discussion                       111  
 
 
6.1.     Summary of results 
The main goals of the present thesis were to develop a specific animal model of SAD and to 
assess the therapeutic efficacy of OT in reversing social and cued fear. In order to achieve 
this, I established the social fear conditioning paradigm (chapter 2; Toth et al., 2012b) in a 
way that is very similar in both the conditioning and extinction procedure with the cued fear 
conditioning paradigm described in the literature (Muigg et al., 2008; Toth et al., 2012a). The 
similarity between these two conditioning paradigms offers the possibility of comparing drug 
effects on conditioned fear in social versus non-social contexts. Afterwards, I administered 
OT to conditioned mice and/or rats and verified the potency of OT to reverse social (chapter 
4; Toth et al., under review) and cued (chapter 5; Toth et al., 2012c) fear.  
In chapter 2, I described the social fear conditioning paradigm in male mice, a model that 
shows both face and predictive validity to SAD. In more detail, I could show that social fear 
conditioning induces a specific and long-lasting (at least two weeks) social fear of unknown 
con-specifics without inducing other behavioral alterations that might account for the 
observed social fear, such as fear of novelty, general anxiety, depressive-like behavior, and 
impaired locomotion. Moreover, I could show that this social fear is reversed by acute 
diazepam and chronic paroxetine treatment, medication that currently provide the best 
response rates in SAD patients. Therefore, I propose the social fear conditioning model as an 
attractive tool to study the mechanisms underlying social fear, which will lead to better 
understanding of the etiology and treatment of SAD.  
In chapter 3, I described step by step how to perform the the social fear conditioning 
paradigm in male and female rodents. I also described theoretical and practical aspects to be 
considered when performing the experiments, and how to analyze and interpret the obtained 
data.   
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In chapter 4, using the social fear conditioning paradigm to induce social fear, I could 
demonstrate that social fear is accompanied by alterations in the brain OT system at the level 
of the limbic system, namely by an increased OTR binding in the bilateral DLS, right CeA, 
right DG, and right CA1. I could also show that these alterations normalized after extinction 
of social fear, suggesting that OTR expression within these brain regions might be involved in 
the development and/or neural support of social fear. Moreover, I could show that while the 
endogenous OT system is needed for naturally-occurring social investigation, exogenous OT 
administered into the ventricular system reverses social fear through OTR-mediated actions. 
Additionally, based on the OTR alterations, I could localize these effects within the brain and 
demonstrate that the DLS mediates the effects of OT on social fear. These results demonstrate 
the therapeutic efficacy of OT in disorders associated with social anxiety and fear, such as 
SAD and possibly PTSD due to social trauma. 
In chapter 5, using the cued fear conditioning paradigm to induce cued fear, I could show that 
modulation of the OT system differentially affects extinction of cued fear depending on the 
time-point of administration. In more detail, I could show that when administered before cued 
fear conditioning OT facilitates, whereas OTR-A impairs cued fear extinction 24 h later, 
indicating that an activated endogenous OT system during traumatic events is likely to 
attenuate formation of fear memories. In contrast, when administered before cued fear 
extinction, which would be the comparable time-point for psychotherapy in PTSD patients, 
OT impairs cued fear extinction, while OTR-A has no effect, suggesting a lack of 
involvement of the endogenous OT system at this time-point. As both the conditioning and 
extinction procedure involve learning, these results suggest that exogenous OT impairs 
learning processes that occur during non-social fearful situations and indicate that caution is 
needed before recommending OT for the treatment of PTSD due to non-social trauma. 
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In summary, after establishing a specific animal model of SAD, I provided evidence for a 
differential effect of synthetic OT on social versus cued fear in rodents. Not only could I show 
that OT has the potential to reverse social fear, while it rather delays extinction of cued fear, 
but I could also identify a part of the brain network involved in mediating OT effects on 
social fear, i.e. the DLS. These studies raise attention to the importance of the feared situation 
when recommending OT for the treatment of SAD and PTSD. Furthermore, the social fear 
conditioning model represents an attractive animal model for studying the brain mechanisms 
underlying social fear, which might lead to a better understanding of the etiology of SAD and, 
in turn, more specific medication for these patients. 
6.2.     Social fear conditioning as an animal model of SAD 
Many psychiatric disorders are associated with social anxiety symptoms, which cannot be 
appropriately treated by current medication. Social anxiety might either represent the major 
symptom of the disorder, as seen in SAD, or a comorbid condition to other psychiatric 
disorders, as seen in depression and schizophrenia. In order to develop medications that 
specifically target and might be, therefore, more efficient in reversing social anxiety 
symptoms, animal models that induce specific social fear are needed to understand the basic 
mechanisms of how social anxiety develops. Several paradigms, including acute and chronic 
social defeat have been shown to induce lasting social avoidance and fear in rodents (see 
section 1.7.1.), and have contributed a great deal of knowledge regarding the mechanisms 
underlying social fear. However, they are rather unspecific with respect to the behavioral 
alterations that they induce, as increased general anxiety, depressive-like behavior, fear of 
novelty, and impaired locomotion were shown to accompany the induced social fear (see 
section 1.7.1.). Therefore, when using the social defeat paradigms, it is not clear whether 
social avoidance and fear are the major deficits induced, or whether they result as comorbid 
conditions from the above mentioned behavioral alterations. Unlike the social defeat 
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paradigms, the social fear conditioning paradigm described in chapter 2 and 3 induces a very 
specific type of social fear without these potentially confounding behavioral alterations. 
Importantly, all these behavioral measures were performed one day after social fear 
conditioning. Given that at least one other psychiatric disorder is present in the majority of 
SAD patients, such as agoraphobia (Magee et al., 1996), depression (Schneier et al., 1992; 
Regier et al., 1998), or substance abuse (Schneier et al., 2010; Regier et al., 1998), and that 
SAD generally precedes all these disorders (see section 1.2.), it is not excluded that other 
behavioral alterations might occur in conditioned mice several weeks after social fear 
conditioning. This is an attractive aspect that has not been investigated in the present thesis 
and needs further elucidation. An interesting question that arises is whether treating social 
anxiety symptoms might improve general anxiety and depression symptoms in an animal 
model like chronic social defeat or such symptoms that might develop in conditioned mice 
several weeks after social fear conditioning. 
6.3.     Relevance of the social fear conditioning model for future research 
Although the specificity of the behavioral effects and the validity of the social fear 
conditioning model have been repeatedly discussed in the present thesis, I would like to 
highlight several additional advantages of the social fear conditioning paradigm. First, the 
simplicity of the paradigm needs mentioning. While chronic social defeat (Avgustinovich et 
al., 2005; Berton et al., 2006) requires defeating animals repeatedly over several days by 
different dominant aggressive males, social fear conditioning is performed within a few 
minutes using a single stimulus animal. The behavioral impairment, however, is as severe as 
when induced by chronic social defeat, and it lasts for at least two weeks (chapter 2). This 
long-term maintenance of social fear offers not only the possibility to test medication with 
fast, but also with a delayed onset of action, such as antidepressants (Katz et al., 2006; 
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Mitchell, 2006; Priest, 2006). Additionally, the sensitization of the induced social fear over 
time offers the possibility to assess acute drug effects on a more severe type of social fear. 
Second, the social fear conditioning paradigm closely resembles the cued fear conditioning 
paradigm with respect to both the conditioning and extinction procedure. These similarities 
between the two conditioning paradigms offers the possibility for comparison between 
conditioned fear in social versus non-social contexts, being at the level of neuronal circuitry, 
underlying molecular mechanisms, or therapeutic approaches. However, these paradigms also 
differ in at least three aspects, namely in the type of learning they imply, in the controllability 
of the aversive stimuli, and in the rewarding properties of the conditioned stimuli. The type of 
learning they imply, namely learning the association between a behavior and its consequence, 
i.e. operant conditioning (Thorndike, 1933) in the case of social fear conditioning, and 
learning the association between two stimuli, i.e. classical conditioning (Pavlov, 1927) in the 
case of cued fear conditioning, might recruit slightly different neuronal circuitries. The 
controllability of the aversive stimuli, namely the possibility to avoid the foot shocks by 
stopping to approach the social stimulus during social fear conditioning, and the impossibility 
to avoid the foot shocks during cued fear conditioning, might also recruit different neuronal 
circuitries. The rewarding properties of the conditioning stimuli, namely highly rewarding 
social stimuli versus less rewarding cued stimuli, might influence the speed of extinction, as 
observed in the present studies, with extinction of social fear occurring faster than extinction 
of cued fear. It is possible, therefore, that differences in drug sensitivity and underlying 
mechanisms not necessarily related to the type of fear per se, but rather due to the above 
mentioned differences, might occur when studying social and cued fear by using these two 
paradigms.   
Third, the reliability of the social fear conditioning paradigm needs mentioning, as both 
conditioned and unconditioned mice show highly stable levels of social investigation between 
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experiments. Although the model needs to be replicated in other laboratories to demonstrate 
its transferability, the robustness of the induced social fear suggests that the social fear 
conditioning paradigm might be successfully reproduced in different laboratories. 
Another important aspect that needs mentioning is the possibility to use the social fear 
conditioning paradigm not only in male rodents, as demonstrated in this thesis, but also in 
females (Figure 25). Although in several rodent species, such as California mice (Peromyscus 
californicus) and Syrian hamsters (Mesocricetus auratus), females show aggressive territorial 
behavior similar to males, in most rodent species females are not territorial and do not 
typically form dominant-subordinate relationships with other females. Therefore, social defeat 
models which are based on territoriality and establishment of dominant-subordinate 
relationships cannot be reliably used in females. Under certain circumstances, such as when 
defending their pups female rats and mice show high levels of aggressive behavior (Lonstein 
and Gammie, 2002; Bosch and Neumann, 2012), which can be used as a model of social 
defeat in females. However, exposure to repeated maternal defeat induces a rather unspecific 
socially fearful phenotype in defeated females. Although it does not increase general anxiety, 
as the chronic social defeat in males, repeated maternal defeat induces a depressive-like 
behavior in defeated females (Shimamoto et al., 2011; Bourke and Neigh, 2012). The 
behavioral phenotype induced by the social fear conditioning paradigm, on the other hand, is 
very specific and comparable to the behavioral phenotype induced in males, which allows its 
reliable use in females as well. Given the higher prevalence of anxiety disorders including 
SAD in women (Schneier et al., 1992; Talepasand and Nokani, 2010), and the different 
responses to medication between men and women (Franconi et al., 2007; Keers and 
Aitchinson, 2010), the etiology of anxiety disorders and the efficacy of medication needs to 
be studied both in male and female rodents.  
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Importantly, all the studies using the social fear conditioning paradigm described in this thesis 
and performed so far induced only  male-male (chapter 2 and 4) or female-female (Figure 25) 
social fear, in order to exclude any sexually-motivated behaviors. However, given that most 
SAD patients fear and avoid individuals of both sexes, further studies need to investigate the 
underlying mechanisms and treatment responses in rodents conditioned to the opposite sex.  
 
Figure 25. Social fear conditioning induces short-term social fear in female CD1 mice. (A) Investigation of 
the non-social stimulus (empty cage) by unconditioned (UC) and conditioned (C) mice during social fear 
conditioning on day 1 (n = 12 per group). (B) Investigation of non-social (ns1-ns3) and social (cages with female 
CD1 mice; s1-s6) stimuli during social fear extinction on day 2 (3 min exposure to stimulus, 3 min inter-
exposure interval). (C) Investigation of social stimuli (s1-s6) during extinction recall on day 3. Data represent 
mean percentage of investigation time ± SEM. * p<0.05 vs. UC mice. 
 
6.4.     Effects of central OT system manipulation on social and cued fear 
6.4.1.      Effects of exogenous OT on social and cued fear  
Having established the social (chapter 2; Toth et al., 2012b) and cued (Toth et al., 2012a) fear 
conditioning paradigms in our laboratory, in chapter 4 and 5 I assessed the therapeutic 
efficacy of exogenous OT in social and cued fear, respectively, given its pro-social, 
anxiolytic, and stress-attenuating effects and its potential therapeutic role in SAD and PTSD 
(see section 1.6.). In more detail, I could demonstrate that icv administered OT before social 
fear extinction has the potential to reverse social fear. On the other hand, icv administered OT 
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at this same time-point in the cued fear conditioning paradigm impaired extinction of cued 
fear, suggesting that OT has differential effects on social versus cued fear when administered 
before the extinction procedure. These results indicate that while OT might be a promising 
therapeutic approach in patients with social fear, such as SAD or PTSD due to social trauma, 
caution is needed before recommending OT for the treatment of PTSD due to non-social 
trauma. However, the time-point of OT administration in the cued fear conditioning study is 
an important aspect that needs to be considered. When translated to humans, the 
administration of OT before the extinction procedure in rodents would correspond to its 
administration before psychotherapy in PTSD patients, which, based on my results in rats and 
mice, should not be recommended due to the delaying effects of OT on cued fear extinction. 
However, drugs can also be administered after the psychotherapy session in PTSD patients to 
facilitate the consolidation of the “safety” memory trained during psychotherapy, which 
implies that OT might decrease cued fear responses when administered immediately after a 
short extinction procedure. In support of this possibility, I have shown that the mGluR7 
allosteric agonist N,N'-dibenzyhydryl-ethane-1,2-diamine dihydrochloride (AMN082) delays 
cued fear extinction when administered i.p. before extinction, while it decreases fear 
expression when administered immediately after a short extinction procedure (Toth et al., 
2012a). A similar approach might be considered before contra-indicating OT as an adjuvant in 
the treatment of PTSD due to non-social trauma. 
6.4.2.      Effects of exogenous OT on learning 
The impairing effect of icv administered OT on cued fear extinction suggests that OT might 
either prolong the expression of the conditioned fear response or interfere with the new 
learning process that occurs during the extinction procedure (Cammarota et al., 2007; Quirk et 
al., 2010). In an attempt to verify which of these hypotheses is true, I could demonstrate that 
OT decreases fear expression and facilitates cued fear extinction when administered before 
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cued fear conditioning. This suggests that OT impairs the learning processes that occur not 
only during extinction, but also during acquisition of cued fear. In support of my results, 
although not completely comparable due to the local administration, OT impaired fear 
learning when administered into the ventral hippocampus before acquisition of active 
avoidance behavior; i.e. learning to exit from a chamber in which an aversive stimulus was 
delivered (Ibragimov, 1990). On the other hand, OT might either have no effect on or even 
facilitate learning in social contexts. In more detail, in chapter 4 I have shown that icv 
administered OT completely reversed social fear starting from the first exposure to a social 
stimulus and did not gradually facilitate extinction, suggesting that OT is unlikely to reverse 
social fear by facilitating learning. In non-fearful social contexts, however, OT was shown to 
be both needed for and to facilitate social learning and memory. In more detail, icv 
administered OT facilitated (Benelli et al., 1995), whereas OTR-A impaired (Engelmann et 
al., 1998; Lukas, Toth et al., in press) recognition of a previously encountered con-specific. 
Furthermore, both OT and OTR knockout mice show deficits in recognition of previously 
encountered con-specifics, deficits which could be reversed by icv administered OT before, 
but not immediately after, the initial social encounter (Ferguson et al., 2000; Choleris et al., 
2003; Takayanagi et al., 2005). These effects were mediated through the OTR in OT 
knockout mice, and through the AVP receptor 1A in OTR knockout mice (Sala et al., 2011). 
All these studies indicate that OT is needed for social learning and memory in non-fearful 
contexts. However, whether OT exerts different effects on social versus non-social learning in 
fearful contexts needs further elucidation and implies administration of OT before social fear 
conditioning. 
6.4.3.      Effects of endogenous OT on social and cued fear 
As all the behavioral effects described above were mediated via OT actions on the OTR, i.e. 
administration of OTR-A before OT blocked OT effects on both social and cued fear, the 
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involvement of the endogenous OT system in social and cued fear needs mentioning. In the 
context of social fear conditioning, I have shown that icv administered OTR-A decreased 
social investigation in unconditioned mice (chapter 4). This suggests that endogenous OT is 
required for naturally-occurring social investigation in unconditioned mice and confirms our 
previous study in male rats and mice (Lukas et al., 2011). Importantly, even though social 
investigation decreased in unconditioned mice when the activity of the endogenous OT 
system was blocked, I observed no typical signs of social fear, such as freezing, attempt 
approaches, and defensive burying, which suggests that the endogenous OT system modulates 
social preference and motivation, but not social fear. Importantly, the endogenous OT system 
does not appear to regulate social investigation in conditioned mice, probably due to the 
socially-fearful phenotype and to the already low level of social investigation. In the cued fear 
conditioning, however, blockade of the endogenous OT system before cued fear conditioning 
impaired fear extinction, whereas before cued fear extinction had no affect on fear extinction. 
These results indicate that, at least in non-social contexts, the endogenous OT system plays a 
crucial role during traumatic experiences and protects against the development of traumatic 
memory pathologies. After the development of traumatic memories, however, the endogenous 
OT system has little modulatory effect on both social and cued fear memory. An interesting 
aspect that needs further elucidation is whether the endogenous OT system might also protect 
against the development of traumatic memory pathologies in social contexts and implies 
administration of OTR-A before social fear conditioning.  
6.5.    Neurocircuitry of social and cued fear 
The differential role of the OT system in modulating social and cued fear goes beyond 
differential effects on behavior and learning processes, and might be more complex than 
outlined above. Although the brain regions involved in mediating the effects of OT on social 
and cued fear are quite similar, the directionality of OT effects within these brain regions 
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differs (Figure 26). Substantial research has been performed to identify the neuronal circuitry 
involved in social fear; however, little is known from the literature about the brain regions 
that actually mediate the effects of OT on social fear. In chapter 4, I have shown that social 
fear is accompanied by alterations in the OT system, namely by an increased OTR binding in 
the bilateral DLS, right CeA, and right hippocampus (DG, CA1). These alterations 
normalized after extinction of social fear, and suggest that OTR expression and, therefore, OT 
neurotransmission within this limbic network might be involved in the development and/or 
neural support of social fear. In support of this hypothesis, pharmacological induction of 
social avoidance by chronic administration of phencyclidine was shown to increase OTR 
binding in the CeA (Lee et al., 2005), whereas chronic social defeat increased OTR mRNA 
expression in the LS of defeated mice (Litvin et al., 2011). The involvement of the LS in 
mediating OT effects on social fear is strengthened by the fact that OT reversed social fear 
when administered into the DLS of conditioned mice (chapter 4). Although the DLS and CeA 
showed the same pattern of OTR binding alterations, OT did not reverse social defeat-induced 
social fear when administered into the CeA (Lukas et al., 2011). Two possible theories might 
explain the lack of OT effects within the CeA of acutely social defeated rats, namely the 
possible region-dependent effects of OT on social fear and the severity of the induced social 
fear. The possible region-dependent effects of OT on social fear suggests that OT might exert 
different effects within distinct brain regions that mediate its effects on social fear, and would 
imply that OT reverses social fear when administered into the DLS, but not when 
administered into the CeA. This hypothesis is supported by the fact that OT exerts differential 
effects on extinction of passive avoidance, i.e. refraining from entering a chamber in which an 
aversive stimulus was previously delivered, when administered into the CeA, hippocampal 
DG, dorsal raphe nucleus, and the LS (see below; Kovács et al., 1979; Roozendaal et al., 
1992; Viviani et al., 2011). The severity of the induced social fear, namely fear of general 
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social stimuli in the case of social fear conditioning and fear of a specific individual in the 
case of acute social defeat, might involve recruitment of different brain regions to mediate the 
effects of OT. This hypothesis is supported by the fact that additional brain regions are 
progressively recruited as the complexity of behaviors increase to encode the processed 
information (Fanselow and Ponnusamy, 2008), and would imply that the CeA mediates the 
effects of OT on a general and, therefore, more severe type of social fear, such as that induced 
by social fear conditioning, but not on an individual type of social fear induced by acute 
social defeat. These hypotheses are not mutually exclusive, but whether OT reverses social 
fear induced by social fear conditioning when administered into the CeA remains to be 
verified. 
In contrast with the limited knowledge about the brain regions that mediate the effects of OT 
on social fear, much more is known about the brain regions that mediate the effects of OT on 
cued fear. Thus, transgenic mice with decreased OTR binding within the LS, CeA, and 
hippocampus after post-natal day 21 show decreased fear responses during cued fear 
conditioning (Lee et al., 2008; Pagani et al., 2011). Several studies using the cued fear 
conditioning and passive avoidance paradigms have also demonstrated that the CeA 
(Roozendaal et al., 1992; Viviani et al., 2011), hippocampal DG, dorsal raphe nucleus, and 
the dorsal septum (Kovács et al., 1979) mediate OT effects on cued fear. Interestingly, 
differential effects were found when OT was administered into these regions, i.e. OT 
facilitated extinction of cued fear and passive avoidance when administered into the CeA 
(Roozendaal et al., 1992; Viviani et al., 2011), hippocampal DG, and into the dorsal raphe 
nucleus (Kovács et al., 1979), but impaired extinction of passive avoidance when 
administered into the dorsal septum (Kovács et al., 1979). This not only suggests that quite 
similar brain regions modulate the effects of OT on social versus cued fear, but that OT 
affects cued fear extinction in a region-dependent manner. Probably the most striking 
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difference is the fact that OT differentially modulates social and cued fear at the level of the 
LS, i.e. reverses social fear (chapter 4), but impairs cued fear extinction (Kovács et al., 1979). 
Behavioral differences also occur when OT is infused into the CeA, i.e. OT does not reverse 
social defeat-induced social avoidance (see above; Lukas et al., 2011), but facilitates cued fear 
extinction (Roozendaal et al., 1992; Viviani et al., 2011). Future studies will assess the effect 
of CeA and DG administered OT on social fear induced by social fear conditioning, and the 
involvement of the dorsal raphe nucleus in social fear. 
 
Figure 26. Diagram depicting the effects of exogenous oxytocin (OT) within brain regions mediating social 
(A) and cued (B) fear. Brain regions where OT infusion dampens (green), promotes (red), or does not affect 
(yellow) fear expression. Brain regions depicted in white represent regions involved in fear expression where OT 
was not administered to date. PL, prelimbic cortex; IL, infralimbic cortex; DLS, dorso-lateral septum; LS; lateral 
septum; LV, lateral ventricle; DG, dentate gyrus; CeA, central amygdala; BLA, basolateral amygdala; DR, 
dorsal raphe nucleus. Summarized from Kovács et al., 1979; Roozendaal et al., 1992; Lukas et al., 2011; Viviani 
et al., 2011; Toth et al., 2012c; chapter 4. 
 
6.6.     A possible mechanism underlying OT effects on social and cued fear 
Although the behavioral effects of OT on social and cued fear assessed so far are quite 
straightforward, the underlying mechanisms of these effects are not clear yet. However, 
considering the behavioral data obtained in the present thesis, I could at least demonstrate that 
the effects observed on social and cued fear are unlikely due to the general anxiolytic 
properties of OT, as general anxiety was not affected by the doses of OT used in the fear 
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conditioning experiments (Figure 19; Slattery and Neumann, 2010). A possible mechanism 
that might explain the effects of OT on both social and cued fear is through the modulatory 
effect on CORT secretion. While chronic OT has been shown to reduce stress-induced CORT 
release in female rats (Windle et al., 1997), OTR-A increased CORT release in both male and 
female rats (Neumann et al., 2000). As high CORT levels during learning processes facilitate 
cognitive processing (Sandi, 1998; de Kloet et al., 1999), and OT impairs the learning 
processes that occur during both cued fear conditioning and extinction, this hypothesis seems 
plausible for the effects of OT on cued fear. In the case of social fear, it has been suggested 
that by reducing the behavioral and neuroendocrine responses to social stress, OT may inhibit 
defensive behaviors and enable animals to overcome their natural avoidance of proximity 
(Carter and Altemus, 1997; Carter, 1998; Unväs-Moberg, 1998). If this is the case, it seems 
likely that by reducing CORT release prior to social fear extinction, OT facilitates social 
approach, and thereby reverses social fear. 
 
Another aspect that needs mentioning is the apparent lateralization of the OTR binding 
alterations found in socially-fear conditioned mice, which is difficult to interpret at the 
moment due to the sparse evidence in rodents, and the amygdala-focused research in humans. 
Although neuroimaging studies have provided substantial evidence for the amygdala as one of 
the core regions involved in mediating the fear response in the human brain, the contribution 
of the two hemispheres in the fear response is not clear yet. While some studies report 
increased activity in the right, but not the left amygdala during fear conditioning in healthy 
volunteers (Furmark et al., 1997), and symptom provocation in SAD (Tillfors et al., 2001), 
specific phobia (Veltman et al., 2004; Ahs et al., 2009), and PTSD (Pissiota et al., 2002) 
patients, other studies report increased activity both in the right and the left amygdala 
(Schienle et al., 2007; Petrovic et al., 2008b; Flemingham et al., 2010; Labuschagne et al., 
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2010; Brühl et al., 2011; Wood et al., 2012). A recent study in mice has shown that 
observational fear learning (see section 1.1.) is controlled by the right, but not the left anterior 
cingulate cortex (Kim et al., 2012), suggesting that asymmetrical hemispheric mechanisms are 
underlying fear learning. Importantly, although I found significant increases in OTR binding 
only in the right CeA and hippocampus (DG, CA1) of conditioned mice, the direction of 
alterations was similar in both hemispheres, however, without reaching significance in the left 
hemisphere. Although it has been proposed that the right hemisphere controls aversive 
conditioning (Hugdahl, 1995), it is not yet clear whether the left-right differences found in the 
human amygdala activity and in the OTR distribution in the CeA and hippocampus of 
conditioned mice might reflect a functional segregation between the left and right brain 
regions in mediating fear and aversively-motivated behaviors.  
Probably the most intriguing aspect is that although the effects of OT on human behavior and 
amygdala activity have been repeatedly shown (see section 1.6.), the only OTR 
autoradiography studies in post-mortem human brains reported high densities of OTR in the 
VLS, less in the DLS, but none in the hippocampus and amygdala (Loup et al., 1989, 1991). 
Given the similarity of the behavioral effects of OT between humans and rodents, it might be 
possible that in humans the behavioral effects of OT are mediated by OTR found in brain 
regions upstream of the hippocampus and amygdala. However, considering that the 
distribution of the OTR is quite well preserved between mammalian species (O’Connell and 
Hofmann, 2012), the assessment of OTR distribution with more sensitive techniques, such as 
radioligand binding studies in combination with positron emission tomography (PET) or 
single photon emission computed tomography (SPECT), might prove useful to gain more 
accurate information about the distribution of OTR in the human brain.  
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6.7.     Relevance of the present thesis 
The results described in this thesis are highly relevant due to the increasing interest in using 
OT in combination with cognitive-behavioral therapy in SAD and PTSD patients. Human 
studies demonstrated the efficacy of OT in reducing conditioned social fear in healthy 
volunteers (Petrovic et al., 2008a) and some symptoms of social anxiety in psychiatric 
disorders, such as SAD (Guastella et al., 2008; Labuschagne et al., 2010), autism spectrum 
disorder (Baron-Cohen et al., 2001; Andari et al., 2010), schizophrenia (Feifel et al., 2010; 
Goldman et al., 2011), and fragile X syndrome (Hall et al., 2012). The similarity between the 
behavioral effects observed after intranasal administration of OT in humans and icv 
administration of OT in conditioned mice, as shown in the present thesis, increases the 
possibility that similar brain circuitries and molecular mechanisms underlie the social deficits 
found in patients and in social fear conditioned rodents. The social fear conditioning model 
might bring us closer to understanding the etiology of SAD, identifying the neural circuitries 
altered in SAD, the molecular mechanisms underlying this disorder, and hopefully more 
specific medication for SAD patients.  
The results described in this thesis demonstrate that the DLS and possibly CeA and 
hippocampus are important brain region mediating OT effects on social fear in rodents. To 
my knowledge, there are no human studies investigating the involvement of the septum or the 
hippocampus in social fear. Given the possibility of intranasal administration of OT in 
humans, my results provide a strong rationale for future studies to determine the involvement 
of these brain regions in social anxiety and fear in humans. 
In conclusion, with this thesis, I raised attention to the importance of the feared situation 
when recommending OT for the treatment of SAD and PTSD and to the implications of the 
time-point of OT administration in report to psychotherapy. I also tried to contribute to a 
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better understanding of the etiology of SAD by identifying alterations in the OT system that 
might serve as possible therapeutic targets for SAD. 
6.8.     Perspective for future studies 
The findings described in this thesis open up a number of additional research questions, which 
will lead to a better understanding of the etiology of SAD and PTSD and of the underlying 
mechanisms responsible for the differential effects of OT on social and cued fear. These 
future studies can be divided into the following sections: 
 Icv manipulation studies to further elucidate the effects of the OT system on social and 
cued fear 
Given that an activated OT system during cued fear conditioning attenuates fear learning in a 
non-social context (Figure 20), administration of OT and OTR-A before social fear 
conditioning would determine whether manipulation of the OT system might also affect fear 
learning in a social context. As blockade of fear consolidation attenuates subsequent fear 
expression, administration of OT and OTR-A immediately after social and cued fear 
conditioning would determine whether manipulation of the OT system affects fear 
consolidation in social and non-social contexts. Although OT impaired cued fear extinction 
when administered before the extinction procedure (Figure 21 and 22), administration of OT 
immediately after a short extinction procedure would determine whether OT facilitates the 
consolidation of extinction memory, and, thereby, might represent a relevant therapeutic 
approach in patients with PTSD due to non-social trauma.  
Given that OT reverses social fear starting from the first exposure to a social stimulus (Figure 
14), it is not clear whether OT impairs expression and/or recall of social fear, or completely 
erases the fear memory. Administration of OT 24 h after social fear conditioning, followed by 
the social fear extinction procedure 24 h later, would reveal whether OT erases the fear 
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memory. This approach would also reveal whether exposure to social stimuli is required for 
OT to reverse the social fear. Alternatively, OT might induce a rapid extinction of social fear 
as a result of social exposure, which might be observed only by analyzing multiple time bins 
in the first 3 min of exposure to a social stimulus.  
 OTR binding studies in socially- and cued-fear conditioned animals 
To compare the alterations at the level of the OT system in socially- and cued-fear 
conditioned animals, it would be important to perform a similar OTR binding study in the 
cued fear conditioning experiments as described in chapter 4. This study might reveal 
differential alterations in OTR expression induced by social and cued fear in brain regions 
involved in the fear circuitry, and might also identify additional brain regions that might 
mediate the effects of OT on cued fear. 
 Local manipulation studies to further elucidate the effects of the OT system on social and 
cued fear 
Given that the OT system has region-dependent effects on cued fear (section 6.5.; Figure 26), 
future studies should locally manipulate the OT system in the regions of interest revealed by 
the OTR binding study mentioned above, to further understand the modulatory effects of the 
OT system on cued fear. Additionally, local manipulations of the PL, IL, and BLA (Figure 
26) are needed to determine whether and how OT affects cued fear at the level of these brain 
regions. As OT administered icv and into the DLS before the extinction procedure has 
differential effects on social versus cued fear, it would be important to perform these local 
manipulations in both socially- and cued-fear conditioned animals. Similar to the icv 
manipulations mentioned above, it would be important to consider different time-points of 
local manipulation, i.e. before and after fear conditioning, and before fear extinction, to 
provide more detailed information about the role of these brain regions in mediating the 
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effects of OT on different stages of social and cued fear learning and memory, i.e. acquisition, 
consolidation, expression, and extinction. 
 OT release and signaling studies in socially- and cued-fear conditioned animals  
The significance of the OTR up-regulation in socially-fear conditioned mice is not clear so 
far, however, it might represent a compensatory mechanism for a decreased local OT release 
and, thus, extracellular availability, and/or for an impaired OTR signaling. Therefore, 
measuring and comparing OT release between unconditioned mice and conditioned mice 
before and after extinction of social fear in brain regions that mediate the effects of OT on 
social fear, such as those revealed in chapter 4, i.e. the DLS, and possibly the CeA, DG, and 
CA1, would provide important information about the extracellular availability of OT in social 
fear. A similar OT release study should be employed in the cued-fear conditioned animals in 
brain regions that mediate OT effects on cued fear, such as the LS, CeA, and DG (Figure 26), 
but also in brain regions revealed by the OTR binding and local manipulation studies 
mentioned above.  
Given the role of extracellular signal-regulated kinases (ERK) in learning and memory (Davis 
and Laroche, 2006), social behavior, and anxiety-related behavior (Satoh et al., 2011; Jurek et 
al., 2012), and the fact that OT has been shown to activate this pathway (Jurek et al., 2012), 
investigation of the c-Raf - MEK1/2 - ERK1/2 mitogen-activated protein kinase (MAPK) 
signaling cascade in relevant brain regions (see above) in conditioned mice might provide 
more detailed information about OTR signaling in social fear, and might explain the 
differences in OTR expression found in these mice. An interesting question that arises is 
whether OTR expression and signaling is differentially affected by social and cued fear, 
which might explain the differential behavioral effects of central OT on social and cued fear. 
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 Genetic and viral studies 
Although OTR knock-out mice do not show any alterations in social or cued fear when 
compared with OTR heterozygous or wild-type mice (Toth et al., unpublished), probably due 
to compensatory mechanisms, the use of OT knock-out mice for the social and cued fear 
conditioning experiments is appealing, given the effects of OT described in this thesis. It 
would be important to determine whether OT knock-out mice show altered social and cued 
fear learning and extinction, and whether these possible deficits might be rescued by icv and 
local OT. Given the possibility to up-regulate OTR expression by using the AAV-OTR-IRES-
Venus vector (Sato et al., 2009), it would be interesting to determine whether social fear 
might be induced in naïve mice by up-regulating OTR in the DLS, CeA, DG, and CA1, as 
OTR were up-regulated in these brain regions in conditioned mice. It would be also important 
to verify whether the alterations in social and cued fear learning and extinction which might 
be observed in OT knock-out mice might be rescued with this viral vector.  
 Studies to elucidate the effects on OT on different types of social fear 
A relevant aspect concerning OT effects on social fear is whether these effects depend on how 
social fear was acquired, and, thus, how severe the social fear is, i.e. fear of a specific 
individual and no additional behavioral deficits in the case of acute social defeat, fear of 
general social stimuli and no additional shot-term behavioral deficits in the case of social fear 
conditioning, and fear of general social stimuli and severe additional behavioral deficits in the 
case of chronic social defeat. Although icv administered OT reversed both acute social defeat- 
(Lukas et al., 2011) and social fear conditioning- (chapter 4) induced social fear, the effects of 
OT on chronic social defeat-induced social fear have not been assessed so far. The question 
arises whether treating the social fear might also improve general anxiety and depression 
symptoms observed in chronically social-defeated rodents. Furthermore, as the severity of 
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social fear increases, additional brain regions might be recruited to process the increasing 
amount of information and/or functional alterations might appear in an increasing number of 
brain regions involved in the fear circuitry. A comparative study between social fear induced 
by social fear conditioning, acute and chronic social defeat, implying icv and local 
manipulation of the OT system, assessment of OTR expression and signaling, as described 
above, would provide important information about the therapeutic potency of OT and the 
neurocircuitry involved and/or altered in social fear depending on the severity of symptoms.  
 Studies to further characterize the social fear conditioning paradigm 
Given that in SAD patients at least one other psychiatric disorder is present, and that SAD 
generally precedes all these disorders (see section 1.2.), it would be important to verify 
whether conditioned mice show additional behavioral deficits, such as increased general 
anxiety or depressive-like behavior, several weeks after social fear conditioning.  
Although conditioned mice show intense social fear, it is not clear so far which aspect(s) of 
the social stimulus, i.e. sight, smell, sound, movement, or all together, trigger(s) the fear 
response in these mice. Encaging the stimulus mice in sound- and smell-isolated transparent 
cages would reveal whether social fear is triggered by the sight of a con-specific. By using a 
con-specific odor, recordings of con-specifics, i.e. positive and/or negative ultrasound 
vocalizations (Knutson et al., 2002), or anesthetized mice as social stimuli, it could be 
revealed whether the smell, the sound, and/or the movement of a con-specific are/is necessary 
to trigger the fear response.  
Given that the social fear conditioning studies performed so far induced only male-male 
(chapter 2 and 4) and female-female (Figure 25) social fear, and that most SAD patients fear 
and avoid individuals of both sexes, future studies could investigate social fear in rodents 
conditioned to the opposite sex. These studies might also investigate the connection between 
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social fear and the reward system, given the sexually-motivated behaviors. Further studies 
might investigate the underlying mechanisms and treatment responses in rodents conditioned 
to the opposite sex.  
 Comparative studies between male and female rodents 
Given the sexual dimorphism of the OT system (Uhl-Bronner et al., 2005) and the fact that 
OT has been shown to reverse the acute social defeat-induced social fear in male (Lukas et al., 
2011), but not in female (Lukas et al., unpublished) rats, comparative social and cued fear 
conditioning studies between male and female rodents are appealing. These studies should 
imply icv and local manipulation of the OT system at different time-points during the 
conditioning procedure, assessment of OTR binding and signaling (see above), and would 
provide important information about the involvement of the OT system in social and cued fear 
in both sexes. 
 Studies on other possible targets to treat social and cued fear 
Additional therapeutic approaches in social and cued fear might involve manipulation of the 
AVP and corticotropin releasing hormone (CRH) systems. Administration of AVP receptor 
1b antagonists might prove relevant, given that OT and AVP often exert opposite effects on 
behavior (Roozendaal et al., 1992; Thompson and Walton, 2004), and that these antagonists 
have been shown to attenuate the chronic social defeat-induced social fear (Litvin et al., 
2011). Administration of CRH receptor type 1 antagonists might be relevant, since they have 
been shown to reduce the behavioral and endocrine responses to stressors (French et al., 2007; 
Ising and Holsboer, 2007), and to exert anxiolytic effects (Ising and Holsboer, 2007). 
Administration of NPS might also be interesting, since this neuropeptide has been shown to 
exert anxiolytic effects and to reduce fear responses by facilitating fear extinction and 
attenuating contextual fear (Pape et al., 2010).  
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AMN082 N,N'-dibenzyhydryl-ethane-1,2-diamine dihydrochloride 
ANOVA analysis of variance 
AVP  arginine vasopressin 
BA  basal amygdala 
BLA  basolateral amygdala 
BNST  bed nucleus of the stria terminalis 
C  conditioned mice 
CA  closed arms of the elevated plus-maze 
CA1  cornu ammunis 1 
CA3  cornu ammunis 3 
CC  cingulate cortex 
CeA  central amygdala 
CORT  corticosterone 
CRH  corticotropin releasing hormone 
CS  conditioned stimulus 
DG  dentate gyrus 
Dia  diazepam 
DLS  dorso-lateral septum 
dmPFC dorsal division of the medial prefrontal cortex 
DSM  Diagnostic and Statistical Manual of Mental Disorders 
EPM  elevated plus-maze 
ERK  extracellular signal-regulated kinase 
FST  forced swim test 
GABA  gamma-aminobutyric acid 
HPA  hypothalamic-pituitary-adrenal 
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i.e.   latin id est, meaning “that is” 
i.p.  intraperitoneal 
icv  intracerebroventricular 
IL  infralimbic cortex 
ITC  intercalated cell masses 
LA  lateral amygdala 
LS  lateral septum 
MAPK mitogen-activated protein kinase 
MeA  medial amygdala 
mPFC  medial prefrontal cortex 
MPOA medial preoptic area 
mRNA messenger ribonucleic acid  
n.a.  not analysed 
n.s.  not significant 
NAc  nucleus accumbens 
NPS  neuropeptide S 
ns  non-social stimulus 
NSI  non-social investigation 
OA  open arms of the elevated plus-maze 
OT  oxytocin 
OTR  oxytocin receptor 
OTR-A oxytocin receptor antagonist 
Par  paroxetine 
PET  positron emission tomography 
PL  prelimbic cortex 
PTSD  post-traumatic stress disorder 
PVN  paraventricular nucleus 
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s  social stimulus 
s.c.   subcutaneous 
SAD  social anxiety disorder 
SEM  standard error of the mean 
SI  social investigation 
SON   supraoptic nucleus 
SPECT single photon emission computed tomography 
SSRI  selective serotonin reuptake inhibitor 
UC  unconditioned mice 
US  unconditioned stimulus 
Veh  vehicle 
VLS  ventro-lateral septum 
vmPFC ventral division of the medial prefrontal cortex 
  
Acknowledgements 
I thank Prof. Dr. Inga Neumann for the opportunity to perform my research in her group, for 
the permanent support and scientific guidance that contributed not only to the quality of this 
thesis, but also to my personal and scientific development.  
I express my gratitude to my supervisor, Dr. David Slattery, for the excellent expertise, 
knowledge shared, and for all the encouragement and support he offered during my PhD 
thesis. I also thank David for the competent collaboration and for introducing me to the 
scientific field.  
Special thanks go to Dr. Michael Lukas for the helpful scientific discussions and statistical 
support. I also thank Michael and Prof. Dr. Alexa Veenema for their irreplaceable guidance 
during the initial steps in the lab that modeled my practical skills and experimental planning.  
I thank Rodrigue Maloumby, Gabriele Schindler, and Martina Fuchs for the great help with 
surgery, brain cutting, and receptor autoradiography.   
Special thanks go to the Bachelor/Master students Lena Bockreiß, Andreas Thuy, and Thomas 
Neder for excellent experimental assistance. 
Great thanks go to Christine Hübner, Young Rottermund, and Cornelia Besand for the patient 
and endless bureaucratic help.   
I thank my roommates Michael Lukas, Ben Jurek, Katharina Hillerer and all the members of 
the group, especially Manuela Bartlang, Stefanie Klampfl, and Doris Bayerl, for the friendly 
atmosphere in the lab and not only.     
Acknowledgements                       158  
 
 
I thank the senior scientists PD Dr. Stefan Reber, PD. Dr. Oliver Bosch, Dr. Erwin van den 
Burg, Dr. Daniela Beiderbeck, and Dr. Trynke de Jong for their kind advice and 
encouragement.  
Warm acknowledgements go to my family and friends for the mental support, positive 
thinking, and permanent encouragement.  
Finally, I would like to thank the Bayerische Forschungsstiftung (BFS) for the 3-year 
financial support.  
  
Curriculum Vitae  
Personal information 
 
Date of birth:         
Place of birth:   
Nationality:  












2002 – 2006  
 
 
1998 – 2002 
1994 – 1998 
1990 – 1994  
 PhD student in Neurobiology  
Department of Behavioral and Molecular Neurobiology, University 
of Regensburg. Supervisors: Prof. Dr. Inga Neumann, Dr. David 
Slattery 
M.Sc. in Experimental and Clinical Neurosciences (ECN) 
University of Regensburg. Master thesis: Role of oxytocin in social 
memory and social approach behavior in male C57BL/6 mice. 
Overall grade: 1.2 
B.Sc. in Biology 
Western University of Timisoara                 .                             
Overall grade: 9.75 (scale 5-10; 10 maximum) 
Colegiul National Banatean High-school, Timisoara 
Scoala Generala nr. 18 Gymnasium, Timisoara  
Nikolaus Lenau Elementary School, Timisoara 
Curriculum Vitae                       160  
 
 











2007 - 2009  
 
2005 - 2006 
2002 - 2005 
 Young Scientists Award - ECNP, Vienna, Austria 
EBBS Fellowship - Frontiers in Stress and Cognition: From 
Molecules to Behavior, Ascona, Switzerland 
Travel Award to ECNP Workshop on Neuropsychopharmacology, 
Nice, France 
Graduate Research Fellowship, Bayerische Forschungsstiftung 
(BFS), Germany  
Final Degree Award from University of Regensburg Alumni 
(Studienabschlusspreis der EsdUR), Germany  
Study Fellowship for Graduates, Deutscher Akademischer 
Austausch Dienst (DAAD), Germany 
Excellence Scholarship, Western University of Timisoara, Romania 
Merit Scholarship, Western University of Timisoara, Romania  
  
Publications 
Toth I, Neumann ID, Slattery DA (under review) Social fear conditioning as an animal model 
of social anxiety disorder. Invited manuscript to Current Protocols in Neuroscience 
Toth I, Neumann ID, Slattery DA (under review) Brain oxytocin in social fear conditioning 
and its extinction: involvement of the lateral septum. Biological Psychiatry 
Lukas M*, Toth I*, Veenema AH, Neumann ID (in press) Oxytocin mediates rodent social 
memory within the lateral septum and the medial amygdala depending on the relevance of the 
social stimulus: juvenile versus adult female. Psychoneuroendocrinology 
Toth I, Neumann ID, Slattery DA (2012) Central administration of oxytocin receptor ligands 
affects cued fear extinction in rats and mice in a time-point dependent manner. 
Psychopharmacology (Berl) 223(2):149-158 
Toth I, Neumann ID, Slattery DA (2012) Social fear conditioning: a novel and specific 
animal model to study social anxiety disorder. Neuropsychopharmacology 37(6):1433-1443 
Toth I, Dietz M, Peterlik D, Huber SE, Fendt M, Neumann ID, Flor PJ, Slattery DA (2011) 
Pharmacological interference with metabotropic glutamate receptor subtype 7 but not subtype 
5 differentially affects within- and between-session extinction of Pavlovian conditioned fear. 
Neuropharmacology 62(4):1619-1626 
Lukas M, Toth I, Reber SO, Slattery DA, Veenema AH, Neumann ID (2011) The 
neuropeptide oxytocin facilitates pro-social behavior and prevents social avoidance in rats and 
mice. Neuropsychopharmacology 36(11): 2159-2168 
* equal contribution to the manuscript 
 
